
<html lang="en"     class="pb-page"  data-request-id="3bda8908-60a8-44f4-89bc-a5bf29223d0a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2016.59.issue-2;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.5b01092;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents" /></meta><meta name="dc.Creator" content="Jaeki  Min" /></meta><meta name="dc.Creator" content="Kexiao  Guo" /></meta><meta name="dc.Creator" content="Praveen K.  Suryadevara" /></meta><meta name="dc.Creator" content="Fangyi  Zhu" /></meta><meta name="dc.Creator" content="Gloria  Holbrook" /></meta><meta name="dc.Creator" content="Yizhe  Chen" /></meta><meta name="dc.Creator" content="Clementine  Feau" /></meta><meta name="dc.Creator" content="Brandon M.  Young" /></meta><meta name="dc.Creator" content="Andrew  Lemoff" /></meta><meta name="dc.Creator" content="Michele C.  Connelly" /></meta><meta name="dc.Creator" content="Michael B.  Kastan" /></meta><meta name="dc.Creator" content="R. Kiplin  Guy" /></meta><meta name="dc.Description" content="We previously reported a novel inhibitor of the ataxia-telangiectasia mutated (ATM) kinase, which is a target for novel radiosensitizing drugs. While our initial lead, compound 4, was relatively po..." /></meta><meta name="Description" content="We previously reported a novel inhibitor of the ataxia-telangiectasia mutated (ATM) kinase, which is a target for novel radiosensitizing drugs. While our initial lead, compound 4, was relatively po..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 12, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01092" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01092" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01092" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01092" /></link>
        
    
    

<title>Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01092" /></meta><meta property="og:title" content="Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0007.jpeg" /></meta><meta property="og:description" content="We previously reported a novel inhibitor of the ataxia-telangiectasia mutated (ATM) kinase, which is a target for novel radiosensitizing drugs. While our initial lead, compound 4, was relatively potent and nontoxic, it exhibited poor stability to oxidative metabolism and relatively poor selectivity against other kinases. The current study focused on balancing potency and selectivity with metabolic stability through structural modification to the metabolized site on the quinazoline core. We performed extensive structure–activity and structure–property relationship studies on this quinazoline ATM kinase inhibitor in order to identify structural variants with enhanced selectivity and metabolic stability. We show that, while the C-7-methoxy group is essential for potency, replacing the C-6-methoxy group considerably improves metabolic stability without affecting potency. Promising analogues 20, 27g, and 27n were selected based on in vitro pharmacology and evaluated in murine pharmacokinetic and tolerability studies. Compound 27g possessed significantly improve pharmacokinetics relative to that of 4. Compound 27g was also significantly more selective against other kinases than 4. Therefore, 27g is a good candidate for further development as a potential radiosensitizer." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="We previously reported a novel inhibitor of the ataxia-telangiectasia mutated (ATM) kinase, which is a target for novel radiosensitizing drugs. While our initial lead, compound 4, was relatively potent and nontoxic, it exhibited poor stability to oxidative metabolism and relatively poor selectivity against other kinases. The current study focused on balancing potency and selectivity with metabolic stability through structural modification to the metabolized site on the quinazoline core. We performed extensive structure–activity and structure–property relationship studies on this quinazoline ATM kinase inhibitor in order to identify structural variants with enhanced selectivity and metabolic stability. We show that, while the C-7-methoxy group is essential for potency, replacing the C-6-methoxy group considerably improves metabolic stability without affecting potency. Promising analogues 20, 27g, and 27n were selected based on in vitro pharmacology and evaluated in murine pharmacokinetic and tolerability studies. Compound 27g possessed significantly improve pharmacokinetics relative to that of 4. Compound 27g was also significantly more selective against other kinases than 4. Therefore, 27g is a good candidate for further development as a potential radiosensitizer." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0007.jpeg" /></meta><meta name="twitter:title" content="Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01092"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01092">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01092&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01092&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01092&amp;href=/doi/10.1021/acs.jmedchem.5b01092" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 559-577</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01089" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01153" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jaeki++Min">Jaeki Min</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kexiao++Guo">Kexiao Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Praveen+K.++Suryadevara">Praveen K. Suryadevara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fangyi++Zhu">Fangyi Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gloria++Holbrook">Gloria Holbrook</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yizhe++Chen">Yizhe Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clementine++Feau">Clementine Feau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brandon+M.++Young">Brandon M. Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Lemoff">Andrew Lemoff</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele+C.++Connelly">Michele C. Connelly</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+B.++Kastan">Michael B. Kastan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=R.+Kiplin++Guy">R. Kiplin Guy</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff4"><span class="aff-text"><sup>†</sup>Department of Chemical Biology and Therapeutics, <sup>‡</sup>Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#ddb6b4adf3baa8a49daea9b7a8b9b8f3b2afba"><span class="__cf_email__" data-cfemail="73181a035d14060a330007190617165d1c0114">[email protected]</span></a>. Phone: 901-595-5714. Fax: 901-595-5715.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01092&amp;href=/doi/10.1021%2Facs.jmedchem.5b01092" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 559–577</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 3, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 July 2015</li><li><span class="item_label"><b>Published</b> online</span>12 January 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 January 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01092" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01092</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D559%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJaeki%2BMin%252C%2BKexiao%2BGuo%252C%2BPraveen%2BK.%2BSuryadevara%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D2%26contentID%3Dacs.jmedchem.5b01092%26title%3DOptimization%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BAtaxia-Telangiectasia%2BMutated%2BKinase%2BInhibitors%2Bas%2BPotential%2BRadiosensitizing%2BAgents%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D577%26publicationDate%3DJanuary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01092"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2920</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01092" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jaeki&quot;,&quot;last_name&quot;:&quot;Min&quot;},{&quot;first_name&quot;:&quot;Kexiao&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Praveen&quot;,&quot;last_name&quot;:&quot;K. Suryadevara&quot;},{&quot;first_name&quot;:&quot;Fangyi&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Gloria&quot;,&quot;last_name&quot;:&quot;Holbrook&quot;},{&quot;first_name&quot;:&quot;Yizhe&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Clementine&quot;,&quot;last_name&quot;:&quot;Feau&quot;},{&quot;first_name&quot;:&quot;Brandon&quot;,&quot;last_name&quot;:&quot;M. Young&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Lemoff&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;C. Connelly&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;B. Kastan&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Kiplin Guy&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;559-577&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01092&quot;},&quot;abstract&quot;:&quot;We previously reported a novel inhibitor of the ataxia-telangiectasia mutated (ATM) kinase, which is a target for novel radiosensitizing drugs. While our initial lead, compound 4, was relatively potent and nontoxic, it exhibited poor stability to oxidative metabolism and relatively poor selectivity against other kinases. The current study focused on balancing potency and selectivity with metabolic stability through structural modification to the metabolized site on the quinazoline core. We performed extensive structure–activity and structure–property relationship studies on this quinazoline ATM kinase inhibitor in order to identify structural variants with enhanced selectivity and metabolic stability. We show that, while the C-7-methoxy group is essential for potency, replacing the C-6-methoxy group considerably improves metabolic stability without affecting potency. Promising analogues 20, 27g, and 27n were selected based on in vitro pharmacology and evaluated in murine pharmacokinetic and tolerability studi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01092&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01092" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01092&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01092" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01092&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01092" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01092&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01092&amp;href=/doi/10.1021/acs.jmedchem.5b01092" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01092" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01092" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01092%26sid%3Dliteratum%253Aachs%26pmid%3D26632965%26genre%3Darticle%26aulast%3DMin%26date%3D2016%26atitle%3DOptimization%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BAtaxia-Telangiectasia%2BMutated%2BKinase%2BInhibitors%2Bas%2BPotential%2BRadiosensitizing%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D2%26spage%3D559%26epage%3D577%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292593" title="Liquid chromatography-mass spectrometry">Liquid chromatography-mass spectrometry</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/2" title="Go to Volume 59, Issue 2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/jmcmar.2016.59.issue-2/20160128/jmcmar.2016.59.issue-2.largecover.jpg" alt="Go to Volume 59, Issue 2"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We previously reported a novel inhibitor of the ataxia-telangiectasia mutated (ATM) kinase, which is a target for novel radiosensitizing drugs. While our initial lead, compound <b>4</b>, was relatively potent and nontoxic, it exhibited poor stability to oxidative metabolism and relatively poor selectivity against other kinases. The current study focused on balancing potency and selectivity with metabolic stability through structural modification to the metabolized site on the quinazoline core. We performed extensive structure–activity and structure–property relationship studies on this quinazoline ATM kinase inhibitor in order to identify structural variants with enhanced selectivity and metabolic stability. We show that, while the C-7-methoxy group is essential for potency, replacing the C-6-methoxy group considerably improves metabolic stability without affecting potency. Promising analogues <b>20</b>, <b>27g</b>, and <b>27n</b> were selected based on in vitro pharmacology and evaluated in murine pharmacokinetic and tolerability studies. Compound <b>27g</b> possessed significantly improve pharmacokinetics relative to that of <b>4</b>. Compound <b>27g</b> was also significantly more selective against other kinases than <b>4</b>. Therefore, <b>27g</b> is a good candidate for further development as a potential radiosensitizer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02842" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02842" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ATM kinase, a member of the phosphatidylinositol 3-kinase (PI3K)-related kinase (PIKK) family,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> plays a central role in maintaining genome integrity by regulating the detection and repair of DNA double-strand breaks (DSBs).<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> Unattended DSBs can lead to cell death, genomic instability, and tumorigenesis.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> The genetic disorder ataxia-telangiectasia (A-T), which results from mutations in the ATM gene, is characterized by genome instability, cerebral and thymic degeneration, immunodeficiency, radiosensitivity, and predisposition to cancer.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Cells derived from A-T patients show abnormal cell cycle arrest in G<sub>1</sub>, S, and G<sub>2</sub> phases; increased chromosomal breakage; and hypersensitivity to ionizing radiation and radiomimetic drugs. Loss of ATM kinase activity by gene mutation, small molecule inhibition, or gene expression downregulation causes significant increases in the sensitivity of virtually every cell type to clinically relevant doses of irradiation, making the ATM kinase an attractive target for clinical radiosensitization.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a></div><div class="NLM_p">ATM exists as an inactive dimer in unstressed cells. In response to ionizing radiation (IR) or other treatments that introduce DSBs, ATM kinase is rapidly activated by intermolecular autophosphorylation of ATM serine 1981, leading to dimer dissociation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Activated ATM then phosphorylates a series of downstream substrates that regulate IR-induced cell cycle arrest in G<sub>1</sub> phase (e.g., p53, Mdm2, and CHK2), S phase (e.g., NBS1, Smc1, BRCA1, and FancD2), and G<sub>2</sub> phase (e.g., BRCA1 and Rad17).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> ATM phosphorylation of these and other targets enables optimal cellular response to DNA damage, while blockade of this signaling pathway by ATM inhibition results in significant radiosensitization.<a onclick="showRef(event, 'ref10 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref13 ref14">(10, 13, 14)</a></div><div class="NLM_p">Locally applied radiotherapy is a key component of treatment for a large percentage of cancers, but its efficacy can be limited by toxicity to normal tissues or resistance from tumor cells.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Systemic administration of an effective sensitizer can complement radiotherapy by either lowering the dose of radiation needed to achieve a therapeutic effect or enhancing efficacy toward resistant tumors. Since external beam radiation therapy is typically delivered locally to tumor sites in 1–2 Gy dose daily fractions over a period of weeks, the ideal radiosensitizer would possess a pharmacokinetic (PK) profile amenable to daily administration in conjunction with standard radiation dosing. Additionally, it must quickly yield efficacious drug concentrations in tissue, maintain exposure for several hours, and then rapidly clear from the body. To speed onset and reduce absorption-induced variability, parenteral dosing is preferred, but oral dosing could also be effective if absorption kinetics were predictable and relatively uniform.</div><div class="NLM_p">Only a handful of ATM inhibitors have been reported to date (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The well-known nonspecific kinase inhibitors wortmannin and caffeine inhibit ATM, but they are not particularly useful either as pharmacological probes or as leads for drug development due to poor selectivity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Compound <b>1</b> (KU55933),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> a relatively selective ATM inhibitor developed by Kudos Pharmaceuticals, was shown to sensitize human cancer cells to IR, but it lacked oral bioavailability. Optimization of <b>1</b> led to the second-generation compound <b>2</b> (KU60019)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> with a 10-fold better potency and oral availability. These compounds were effective in blocking the radiation-induced phosphorylation of key ATM targets in cells in vitro.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> However, these two inhibitors have not progressed into the clinic, likely due to challenges with their potency and pharmacological properties. Recently, compound <b>3</b> (NVP-BEZ235),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> a PI3K/mTOR inhibitor currently in Phase I clinical trials, was reported to be an inhibitor of ATM and DNA-dependent protein kinase catalytic subunit (DNA-PKcs), thus blocking both nonhomologous end joining and homologous recombination, the two major pathways of DSB repair. However, this compound is not progressing in clinical development because of toxicity and poor efficacy. The lack of a clinically viable ATM inhibitor at this time creates a need to develop alternate inhibitors with improved pharmacological and biological characteristics.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative ATM inhibitors. The median potency (IC<sub>50</sub>) of the inhibitors is shown, measured using either the in vitro kinase assay (biochemical) or the in-cell western assay (cellular).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We recently reported a reasonably potent and moderately selective ATM inhibitor <b>4</b> (CP466722),<a onclick="showRef(event, 'ref14 ref22'); return false;" href="javascript:void(0);" class="ref ref14 ref22">(14, 22)</a> which was identified through screening of a Pfizer kinase inhibitor collection. This novel quinazoline inhibitor blocked ATM activity in cellular assays with an IC<sub>50</sub> of 370 nM, equivalent to the first-generation Kudos Pharmaceuticals compound, <b>1</b>, and roughly 5-fold less potent against cells than the second-generation compound, <b>2</b>. We pursued a hit-to-lead process, including in vivo PK and pharmacodynamics (PD) studies to determine if the series could offer advantages over the other two existing ATM inhibitors.</div><div class="NLM_p">To define the time scale on which <b>4</b> works in cells and thus define the desired exposure curve in vivo, cellular PD experiments were performed. HeLa cells were exposed to IR in the presence of varying concentrations of <b>4</b>, and the phosphorylation of ATM substrates was monitored over time. We found that compound <b>4</b> is a reversible inhibitor of ATM that rapidly reaches maximal cellular effect, with 4 h or less of treatment duration being sufficient to enhance the IR sensitivity of HeLa cells. Importantly, clonogenic survival assays with IR-treated cells from A-T patients do not show much difference in the presence or absence of <b>4</b>, suggesting that the radiosensitization was, in fact, due to ATM inhibition and not an off-target effect.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Below, we describe detailed structure–activity and structure–property relationship studies (<a class="ref internalNav" href="#fig3" aria-label="Figure 2">Figure 2</a>) for this lead series. Overall, we maintained potency against ATM while significantly improving the metabolic stability of the series, making them suitable candidates for development into radiosensitizing drugs.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Outline of lead optimization studies of compound <b>4</b> presented herein, indicating positions varied in the studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The general route used to synthesize most target compounds involved the condensation of 4-chloroquinazoline <b>11</b> with triazole <b>14</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Compound <b>11</b> was synthesized from its 3,4-disubstituted benzoate ester precursor <b>8</b> in four steps. Nitration of <b>8</b> using HNO<sub>3</sub> and AcOH at 50 °C afforded the nitrobenzoate in 92% average yield. The nitro group was then reduced to the corresponding amine <b>9</b> using one of two methods: (1) FeCl<sub>3</sub> and AcOH or (2) catalytic hydrogenation. Both methods gave an average 90% yield. The quinazoline ring was then installed by condensing amine <b>9</b> with formamide at 190 °C with 80% average yield. Heating compound <b>10</b> in excess thionyl chloride afforded 4-chloro quinazoline <b>11</b> in 95% yield. The other intermediate <b>14</b> was synthesized in one pot by condensing 2-picolinic acid <b>12</b> and amino guanidine sulfate <b>13</b> at an elevated temperature with a quantitative yield.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> The nucleophilic displacement of chlorine in compound <b>11</b> by the most nucleophilic nitrogen on the triazole ring of <b>14</b> proceeded in the presence of Cs<sub>2</sub>CO<sub>3</sub> in DMF at 100–130 °C and produced the target compounds in variable yields (50–85%).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0015.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Route for the Synthesis of Substituted Triazol <b>14</b> and Quinazoline Derivatives <b>15</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 70% HNO<sub>3</sub>, AcOH, 50 °C, 3 h, 91–94%; (b) Fe/FeCl<sub>3</sub>, AcOH, EtOH, H<sub>2</sub>O, or H<sub>2</sub>Pd–C, MeOH, 80 °C, 90%; (c) NH<sub>2</sub>CHO, 190 °C, 75–86%; (d) SOCl<sub>2</sub>, catalytic DMF, 85 °C, 95%; (e) substituted 1,2,4-triazol-5-amines, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 50–85%; (f) reflux/Wood’s metal bath, 210 °C, 2 h, quant.</p></p></figure><div class="NLM_p">Modifications at the C-6 and C-7 positions to produce compounds <b>15</b>–<b>19</b> required the synthesis of alternate versions of intermediate <b>11</b> from commercially available precursors <b>8</b>, as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Introducing either electron-withdrawing groups or an amine at C-6 or C-7 lowered the synthetic yields. The target intermediate for <b>19</b> was obtained from the etherification of 6,7-dihydroxy-4-chloro quinazoline with bromomethylcyclopropane in the presence of potassium carbonate. Compound <b>20</b> was synthesized from commercially available chloroquinazoline intermediate <b>11</b>, as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. A set of varied lipophilic and hydrophobic groups <b>22a</b>–<b>j</b> were introduced at the C-2 position of the quinazoline core from the commercially available quinazoline <b>21</b> and triazole <b>14</b>, as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Compounds <b>22a</b>, <b>g</b>, and <b>h</b> were synthesized from their commercially available precursors <b>21a</b>, <b>g</b>, and <b>h</b>, respectively. Alkyl amines <b>22b</b>–<b>e</b> were produced by heating compound <b>21a</b> in NMP in the presence of the corresponding amine at 140 °C. Hydrolysis of <b>22e</b> in the presence of lithium peroxide afforded acid <b>22f</b> in moderate yields. The precursor 4-chloro-6,7-dimethoxyquinazolin-2-amine <b>21j</b> was prepared from 2-amino-4,5-dimethoxy benzoate and cyanamide as described in the literature.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0016.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of C-2-Substituted Quinazolines <b>22a</b>–<b>j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 6 h, 61%; (b) morpholine (for <b>22b</b>), <i>N</i>-methyl piperizine (for <b>22c</b>), 2-(piperazine-1-yl) ethanol (for <b>22d</b>), or ethyl-2-amino acetate·HCl (for <b>22e</b>), NMP, 140 °C, 4 h, 52–70%, diethylamine, <i>i</i>-PrOH, 4 M HCl/dioxane, microwave, 160 °C, 10 min, 55% (for <b>22i</b>); (c) Li<sub>2</sub>O<sub>2</sub>, MeOH/H<sub>2</sub>O (3:1), 40 min, rt, 45% (for <b>22f</b>).</p></p></figure><div class="NLM_p">Compounds <b>23a</b>–<b>k</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) were prepared by coupling of commercially available amines, anilines (<b>23a</b>–<b>c</b>), and several synthetic triazole fragments (<b>23d</b>–<b>k</b>) with 4-chloroquinazole intermediate <b>11g</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The synthesis of alternate triazole fragments was completed for each using the commercially available carboxylic acids as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Compounds <b>24a</b>–<b>f</b> were synthesized from commercially available intermediates <b>11a</b>, <b>b</b>, <b>e</b>, and <b>f</b> following a published procedure (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Compounds <b>24b</b> and <b>24d</b> were prepared from <b>24a</b> and <b>24c</b> by catalytic hydrogenation.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0017.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>23a</b>–<b>k</b> and <b>24a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amines, anilines, or substituted triazoles, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90–130 °C, 6–16 h, 46–75%; (b) <b>14</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 6 h, 65–75%; (c) 10% Pd–C/MeOH, 80–85%.</p></p></figure><div class="NLM_p">Introducing hydrophobic side chains at C-6 was accomplished using the route shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> to afford compounds <b>27a</b>–<b>s</b>. Quinazoline <b>25</b> was synthesized from commercially available 6,7-dimethoxy-4-quinolone as described in the literature.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> In general, the reaction of <b>25</b> with the corresponding alcohols under Mitsunobu conditions provided intermediates <b>26d</b>, <b>26e</b>, and <b>26g</b>, and its reaction with halogenated chains using inorganic base produced other intermediates <b>26a</b>–<b>c</b>, <b>26f</b>, and <b>26h</b>–<b>o</b>. Subsequent nucleophilic displacement of <b>14</b> afforded the target compounds in moderate to good yields.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0018.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthesis of Compounds <b>27a</b>–<b>s</b> Containing Linkers at the C-6 Position<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) substituted alcohols (correspond to <b>27d</b>, <b>27e</b>, and <b>27g</b>), DTAD, TPP, DCM, 0 °C to rt, 55–70%; (b) substituted alkyl halides (correspond to <b>27a–c</b>,<b> 27f</b>, and <b>27h</b>–<b>o</b>), K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 70–75%; (c) <b>14</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 6–8 h, 50–65%; (d) HCl/THF, rt, 1 h, 95%; (e) substituted chloroformates (for <b>27p</b>–<b>r</b>) or CF<sub>3</sub>C(O)Cl (for <b>27s</b>), TEA/DCM, 0 °C to rt, overnight, 70–85%.</p></p></figure><div class="NLM_p">Compound <b>27i</b> was synthesized from <b>25</b> as described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Compound <b>25</b> was treated with <i>N</i>-(3-chloropropyl)-2-((2<i>S</i>,6<i>R</i>)-2,6-dimethylmorpholino)acetamide<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><b>34</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Scheme S2</a>) using potassium carbonate in DMF to prepare <b>26i</b> with 58% yield, which was further treated with <b>14</b> to afford compound <b>27i</b> in 54% overall yield.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0019.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route for the Preparation of Compound <b>27i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>34</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 4 h, 62%; (b) <b>14</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 4 h, 54%.</p></p></figure><div class="NLM_p">A series of carbamates<b>27j</b>–<b>o</b> was prepared from chlorinated propyl carbamate intermediates available either commercially or synthetically (<b>30m</b>–<b>o</b>; <a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Scheme S1</a>) coupled with <b>25</b>, as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Other C-6 linker analogues <b>27p</b>–<b>s</b> were synthesized from key intermediate <b>26j</b> by introducing new substituted chloroformates or a trifluororacetyl group after deprotection of the Boc group (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><div class="NLM_p last">All of the compounds used in the studies described below were purified by reverse-phase preparative HPLC to greater than 95% purity prior to biological studies. Identity was confirmed by both LC-MS and proton NMR analysis. Purity was confirmed by parallel LC-MS/ELSD/CLND, with reported purities calculated as the average by all spectral methods.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compounds were formulated as stock solutions in DMSO with the concentrations being confirmed by CLND analysis.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro ADME and Pharmacokinetic Study</h3><div class="NLM_p">Preliminary assessment of the physiochemical properties and membrane permeability of compound <b>4</b> revealed reasonable solubility in PBS (20 μM), reasonable permeability (100 × 10<sup>–6</sup> cm/s), and good stability in aqueous buffers (<i>t</i><sub>1/2</sub> > 48 h). Intravenous administration of compound <b>4</b> to mice at 10 and 20 mg/kg doses was well-tolerated (<a class="ref internalNav" href="#fig4" aria-label="Figure 3">Figure 3</a>). Even though the peak plasma concentration was reached at 5 min with a maximal concentration of 4 μM, 1.4-fold higher than the cellular IC<sub>90</sub>, the total clearance was high (CL = 160 mL/h, <i>t</i><sub>1/2</sub> = 1 h at 10 mg/kg). In order to determine what drives the rapid clearance of <b>4</b>, in vitro metabolic stability was measured using mouse, rat, dog, and human liver microsome models (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Compound <b>4</b> displayed rapid clearance in these models (mouse, <i>t</i><sub>1/2</sub> = 0.9 h; CL<sub>int</sub> = 61.7 mL/min/kg body weight), which correlated well with the PK data. Compound <b>4</b> was well-distributed into the majority of mouse organs (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Table S2</a>). Most organs had significantly higher peak levels and slower clearance than plasma.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacokinetics of compounds <b>4</b>, <b>20</b>, and <b>27g</b> observed during in vivo murine dose ranging studies by the intravenous route. Graph shows plasma concentrations of parent molecule versus time after dosing. Each compound (20 mg/kg) was dissolved in 5% DMSO with a final formulation of 5:45:50 (v/v/v) EtOH/PPG/PBS (pH 7.4) and HβCD (10 mM) and was dosed via tail vein injection. At 5, 15, and 30 min and 1, 4, 24, and 48 h, blood was taken and plasma was analyzed by LC-MS. Concentrations of all three compounds vs time were plotted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the quinazoline methoxy group could be a susceptible metabolic site,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> we evaluated the metabolic stability of <b>4</b> and identified the Phase I and II metabolites (<a class="ref internalNav" href="#fig2" aria-label="Figure 4">Figure 4</a>) through PK studies in mice using qualitative tandem mass spectrometry methods. The observed major metabolite <b>6</b> was generated by demethylation of one of the methoxy groups (C-6-methoxy). The minor metabolite <b>5</b> resulted from the loss of both methyl groups from the methoxys and a subsequent hydroxylation of the adjacent ring. The observed major Phase II metabolite <b>7</b> was the glucoronide of the phenol (<b>6</b>). To confirm their structures, the putative metabolites were synthesized (<b>24b</b>) and compared to the samples (<b>6</b>) obtained from the metabolism experiments. These experiments clearly supported the hypothesis that the initial demethylation step occurs at the C-6-methoxy and suggest that this moiety should be modified to reduce demethylation.</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Observed in vivo metabolism of compound <b>4</b>. Three metabolites were identified: phase I metabolites <b>5</b> and <b>6</b> and phase II metabolite <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of these observations, our primary goal became to decrease inhibitor clearance by roughly 4-fold while maintaining the volume of distribution. To identify a compound with these desired PK/PD properties, we sought replacements for the methyl of the C-6-methoxy group (<a class="ref internalNav" href="#fig2" aria-label="Figure 4">Figure 4</a>; R<sup>2</sup>) that could block the vulnerable metabolic site but maintain or improve potency.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationship (SAR)</h3><div class="NLM_p">To establish the SAR and optimize the potency and oral bioavailability, compound <b>4</b> was divided into four segments (A–D rings). We primarily focused our modifications on the B and D rings (<a class="ref internalNav" href="#fig2" aria-label="Figure 4">Figure 4</a>). Individual compounds were purified to better than 95% purity as confirmed by UPLC-MS and <sup>1</sup>H NMR. Each compound was tested for ATM inhibition using a cell-based assay that we developed.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> All inhibitory potencies are reported as IC<sub>50</sub> values representing the mean of two independent assays, each of which was run with internal triplicates for a total of six replicates (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In order to provide a broader assessment of cytotoxicity, all compounds were also tested for growth inhibitory activity against four mammalian cell lines (HEK293, HepG2, Raji, and BJ; <a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Table S3</a>), and solubility and permeability data were generated to aid in the interpretation of SAR.</div><div class="NLM_p">Given the in vivo metabolism of <b>4</b>, we explored SAR for possible replacements of the methoxy groups at the C-6,7 positions (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Complete deletion of methoxy groups (<b>15a</b>–<b>d</b>) or the introduction of a chloride (<b>15e</b>–<b>h</b>) at one of these methoxy sites strongly diminished activity. Replacement of both methoxy groups with fluorine (<b>16</b>) or a bridging ethylenedioxy group (<b>17</b>) also abrogated activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Exploration of the B Ring Modified at C-6,7 Positions for Compounds <b>15a</b>–<b>20</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0020.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0021.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values are means of three independent experiments, each run in triplicate.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Values are means of two independent experiments, each run in triplicate.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">ND, not determined.</p></div></div><div></div></div><div class="NLM_p">Due to the importance of the C-6 group in metabolism, a number of other substitutions were attempted. Translocation of the nitrogen in the pyridine ring from the 2-position to the 3- or 4-position (<b>18a</b>–<b>b</b>) caused strong or moderate decreases in potency, respectively. This suggests that the role of the nitrogen is not simply solvation; it may also contribute to an electrostatic interaction or to the conformation of the molecule by enforcing interactions between the C and D rings. Replacement of the pyridyl group with a phenyl ring (<b>18c</b>) showed a moderate decrease in potency, whereas further substituents at the <i>para</i> position (<b>18d</b> and <b>18e</b>) or saturated ring systems (<b>18f</b>) diminished activity. Replacement of C-6-methoxy with a bulkier ether was also counterproductive (<b>19</b>). Surprisingly, the methyl group at the C-6 position could be replaced productively with a longer, linear, and more flexible side chain that incorporated a second oxygen atom (<b>20</b>). In summary, most changes to the major site of metabolism (C-6-methoxy) abolished or strongly attenuated activity. Likewise, most changes to the pyridyl ring strongly attenuated activity.</div><div class="NLM_p">On the basis of precedent from other structurally similar kinase inhibitors, we attempted to introduce several additional substituents to the C-2 position of the quinazoline (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). All of the changes significantly reduced potency (<b>22a</b>–<b>j</b>), with most abolishing activity. Only small groups, such as methyl (<b>22h</b>) and amine (<b>22j</b>), were tolerated. Notably, replacement of the proton with an NH<sub>2</sub> group (<b>22j</b>) was fairly well-tolerated.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Exploration of the A Ring Modified at the C-2 Position for Compounds <b>22a</b>–<b>j</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0022.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0023.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Values are means of three independent experiments, each run in triplicate.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Values are means of two independent experiments, each run in triplicate.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">DL, detection limit.</p></div></div><div></div></div><div class="NLM_p">We further analyzed the role of the C and D rings in defining the core pharmacophore, as discussed in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> (<b>23a</b>–<b>k</b>). Modification of a two-ring pyridyltriazole to single rings, such as pyridyl amines (<b>23a</b>–<b>b</b>), led to a complete loss of activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Replacement of the triazole C ring with a phenyl (<b>23c</b>) led to a significant loss in potency (IC<sub>50</sub> = 13 μM) as well as diminished solubility. Likewise, removal of the amino group from the triazole (<b>23d</b>–<b>e</b>) led to a loss in potency. These findings suggest that the nitrogens either form a hydrogen bond within the binding pocket or intramolecularly enforce the inhibitor conformation. The replacement of the central triazole with pyrazole (<b>23f</b>) caused only a moderate decrease in potency but led to poor solubility. Replacement of the pyridyl ring in this context with a phenyl or substituted phenyl derivatives led to a dramatic or complete loss of activity (<b>23g</b>–<b>i</b>). However, movement of the pyridyl ring from the C-3 to the C-4 position on pyrazole was tolerated (<b>23j</b>). As expected, deletion of the pyridyl ring (<b>23k</b>) abolished activity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Analysis of Modification to the C and D Rings for Compounds <b>23a</b>–<b>k</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0001.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0002.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Values are means of three independent experiments, each run in triplicate.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Values are means of two independent experiments, each run in triplicate.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">ND, not determined.</p></div></div><div></div></div><div class="NLM_p">On the basis of the preliminary SAR study, replacing the methoxy groups at C-6 and C-7 with other functional groups was expected to abrogate activity. To understand which methoxy group is more critical for potency, O-benzylated or demethylated derivatives <b>24a</b>–<b>f</b> were synthesized and tested, with the expectation that either modification would be detrimental if the individual methoxy group was critical. Changes made to the C-7 methoxy resulted in much stronger effects on inhibitory potency than those made to C-6 (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). For example, compound <b>24e</b> is 20-fold more potent than <b>24f</b>. This observation was consistent with prior SAR data (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) for this series and suggests that a compound with a C-7 methoxy and variant substitution at the C-6 position could maintain potency and exhibit better in vivo stability. Therefore, a systematic SAR study was undertaken to investigate the effect of C-6 substitutions on overall potency (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Selected Modifications of the B Ring for Compounds <b>24a</b>–<b>f</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0003.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0004.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Values are means of three independent experiments, each run in triplicate.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Values are means of two independent experiments, each run in triplicate.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Further SAR Studies of Substituents at C-6 for Compounds <b>27a</b>–<b>s</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0005.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0006.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Values are means of three independent experiments, each run in triplicate.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Values are means of two independent experiments, each run in triplicate.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">ND, not determined.</p></div></div><div></div></div><div class="NLM_p">Introducing a propyl-<i>N</i>,<i>N</i>-dimethylaminoether at the C-6 position (<b>27a</b>) reduced potency (IC<sub>50</sub> = 7 μM). Other modifications of the amine, including replacement of the methyl groups with isopropyl groups (<b>27b</b>) or introduction of cyclic amines such as piperidine, pyrrolidine, and morpholine (<b>27c</b>–<b>f</b>), maintained potency at roughly the same level with less than 3-fold variation. Interestingly, introducing a 2-methoxy ethoxy group at the C-6 position increased overall potency (<b>27g</b>) compared to that of other substituted alkyl amine linkers (<b>27a</b>–<b>f</b>). Subsequent studies focused on longer substituents (<b>27i</b>–<b>s</b>). Compound <b>27j</b>, which has a 3-carbon chain capped with a bulky carbamate, displayed improved potency. However, it showed undesirable PK properties including poor solubility and a short half-life based on a microsomal stability study (data not shown). The majority of other linker analogues in the series maintained a potency of roughly 1 μM, regardless of substitution patterns. The only notable exceptions to this were the phenyl carbamate and <i>n</i>-pentylcarbamate, both of which were significantly less potent. On the basis of ATM inhibition activity and physicochemical property data on a total of 71 synthetic analogues, compounds <b>20</b>, <b>27g</b>, and <b>27n</b> were selected as promising candidates for further evaluation.</div><div class="NLM_p">We next tested the in vitro pharmacological parameters (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>), including permeability, solubility, and stability in biological media, for the top three candidates and the original hit compound <b>4</b> in order to identify the most suitable candidate for in vivo studies. All three new compounds had reasonable solubility (8–30 μM), although it was somewhat reduced for compounds <b>27g</b> and <b>27n</b>. All four compounds also had reasonable permeability (17 × 10<sup>–6</sup> to 430 × 10<sup>–6</sup> cm/s), although it was better for compounds <b>27g</b> and <b>27n</b>. Therefore, no new issues with physiochemistry had arisen during lead optimization. All three new compounds were reasonably stable in buffer and plasma (>24 h), so no intrinsic stability issues were expected. Likewise, all three new compounds were generally not tightly protein bound (with the exception of <b>20</b> by human plasma proteins). The critical discriminator between the compounds was predicted oxidative stability, which was measured using microsomal models for mouse, rat, dog, and human. Compound <b>27g</b> had significantly better oxidative stability (<i>t</i><sub>1/2</sub>, 2.0 h; CL<sub>int</sub>, 27.1 mL/min/kg for the mouse and >4 h/<12 mL/min/kg for all other species). Compound <b>20</b> also exhibited improved liver microsomal stability in rat, mouse, and dog models, but it displayed reduced stability in human microsomes. All compounds showed potential for saturation of liver metabolism, as evidenced by increased stability at high concentrations (20 μM; <a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Table S6</a>) relative to that at low concentrations (0.8 μM; <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) in the microsomal models.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Pharmacology of Selected ATM Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">in vitro properties</th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>20</b></th><th class="colsep0 rowsep0" align="center"><b>27g</b></th><th class="colsep0 rowsep0" align="center"><b>27n</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (μM)</td><td class="colsep0 rowsep0" align="left">pH 7.4</td><td class="colsep0 rowsep0" align="left">28.8</td><td class="colsep0 rowsep0" align="left">30.1</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">permeability (10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="left">pH 7.4</td><td class="colsep0 rowsep0" align="left">95.9</td><td class="colsep0 rowsep0" align="left">16.6</td><td class="colsep0 rowsep0" align="left">196.3</td><td class="colsep0 rowsep0" align="left">432.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">liver microsome stability <i>t</i><sub>1/2</sub> (h)/CL<sub>int</sub> (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">0.9/61.7</td><td class="colsep0 rowsep0" align="left">2.4/22.9</td><td class="colsep0 rowsep0" align="left">2.0/27.1</td><td class="colsep0 rowsep0" align="left">0.2/329.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">0.8/57.8</td><td class="colsep0 rowsep0" align="left">>4.0/<11.7</td><td class="colsep0 rowsep0" align="left">>4.0/<11.7</td><td class="colsep0 rowsep0" align="left">1.0/45.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">3.4/6.1</td><td class="colsep0 rowsep0" align="left">1.6/12.9</td><td class="colsep0 rowsep0" align="left">>4.0/<5.2</td><td class="colsep0 rowsep0" align="left">1.1/18.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">0.6/52.5</td><td class="colsep0 rowsep0" align="left">>4.0/<8.3</td><td class="colsep0 rowsep0" align="left">>4.0/<8.3</td><td class="colsep0 rowsep0" align="left">>4.0/<7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">plasma stability (h)</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left"> >48</td><td class="colsep0 rowsep0" align="left"> >48</td><td class="colsep0 rowsep0" align="left"> >48</td><td class="colsep0 rowsep0" align="left">>24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">19 ± 1</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">>24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left"> >48</td><td class="colsep0 rowsep0" align="left"> >48</td><td class="colsep0 rowsep0" align="left"> >48</td><td class="colsep0 rowsep0" align="left">>24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">plasma protein binding (%)</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">77.9 ± 2.2</td><td class="colsep0 rowsep0" align="left">78.7</td><td class="colsep0 rowsep0" align="left">94.1</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">73.1 ± 4.2</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">90.1</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">86.7 ± 1.4</td><td class="colsep0 rowsep0" align="left">98.3</td><td class="colsep0 rowsep0" align="left">79.6</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">97.7</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">PBS stability (h)</td><td class="colsep0 rowsep0" align="left">pH 7.4</td><td class="colsep0 rowsep0" align="left">>48</td><td class="colsep0 rowsep0" align="left">>48</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">>24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 5.0</td><td class="colsep0 rowsep0" align="left">>48</td><td class="colsep0 rowsep0" align="left">>48</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">>24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 3.0</td><td class="colsep0 rowsep0" align="left">>48</td><td class="colsep0 rowsep0" align="left">>48</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">>24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">ND = not determined.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo Pharmacokinetics</h3><div class="NLM_p">On the basis of the result of the microsomal stability studies for the top three new candidates, we selected compounds <b>20</b> and <b>27g</b> for in vivo pharmacokinetics using a single intravenous administration at 10 or 20 mg/kg to compare clearance directly with that of initial lead compound <b>4</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 3">Figure 3</a>). Both compounds <b>20</b> and <b>27g</b> were well-tolerated in mice at these doses, with no significant evident toxicity based on a functional observational battery after dosing and examining the gross pathology, histopathology, hematology, and clinical chemistries following sacrifice of the animals. The observed <i>C</i><sub>max</sub> for compounds <b>20</b> and <b>27g</b> at 20 mg/kg was 5.8 and 9.5 μM, respectively. These concentrations are 1.5- and 7-fold above the cellular IC<sub>50</sub> of compounds <b>20</b> and <b>27g</b>, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Table S2</a>). The half-life of compound <b>20</b> was slightly lower than that of compound <b>4</b> in plasma. However, the AUC (area under the curve) of compound <b>20</b> is 1.5-fold higher than that of compound <b>4</b>, showing a moderate increase in plasma exposure despite slightly faster clearance rate. Compound <b>27g</b> showed both a prolonged half-life (19 h at 20 mg/kg) and enhanced plasma exposure (up to 30-fold of above that seen for compound <b>4</b>), which substantiated the hypothesis that replacing the most metabolically labile methoxy groups at C-6 and C-7 significantly improved the in vivo metabolic stability.</div><div class="NLM_p">To test whether these analogues inhibit ATM-dependent signaling pathways, we monitored the phosphorylation of ATM and its downstream targets, KAP1 and p53. In this cellular assay, MCF7 cells were preincubated for 30 min with <b>1</b>, <b>4</b>, <b>20</b>, <b>27g</b>, and <b>27n</b> at three concentrations of 1, 5, and 10 μM. Next, the cells were exposed to 10 Gy of IR, and phosphorylation of ATM, KAP1, and p53 was monitored using western blot analysis. Control compounds <b>1</b> and <b>4</b> inhibited the phosphorylation of ATM (Ser1981), KAP1 (Ser824), and p53 (Ser15) in a dose-dependent manner. Compounds <b>20</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Figure S3</a>), <b>27g</b>, and <b>27n</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) exhibited a similar dose-dependent inhibition; <b>27g</b> and <b>27n</b> potencies of inhibition were comparable to that of compound <b>4</b>, whereas compound <b>20</b> was the weakest inhibitor across all concentrations tested with respect to suppression of phospho-p53 formation. This experiment demonstrates that the optimized compound <b>27g</b> remains on target for ATM kinase with a similar affinity as that of the original lead.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of ATM-driven phosphorylation events by selected analogues after IR-induced DNA damage. MCF7 cells were treated with DMSO or compounds <b>1</b>, <b>4</b>, <b>27g</b>, or <b>27n</b> at concentrations of 1, 5, or 10 μM for 30 min before mock-IR (control) or IR (10 Gy). Cells were lysed 1 h after IR and probed by western blot analysis using anti-phospho-ATM, anti-phospho-KAP1, or anti-phospho-p53 antibodies. Total ATM and β-actin protein levels were used as loading controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have shown in our previous publication that transient inhibition of ATM kinase by <b>4</b> is sufficient to sensitize cells to IR-induced DNA damage.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Hence, a clonogenic assay was performed to evaluate the radiosensitization properties of analogues <b>20</b>, <b>27g</b>, and <b>27n</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). MCF7 cells were pretreated with DMSO or the test compounds (10 μM) and irradiated with increasing doses of IR (0, 2, and 4 Gy). After 4 h, the media was replaced with drug-free media and the cells were cultured for 10 days without selective pressure before the resulting colonies were counted. At a concentration of 10 μM, compounds <b>4</b> and <b>1</b> showed increased radiosensitization compared to that of the negative control (DMSO), as previously published,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> whereas compounds <b>20</b> and <b>27n</b> gave only modest radio sensitization. However, <b>27g</b> exhibited an enhanced radiosensitizing effect, with a similar potency and efficacy as those of <b>4</b> and <b>1</b>. This shows that the optimized compound <b>27g</b> retains the efficacy of the original lead <b>4</b>.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0014.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Sensitization of MCF7 cells to IR-induced DNA damage by compounds <b>1</b>, <b>4</b>, <b>20</b>, <b>27g</b>, or <b>27n</b>. MCF7 cells were plated in triplicate and incubated for 16 h. Cells were preincubated with DMSO or 10 μM of compound <b>4</b>, <b>1</b>, <b>27g</b>, <b>27n</b>, or <b>20</b> for 10 min before being exposed to escalating doses of IR (0–4 Gy). Media was removed 4 h after IR and replaced with fresh media without drugs. After 10 days of incubation, the cells were fixed and stained with crystal violet (0.5%). Surviving colonies on each plate were counted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In order to determine if any drift in selectivity had occurred during the optimization process, compounds <b>4</b> and <b>27g</b> were screened at fixed concentrations of 3 μM against a diverse panel of kinases, and these results were compared with the previously reported kinase specificity of compound <b>2</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> as a reference (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Table S4 and Figure S2</a>; ScanMax by DiscoveRx Corp.). The original hit compound <b>4</b> inhibited both close family members (PI3K and PIKK) and also 106 (26%) kinases out of 451. However, analogue <b>27g</b> displayed significant improvements in overall selectivity by inhibiting only 41 (9%) kinases out of 451 in the panel. Interestingly, unlike compound <b>4</b>, <b>27g</b> did not show any significant inhibition of the MAPK kinases. This suggests that our modifications at the C-6 position not only maintained potency and improved stability but also enhanced the overall selectivity to ATM. In order to quantitate the selectivity of <b>27g</b>, we determined the <i>K</i><sub>d</sub> values of compound <b>27g</b> for the 16 kinases from the panel that exhibited more than 95% inhibition at 3 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">Table S5</a>; <i>K</i><sub>d</sub> determination by DiscoveRx Corp.). Compound <b>27g</b> inhibited substrate binding of 10 different kinases (<i>K</i><sub>d</sub> less than 1 μM) with relatively good potency. Two of these, TYK2 (<i>K</i><sub>d</sub> = 41 nM), which belongs to the JAK (Janus activated kinase) family of tyrosine kinases,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> and NEK6 (<i>K</i><sub>d</sub> = 130 nM), which belongs to the NIMA family kinases,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> were inhibited with potency sufficient to expect efficacy in cells at the doses examined in this study. Neither of these is expected to have any effect on the DNA damage responses or the ATM pathway. Therefore, the data show that <b>27g</b> is significantly more selective within the kinases than the original lead <b>4</b>.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We previously reported the discovery of compound <b>4</b> as a potential inhibitor of ATM kinase. However, the compound showed an undesirable PK profile and was therefore not suitable for further development into a radiosensitizing agent. We targeted the series to improve metabolic stability while maintaining or improving the cellular potency, with a secondary goal of improving selectivity. As shown above, we succeeded in improving the metabolic stability and selectivity of this quinazoline series by optimizing the C-6 and C-7 groups, leading to compound <b>27g</b>, which has significantly overall better exposure in rodents than <b>4</b>. Western blot analysis of <b>27g</b> in IR-treated MCF7 cells demonstrated that it remains on target, reducing ATM autophosphorylation and subsequent phosphorylation of ATM substrates KAP1 and p53, both of which are critical to the DNA damage response pathway. Compound <b>27g</b> exhibited significant stability and selectivity while maintaining potency, and it effectively sensitized cells to IR with low toxicity against human fibroblast cell lines. Given our pharmacokinetic data for the original lead that showed significant exposure in the lungs, these compounds could be beneficial for treating non-small-cell lung cancer, where radiosensitization by ATM inhibition may prove to be important.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All materials were purchased from commercial suppliers and used without further purification. Analytical thin-layer chromatography was performed using silica gel 60 F<sub>254</sub> plate from EMD. Purification of compounds was done by either normal (Biotage Isolera) or reverse-phase column chromatography (Waters prep-HPLC). Structures were determined by NMR spectroscopy, and purity was determined by LC-MS/ELSD and HPLC. <sup>1</sup>H NMR spectra were recorded on a Bruker 400 or 500 MHz instrument. Data were acquired using Masslynx v.4.1 and analyzed using the Openlynx software suite. The flow was then split to an evaporative light scattering detector (ELSD) and SQ mass spectrometer. The total flow rate was 1.0 mL/min and gradient program started at 90% A (0.1% formic acid in H<sub>2</sub>O) and was changed to 95% B (0.1% formic acid in ACN) and then to 90% A. The mass spectrometer was operated in positive-ion mode with electrospray ionization. The conditions were as follows: capillary voltage, 3.4 kV; cone voltage, 30 V; source temperature, 130 °C; desolvation temperature, 400 °C; desolvation gas, 800 L/h; and cone gas, 100 L/h. A full scan range from <i>m</i>/<i>z</i> 110 to 1000 in 0.2 s was used to acquire MS data. The ELSD-drift tube temperature was set at 52 °C. NMR spectra were recorded on a Bruker 400 or 500 MHz and referenced internally to the residual resonance in CDCl<sub>3</sub> (δ 7.26 ppm for hydrogen and δ 77 ppm for carbon atoms). NMR peaks were assigned by MestRec (4.9.9.6) and MestReNova (5.2.2).</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure I for the Synthesis of 3-(Pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>14</b>)</h4><div class="NLM_p last">A finely ground mixture of amino guanidine sulfate (1.8 g, 10.46 mmol) and picolinic acid (1.3 g, 10.56 mmol) was taken into a 100 mL round-bottomed flask. This mixture was heated at 210 °C for about 2 h on a metal bath (Wood’s metal bath) and a reflux condenser. Reaction mixture first melts into a pale yellow liquid and then solidifies. The resulting product was used directly. Product is a pale yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.63–8.59 (m, 1H), 7.95–7.86 (m, 2H), 7.44–7.38 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.73, 149.14, 148.18, 137.21, 123.93, 120.86. LC-MS (ESI): <i>m</i>/<i>z</i> 162.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-(6,7-Dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>4</b>)</h4><div class="NLM_p last">To a mixture of 4-chloro-6,7-dimethoxyquinazoline (0.733 g, 3.26 mmol) and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine <b>14</b> (0.526 g, 3.26 mmol) in DMF (10 mL) was added cesium carbonate (1.27 g, 3.92 mmol). The resulting mixture was heated at 100 °C overnight. After completion, it was cooled, diluted with water, and extracted with chloroform (forms an emulsion). The organic layer was pooled, washed with brine, and dried over MgSO<sub>4</sub>. The crude product was purified by HPLC. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.14 (s, 1H), 8.85 (s, 1H), 8.70 (ddd, <i>J</i> = 4.8, 1.9, 1.0 Hz, 1H), 8.08 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.74 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.34–7.25 (m, 2H), 6.98 (s, 2H), 4.08 (s, 3H), 4.03 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 158.46, 156.08, 153.52, 151.34, 150.74, 150.24, 150.15, 149.32, 136.59, 124.26, 121.35, 111.65, 107.06, 106.14, 77.21, 56.42, 56.26. HRMS (ESI): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>7</sub>O<sub>2</sub><sup>+</sup>, 350.1365; found, 350.1368.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure II for the Synthesis of Quinazolines (<b>15</b>–<b>27</b>)</h4><div class="NLM_p last">To a mixture of substituted 4-Cl-quinazoline <b>11</b> (1 mmol) and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine <b>14</b> (1.2 mmol) in DMF was added Cs<sub>2</sub>CO<sub>3</sub> (1.5 mmol). The reaction mixture was heated at 90–130 °C for 6–18 h, with temperature and time varying depending on the reactivity. The reaction progress was monitored by UPLC and TLC. After the reaction, the mixture was allowed to cool; it was then added to ice-cold water and extracted into chloroform (2×). The combined organic layers were dried over MgSO<sub>4</sub> and purified by reverse-phase HPLC (XbridgeTM C18 5 μM OBD, 30 × 50 mm; mobile phase, water with 0.1% formic acid/acetonitrile with 0.1% formic acid; gradient, 0–90% AcCN; flow rate, 4.0 mL/min) to afford the desired compound.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-Phenyl-1-(quinazolin-4-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15a</b>)</h4><div class="NLM_p last">Compounds <b>15a</b>–<b>h</b> were synthesized from commercially available starting materials as described in general procedure II. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56–8.48 (m, 2H), 8.16 (d, <i>J</i> = 7.1, 2H), 7.88–7.81 (m, 1H), 7.72 (d, <i>J</i> = 8.0, 1H), 7.60 (t, <i>J</i> = 7.6, 1H), 7.53–7.46 (m, 2H), 7.46–7.40 (m, 1H). LC-MS (ESI): <i>m</i>/<i>z</i> 288.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-(Pyridin-2-yl)-1-(quinazolin-4-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.73–8.66 (m, 1H), 8.50 (d, <i>J</i> = 11.4, 2H), 8.25 (d, <i>J</i> = 7.4, 1H), 7.96 (td, <i>J</i> = 7.7, 1.8, 1H), 7.84 (dd, <i>J</i> = 11.1, 4.1, 1H), 7.72 (d, <i>J</i> = 8.1, 1H), 7.61 (t, <i>J</i> = 7.6, 1H), 7.47 (ddd, <i>J</i> = 7.5, 4.8, 1.1, 1H). LC-MS (ESI): <i>m</i>/<i>z</i> 290.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-(4-Methoxyphenyl)-1-(quinazolin-4-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57–8.47 (m, 2H), 8.39 (s, 0H), 8.09 (d, <i>J</i> = 8.7, 2H), 7.85 (dd, <i>J</i> = 11.1, 4.1, 1H), 7.73 (d, <i>J</i> = 8.2, 1H), 7.61 (t, <i>J</i> = 7.6, 1H), 7.09–7.02 (m, 2H), 3.83 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 319.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-(4-Chlorophenyl)-1-(quinazolin-4-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54–8.46 (m, 2H), 8.17 (d, <i>J</i> = 8.4, 2H), 7.85 (t, <i>J</i> = 7.0, 1H), 7.72 (d, <i>J</i> = 8.2, 1H), 7.64–7.52 (m, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 232.7 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(7-Chloroquinazolin-4-yl)-3-phenyl-1<i>H</i>-1,2,4-triazol-5-amine (<b>15e</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (s, 1H), 8.48 (d, <i>J</i> = 8.0, 1H), 8.15 (d, <i>J</i> = 7.3, 2H), 7.77 (s, 1H), 7.65 (dd, <i>J</i> = 8.7, 2.1, 1H), 7.46 (dt, <i>J</i> = 25.2, 7.1, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 323.7 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(7-Chloroquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15f</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.68 (d, <i>J</i> = 4.0, 1H), 8.51–8.43 (m, 2H), 8.35 (s, 1H), 8.23 (d, <i>J</i> = 7.8, 1H), 7.96 (td, <i>J</i> = 7.7, 1.8, 1H), 7.73 (s, 1H), 7.62 (dd, <i>J</i> = 8.7, 2.1, 1H), 7.46 (dd, <i>J</i> = 7.0, 5.4, 1H). LC-MS (ESI): <i>m</i>/<i>z</i> 324.7 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(7-Chloroquinazolin-4-yl)-3-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15g</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.52 (s, 1H), 8.48 (d, <i>J</i> = 8.0 Hz, 1H), 8.07 (d, <i>J</i> = 8.7, 2H), 7.76 (s, 1H), 7.63 (dd, <i>J</i> = 8.7, 2.1, 1H), 7.04 (d, <i>J</i> = 8.9, 2H), 3.82 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 353.7 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-(4-Chlorophenyl)-1-(7-chloroquinazolin-4-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15h</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.52 (s, 1H), 8.48 (d, <i>J</i> = 8 Hz, 1H), 8.17 (d, <i>J</i> = 8.4, 2H), 7.76 (s, 1H), 7.65 (dd, <i>J</i> = 8.7, 2.1, 1H), 7.59–7.53 (m, 2H). LC-MS (ESI): <i>m</i>/<i>z</i> 358.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-(7-Chloro-6-nitroquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15i</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15 (d, <i>J</i> = 2.8 Hz, 1H), 8.94 (s, 1H), 8.56–8.47 (m, 2H), 8.27 (s, 1H), 8.14–7.97 (m, 2H), 7.78–7.62 (m, 1H), 7.10 (s, 1H). LC-MS (ESI): <i>m</i>/<i>z</i> 369.04 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-chloroquinazolin-6-amine (<b>15j</b>)</h4><div class="NLM_p last">A mixture of <b>15g</b> (150 mg, 0.678 mmol) and SnCl<sub>2</sub>·2H<sub>2</sub>O in ethyl acetate (5 mL) was heated to reflux for 2 h. The mixture was cooled, diluted with EtOAc, and washed with saturated NaHCO<sub>3</sub> until a basic pH was acquired. The emulsion was filtered through Celite pad, washed with bicarbonate, and extracted into EtOAc. The combined layers were evaporated to dryness, dissolved in DMSO, and purified by HPLC. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.91 (d, <i>J</i> = 5.2 Hz, 3H), 8.62 (s, 2H), 8.47 (dd, <i>J</i> = 17.0, 7.9 Hz, 4H), 7.91 (t, <i>J</i> = 6.6 Hz, 2H), 7.81 (d, <i>J</i> = 6.3 Hz, 3H), 7.79–7.70 (m, 1H). LC-MS (ESI): <i>m</i>/<i>z</i> 339.7 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(7-Methoxy-6-nitroquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15k</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.19 (d, <i>J</i> = 2.8 Hz, 1H), 9.01 (s, 1H) 8.92 (s, 1H), 8.54–8.37 (m, 1H), 8.27 (s, 2H), 8.16–7.94 (m, 2H), 7.65–7.60 (m, 1H), 6.98 (s, 1H), 3.98 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 365.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-amine (<b>15l</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.12 (d, <i>J</i> = 2.8 Hz, 1H), 8.50–8.42 (m, 1H), 8.35 (s, 2H), 8.23 (s, 2H), 8.14–7.89 (m, 2H), 7.75 (s, 1H), 7.69–7.60 (m, 1H), 6.98 (s, 1H), 3.98 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 335.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(6-Nitro-7-(piperazin-1-yl)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15m</b>)</h4><div class="NLM_p last">Compounds <b>15m</b>–<b>o</b> were synthesized from corresponding starting materials as described below. Compound <b>15i</b> (50 mg, 0.13 mmol) and piperazine (58 mg, 0.678 mmol) were mixed together in ethanol (3 mL), and the reaction mixture was heated at 75 °C for 4 h. The reaction mixture was cooled, evaporated, dissolved in DMSO, and purified by HPLC. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (s, 1H), 8.56–8.43 (m, 1H), 8.21 (s, 2H), 8.14–7.95 (m, 2H), 7.78–7.62 (m, 1H), 7.10 (s, 1H), 3.13 (m, 4H), 3.01 (m, 4H). LC-MS (ESI): <i>m</i>/<i>z</i> 419.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(6-Methoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15n</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.19 (d, <i>J</i> = 2.8 Hz, 1H), 8.99 (s, 1H), 8.78 (d, <i>J</i> = 4.8 Hz, 1H), 8.17 (d, <i>J</i> = 7.9 Hz, 1H), 8.00 (d, <i>J</i> = 9.2 Hz, 1H), 7.83 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.63 (dd, <i>J</i> = 9.2, 2.8 Hz, 1H), 7.45–7.33 (m, 1H), 7.14 (s, 2H), 4.06 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 320.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-(Pyridin-2-yl)-1-(7-(trifluoromethoxy)quinazolin-4-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>15o</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.93 (d, <i>J</i> = 9.6 Hz, 1H), 9.09 (s, 1H), 8.85–8.70 (m, 1H), 8.22 (dt, <i>J</i> = 7.9, 1.0 Hz, 1H), 7.92–7.76 (m, 2H), 7.69–7.55 (m, 1H), 7.40 (ddd, <i>J</i> = 7.5, 4.8, 1.2 Hz, 1H), 7.19 (s, 1H). LC-MS (ESI): <i>m</i>/<i>z</i> 374.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-(6,7-Difluoroquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>16</b>)</h4><div class="NLM_p last">To a mixture of 4-chloro-6,7-difluoroquinazoline (100 mg, 0.499 mmol) and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (96 mg, 0.598 mmol) in a solvent mixture of CHCl<sub>3</sub>/DMF (3:1) was added cesium carbonate (325 mg, 0.997 mmol). The reaction mixture was stirred at 75 °C overnight, cooled, dissolved in DMSO, and purified by HPLC. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.31 (s, 1H), 8.75 (d, <i>J</i> = 4.9, 1H), 8.68 (d, <i>J</i> = 7.9, 1H), 8.25 (s, 2H),  8.15–7.99 (m, 2H), 7.84 (td, <i>J</i> = 7.9, 1.2 Hz, 1H), 7.42 (ddd,  <i>J</i> = 7.9, 5.0, 1.0 Hz, 1H). LC-MS (ESI): <i>m</i>/<i>z</i> 326.3  [M + H] <sup>+</sup>.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-(7,8-Dihydro-[1,4]dioxino[2,3-g]quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>17</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15 (s, 1H), 8.82 (d, <i>J</i> = 0.9 Hz, 1H), 8.70 (ddd, <i>J</i> = 4.8, 2.0, 1.1 Hz, 1H), 8.14 (dq, <i>J</i> = 8.0, 1.0 Hz, 1H), 7.76 (td, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.42 (s, 1H), 7.33–7.25 (m, 1H), 7.16 (s, 2H), 4.46–4.32 (m, 5H). LC-MS (ESI): <i>m</i>/<i>z</i> 348.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(6,7-Dimethoxyquinazolin-4-yl)-3-(pyridin-3-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>18a</b>)</h4><div class="NLM_p last">Compounds <b>18a</b>–<b>f</b> were synthesized from the corresponding starting materials as described in general procedure II. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.29 (s, 1H), 8.63 (dd, <i>J</i> = 4.7, 1.6 Hz, 2H), 8.39 (s, 2H), 8.14–7.72 (m, 1H), 7.57–7.49 (m, 2H), 7.24 (s, 1H), 3.95 (s, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 350.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(6,7-Dimethoxyquinazolin-4-yl)-3-(pyridin-4-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>18b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (d, <i>J</i> = 13.5 Hz, 2H), 8.74 (d, <i>J</i> = 5.8 Hz, 2H), 8.19 (s, 1H), 7.97 (d, <i>J</i> = 6.0 Hz, 2H), 7.46 (s, 2H), 4.03 (d, <i>J</i> = 2.2 Hz, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 350.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(6,7-Dimethoxyquinazolin-4-yl)-3-phenyl-1<i>H</i>-1,2,4-triazol-5-amine (<b>18c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.09 (s, 1H), 8.94 (s, 1H), 8.17–8.07 (m, 4H), 7.56–7.42 (m, 4H), 4.03 (d, <i>J</i> = 2.8 Hz, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 349.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(6,7-Dimethoxyquinazolin-4-yl)-3-(4-methoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>18d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.12 (s, 1H), 8.92 (s, 1H), 8.13 (s, 2H), 8.05–7.99 (m, 2H), 7.42 (s, 1H), 7.11–7.05 (m, 2H), 4.02 (d, <i>J</i> = 2.4 Hz, 6H), 3.83 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 379.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-(4-Chlorophenyl)-1-(6,7-dimethoxyquinazolin-4-yl)-1<i>H</i>-pyrazol-5-amine (<b>18e</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (s, 1H), 8.81 (s, 1H), 7.77–7.69 (m, 2H), 7.37–7.29 (m, 2H), 7.22–7.16 (m, 1H), 7.27 (s, 1H), 5.99 (s, 2H), 5.87 (s, 1H), 4.01 (d, <i>J</i> = 2.7 Hz, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 382.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 3-Cyclohexyl-1-(6,7-dimethoxyquinazolin-4-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>18f</b>)</h4><div class="NLM_p last">Procedure I was followed (33.5% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (s, 1H), 8.21 (s, 1H), 7.54 (s, 1H), 6.98 (s, 1H), 3.83 (d, <i>J</i> = 4.1 Hz, 6H), 2.57–2.45 (m, 1H), 1.89–1.78 (m, 2H), 1.61–1.49 (m, 3H), 1.37 (m, 2H), 1.27–1.01 (m, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 355.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(6,7-Bis(cyclopropylmethoxy)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>19</b>)</h4><div class="NLM_p last">A mixture of 4-chloroquinazoline-6,7-diol (0.05 g, 0.254 mmol), (bromomethyl)cyclopropane (0.086 g, 0.636 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.105 g, 0.763 mmol) in DMF was heated at 80 °C for 6 h. It was cooled, diluted with water, and extracted into ethyl acetate. The obtained product, 4-chloro-6,7-bis(cyclopropylmethoxy)quinazoline (0.05 g, 0.164 mmol), was treated with 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (0.026 g, 0.164) according to the general procedure described above. The crude product was purified by column chromatography (97:3 CHCl<sub>3</sub>/MeOH) to obtain the target compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.26 (s, 1H), 8.89 (s, 1H), 8.77 (td, <i>J</i> = 4.8, 1.8, 0.9 Hz, 1H), 8.16 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.81 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.40–7.31 (m, 1H), 7.05 (s, 1H), 4.14 (d, <i>J</i> = 8.0 Hz, 2H), 4.11 (d, <i>J</i> = 8.0 Hz, 2H),1.61 (s, 3H), 0.75–0.70 (m, 4H), 0.50–0.47 (m, 4H). LC-MS (ESI): <i>m</i>/<i>z</i> 430.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>20</b>)</h4><div class="NLM_p last">To a solution of 4-chloro-6,7-bis(2-methoxyethoxy)quinazoline (80 mg, 0.256 mmol) and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine in DMF (3 mL) was added cesium carbonate (167 mg, 0.512 mmol). The resulting mixture was heated at 70 °C for 4 h. Next, the disappearance of starting material was confirmed by TLC. The reaction mixture was poured into water and then extracted with DCM. The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude mixture was purified by flash column chromatography and repurified by prep-HPLC. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.15 (s, 1H), 8.84 (s, 1H), 8.70 (d, <i>J</i> = 4.7 Hz, 1H), 8.10 (d, <i>J</i> = 7.9 Hz, 1H), 7.75 (t, <i>J</i> = 7.8 Hz, 1H), 7.32–7.27 (m, 2H), 6.98 (s, 2H), 4.37 (t, <i>J</i> = 5.1 Hz, 2H), 4.29 (t, <i>J</i> = 4.9 Hz, 2H), 3.84 (dq, <i>J</i> = 11.2, 6.3, 5.6 Hz, 4H), 3.43 (d, <i>J</i> = 3.3 Hz, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 159.62, 158.48, 155.67, 153.51, 151.22, 150.71, 150.09, 149.70, 149.31, 136.59, 124.25, 121.48, 111.61, 107.93, 107.44, 70.57, 70.40, 68.54, 68.51, 59.41, 59.40. HRMS (ESI): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>24</sub>N<sub>7</sub>O<sub>4</sub><sup>+</sup>, 438.1890; found, 438.1891.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(2-Chloro-6,7-dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>22a</b>)</h4><div class="NLM_p last">To a mixture of 2,4-chloro-6,7-dimethoxyquinazoline <b>21a</b> (0.1 g, 0.386 mmol) and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine <b>14</b> (0.075g, 0.463 mmol) in dry DMF (8 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (0.252g, 0.772 mmol). The resulting mixture was heated at 90 °C for 6–8 h. Then, the reaction mixture was cooled to room temperature and poured onto ice-cold water. The solid deposited was filtered off to obtain the pure compound in excellent yield. The remaining aqueous layer was extracted with chloroform (2 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub>, the solvent was evaporated, and the residue was purified by reverse-phase HPLC to afford compound <b>22a</b> in 60.8% overall yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.26 (s, 1H), 8.81–8.74 (m, 1H), 8.14 (d, <i>J</i> = 8.0 Hz, 1H), 7.83 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.38 (m, 1H), 7.32 (s, 1H), 6.90 (s, 1H), 4.15 (s, 3H), 4.08 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 384.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-(6,7-Dimethoxy-2-morpholinoquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>22b</b>)</h4><div class="NLM_p last">Compound <b>22a</b> (0.05g, 0.13 mmol) and commercially available morpholine (0.057 g, 0.651 mmol) were mixed together in NMP (3 mL) and heated at 140 °C for 3–4 h under an argon atmosphere. The reaction mixture was cooled to room temperature and poured into water. Then, NaCl was added. The resulting precipitate was collected by filtration, washed with water, and dried to give 0.04 g (0.092 mmol, 70.7%) of the title compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.75–8.72 (m, 2H), 8.13 (d, <i>J</i> = 7.9 Hz, 1H), 7.79 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.36–7.33 (m, 1H), 7.00 (s, 1H), 6.61 (s, 2H), 4.03 (s, 3H), 4.02 (s, 3H) 3.87–3.81 (m, 8H). LC-MS (ESI): <i>m</i>/<i>z</i> 435.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(6,7-Dimethoxy-2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>22c</b>)</h4><div class="NLM_p last">Compound <b>22a</b> (0.1 g, 0.26 mmol) and commercially available <i>N</i>-methyl piperazine(0.13 g, 1.3 mmol) were mixed together in NMP (3 mL), and the reaction was carried out as described for the synthesis of compound <b>22b</b>. The crude product was purified by HPLC to afford <b>22c</b> (0.06 g, 51.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.76 (s, 1H), 8.75 (s, 1H), 8.14 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.3–7.34 (m, 1H), 7.00 (s, 1H), 6.71 (s, 2H), 4.04 (s, 3H), 4.03 (s, 3H), 3.04–3.92 (m, 4H), 2.65 (t, <i>J</i> = 5.1 Hz, 4H), 2.43 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 448.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(4-(4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-6,7-dimethoxyquinazolin-2-yl)pipera-zin-1-yl)ethanol (<b>22d</b>)</h4><div class="NLM_p last">Compound <b>22a</b> (0.1 g, 0.26 mmol) and commercially available 2-(piperazin-1-yl)ethanol (0.17 g, 1.3 mmol) were mixed together in NMP (5 mL), and the reaction was carried out as described for the synthesis of compound <b>22b</b>. The crude product was purified by HPLC to afford <b>22d</b> (0.045 g, 36.2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.49 (s, 1H), 8.35 (s, 1H), 7.91 (s, 1H), 7.68 (d, <i>J</i> = 7.7 Hz, 1H), 7.22 (s, 1H), 6.78 (s, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.42 (t, <i>J</i> = 11.1 Hz, 4H), 3.31–3.13 (m, 6H), 3.05 (d, <i>J</i> = 5.4 Hz, 2H). LC-MS (ESI): <i>m</i>/<i>z</i> 478.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Ethyl 2-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-6,7-dimethoxyquinazolin-2-yl)ami-no)acetate (<b>22e</b>)</h4><div class="NLM_p last">Compound <b>22a</b> (0.038 g, 0.1 mmol) and commercially available ethyl 2-aminoacetate hydrochloride (0.103 g, 1.0 mmol) were mixed together in NMP (5 mL), and the reaction was carried out as described for the synthesis of compound <b>22b</b>. Next, ice-cold water was added, the mixture was extracted in ethyl acetate, and the crude product was purified by HPLC to afford <b>22e</b> (0.035 g, 78.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (s, 1H), 8.10 (d, <i>J</i> = 7.9 Hz, 1H), 7.88–7.71 (m, 1H), 7.52 (s, 1H), 6.89 (s, 1H), 4.18 (q, 2H), 4.07 (s, 10H), 3.94 (s, 3H), 3.93 (s, 3H), 3.29–3.26 (m, 2H), 1.29–1.15 (m, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 451.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-6,7-dimethoxyquinazolin-2-yl)amino)acetic Acid (<b>22f</b>)</h4><div class="NLM_p last">A solution of compound <b>22e</b> (0.02 g, 0.044 mmol) was diluted with a mixture of methanol (2 mL) and water (0.3 mL) and then treated with lithium peroxide (0.019 g, 0.022 mmol). The reaction mixture was stirred at room temperature for 0.45 h, acidified with 10% HCl, and evaporated, redissolved in DMSO (1 mL), and purified by HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 13.93 (s, 1H), 8.65 (d, <i>J</i> = 4.2 Hz, 1H), 8.37 (s, 1H), 8.08 (d, <i>J</i> = 7.9 Hz, 1H), 8.00–7.90 (m, 1H), 7.84 (s, 1H), 7.44 (dd, <i>J</i> = 7.5, 4.8 Hz, 1H), 6.84 (s, 1H), 4.01 (s, 2H), 3.98 (s, 3H), 3.97 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 424.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-<i>N</i>,<i>N</i>-diethyl-6,7-dimethoxyquinazolin-2-amine (<b>22g</b>)</h4><div class="NLM_p last">Compound <b>22a</b> (0.05 g, 0.13 mmol) was dissolved in 5 mL of isopropanol. To this solution were added diethylamine (0.057 g, 0.78 mmol) and HCl in dioxane (4.0 M, 0.1 mL). The resulting solution was stirred inside a microwave at 160 °C for 10 min. After cooling, TLC indicated the completion of the reaction. After removal of the solvent by rotary evaporation, the residue was redissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with saturated NaHCO<sub>3</sub> solution. The organic layer was dried, concentrated, and purified by ISCO to give the desired compound (30 mg, 54.8%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.81 (s, 1H), 8.77 (s, 1H), 8.15 (d, <i>J</i> = 7.9 Hz, 1H), 7.79 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.36–7.33 (m, 1H), 6.97 (s, 1H), 6.74 (s, 2H), 4.04 (s, 3H), 4.04 (s, 3H), 3.71 (q, <i>J</i> = 7.1 Hz, 4H), 1.29 (t, <i>J</i> = 7.1 Hz, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 422.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(6,7-Dimethoxy-2-methylquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>22h</b>)</h4><div class="NLM_p last">To a solution of 4-chloro-6,7-dimethoxy-2-methyl quinazoline <b>21g</b> (0.1 g, 0.419 mmol) and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine <b>14</b> (0.075g, 0.503 mmol) in dry DMF (8 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (0.252g, 0.838 mmol). The mixture was heated at 90 °C overnight. The mixture was cooled to room temperature, poured onto ice-cold water, and extracted with chloroform (2 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub> and evaporated, and the residue was purified by reverse-phase HPLC to afford compound <b>22h</b> in 60.8% overall yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.91 (s, 1H), 8.52 (s, 1H), 7.98 (d, <i>J</i> = 7.9 Hz, 1H), 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 7.32–7.27 (m, 1H), 7.14 (s, 1H), 4.21 (s, 13H), 3.92 (s, 3H), 3.89 (s, 3H) 2.64 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 364.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-(6,7-Dimethoxy-2-phenylquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>22i</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR(400 MHz, CD<sub>3</sub>OD): δ 8.95 (s, 1H), 8.49 (s, 1H), 7.98 (d, <i>J</i> = 7.9 Hz, 1H), 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 7.68–7.59 (m, 3H), 7.44–7.37 (m, 2H), 7.30–7.27 (m, 1H), 7.16 (s, 1H), 3.93 (s, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 426.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-6,7-dimethoxyquinazolin-2-amine (<b>22j</b>)</h4><div class="NLM_p last">Compound synthesized using general procedure II for the synthesis of quinazolines as described above. A mixture of 4-chloro-6,7-dimethoxyquinazolin-2-amine <b>21j</b> (0.1 g, 0.417 mmol), 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine <b>14</b> (0.134 g, 0.834 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.543, 1.66 mmol) in DMF (6 mL) was heated at 100 °C for 6 h. Next, the mixture was cooled, diluted with water (10 mL), and extracted into CHCl<sub>3</sub>, and the organic layer was dried over sodium sulfate. After removal of the solvent, the crude extract was purified by flash column chromatography (chloroform/methanol 94:6) to give 0.056 g of the desired compound. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.65 (s, 1H), 8.45–8.38 (m, 1H), 7.90–7.83 (m, 1H), 7.64–7.61 (m, 1H), 7.17–7.14 (m, 1H), 6.64 (s, 1H), 3.89 (s, 3H), 3.76 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 365.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 6,7-Dimethoxy-<i>N</i>-(pyridin-2-ylmethyl)quinazolin-4-amine (<b>23a</b>)</h4><div class="NLM_p last">To a mixture of 4-chloro-6,7-dimethoxy quinazoline <b>11</b> (50 mg, 0.223 mmol) and pyridin-2-ylmethanamine (24.07 mg, 0.223 mmol) in DMF (0.8 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (0.145 g, 0.446 mmol). The reaction mixture was stirred at 130 °C overnight. After completion, it was cooled, diluted with water, and extracted in chloroform (2 × 30 mL). The combined organic layers were dried over magnesium sulfate and evaporated to dryness. The crude material was purified by HPLC to obtain the target compound in 45.5% overall yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (t, <i>J</i> = 5.9 Hz, 1H), 8.55–8.45 (m, 1H), 8.29 (s, 1H), 7.78–7.65 (m, 2H), 7.32 (d, <i>J</i> = 7.9 Hz, 1H), 7.25 (ddd, <i>J</i> = 7.5, 4.9, 1.0 Hz, 1H), 7.11 (s, 1H), 4.85 (d, <i>J</i> = 5.7 Hz, 2H), 3.90 (s, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 297.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 6,7-Dimethoxy-<i>N</i>-(pyridin-2-yl)quinazolin-4-amine (<b>23b</b>)</h4><div class="NLM_p last">Procedure followed as described for <b>15a</b> using pyridine-2-amine as starting material. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.71–8.63 (m, 1H), 8.47 (s, 1H), 8.12–8.02 (m, 1H), 7.89–7.77 (m, 1H), 7.64–7.49 (m, 2H), 7.24 (s, 1H), 3.95 (s, 3H), 3.90 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 283.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 6,7-Dimethoxy-<i>N</i>-(4-(pyridin-2-yl)phenyl)quinazolin-4-amine (<b>23c</b>)</h4><div class="NLM_p last">A mixture of 4-chloro-6,7-dimethoxy quinazoline <b>11</b> (100 mg, 0.445 mmol) and 4-(pyridin-2-yl)aniline (83 mg, 0.490 mmol) in ethanol (3 mL) was heated to reflux for 6 h. The reaction mixture was cooled, evaporated, purified by column chromatography, and eluted (95:5 DCM/MeOH) to afford the target compound in 68.9% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.69 (s, 1H), 8.65 (m, 1H), 8.09–8.04 (m, 3H), 7.96 (ddd, <i>J</i> = 8.1, 7.2, 1.8 Hz, 1H), 7.93–7.88 (m, 3H), 7.77 (s, 1H), 7.42 (ddd, <i>J</i> = 7.3, 5.0, 1.4 Hz, 1H), 4.11 (s, 3H), 4.10 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 359.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6,7-Dimethoxy-4-(3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)quinazoline (<b>23d</b>)</h4><div class="NLM_p last">To a mixture of 4-chloro-6,7-dimethoxy quinazoline <b>11</b> (102 mg, 0.456 mmol) and 2-(1<i>H</i>-1,2,4-triazol-3-yl)pyridine (80 mg, 0.547 mmol) in DMF (0.8 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (0.297 g, 0.912 mmol). The reaction mixture was stirred at 130 °C for 4 h. After completion, it was cooled, diluted with water, and extracted in chloroform (2 × 30 mL). The combined organic layers were dried over magnesium sulfate and evaporated to dryness. The crude material was purified by HPLC to obtain the target compound in 49.2% overall yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70 (s, 1H), 9.07 (s, 1H), 8.77 (d, <i>J</i> = 4.3 Hz, 1H), 8.67 (s, 1H), 8.25 (d, <i>J</i> = 7.8 Hz, 1H), 8.02 (t, <i>J</i> = 7.7 Hz, 1H), 7.56–7.51 (m, 2H), 4.05 (s, 3H), 4.00 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 335.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 6,7-Dimethoxy-4-(4-(pyridin-2-yl)-2<i>H</i>-1,2,3-triazol-2-yl)quinazoline (<b>23e</b>)</h4><div class="NLM_p last">Procedure followed as described above using 2-(2<i>H</i>-1,2,3-triazol-4-yl) pyridine as the key intermediate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.15 (s, 1H), 8.86 (s, 1H), 8.76 (ddd, <i>J</i> = 4.8, 1.7, 0.9 Hz, 2H), 8.27 (s, 1H), 8.18 (d, <i>J</i> = 7.9 Hz, 1H), 8.02 (d, <i>J</i> = 1.8 Hz, 1H), 7.56 (s, 1H), 7.515–7.51 (m, 1H), 4.06 (s, 3H), 3.98 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 335.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-(6,7-Dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-pyrazol-5-amine (<b>23f</b>)</h4><div class="NLM_p last">Procedure followed as described above using 3-(pyridin-2-yl)-1<i>H</i>-pyrazol-5-amine as the key intermediate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.98 (s, 1H), 8.81 (s, 1H), 8.58 (dt, <i>J</i> = 4.8, 1.4 Hz, 1H), 7.99 (dt, <i>J</i> = 8.0, 1.1 Hz, 1H), 7.66 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.24–7.13 (m, 1H), 6.25 (s, 1H), 5.92 (s, 2H), 3.99 (d, <i>J</i> = 2.1 Hz, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 349.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 1-(6,7-Dimethoxyquinazolin-4-yl)-3-phenyl-1<i>H</i>-pyrazol-5-amine (<b>23g</b>)</h4><div class="NLM_p last">Procedure followed as described above using 3-phenyl-1<i>H</i>-pyrazol-5-amine as the key intermediate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15 (s, 1H), 8.80 (s, 1H), 6.00 (s, 2H), 7.85–7.78 (m, 2H), 7.36 (dd, <i>J</i> = 8.2, 6.4 Hz, 2H), 7.21–7.18 (m, 1H), 6.00 (s, 2H), 5.90 (s, 1H), 4.03 (s, 3H), 4.00 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 348.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-(6,7-Dimethoxyquinazolin-4-yl)-3-(<i>p</i>-tolyl)-1<i>H</i>-pyrazol-5-amine (<b>23h</b>)</h4><div class="NLM_p last">Procedure followed as described above using 3-(<i>p</i>-toluyl)-1<i>H</i>-pyrazol-5-amine as the key intermediate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.17 (s, 1H), 8.80 (s, 1H), 7.75–7.66 (m, 2H), 7.23–7.14 (m, 3H), 6.00 (s, 2H), 5.87 (s, 1H), 4.03 (s, 3H), 4.01 (s, 3H), 2.34 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 362.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 3-(4-Chlorophenyl)-1-(6,7-dimethoxyquinazolin-4-yl)-1<i>H</i>-pyrazol-5-amine (<b>23i</b>)</h4><div class="NLM_p last">Procedure followed as described above using 3-(4-chlorophenyl)-1<i>H</i>-pyrazol-5-amine as the key intermediate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (s, 1H), 8.81 (s, 1H), 7.77–7.69 (m, 2H), 7.37–7.29 (m, 2H), 7.22–7.16 (m, 1H), 7.27 (s, 1H), 5.99 (s, 2H), 5.87 (s, 1H), 4.01 (d, <i>J</i> = 2.7 Hz, 6H). LC-MS (ESI): <i>m</i>/<i>z</i> 382.1 [M + H]+.</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-(6,7-Dimethoxyquinazolin-4-yl)-4-(pyridin-2-yl)-1<i>H</i>-pyrazol-5-amine (<b>23j</b>)</h4><div class="NLM_p last">Procedure followed as described above using 4-(pyridin-2-yl)-1<i>H</i>-pyrazol-5-amine as the key intermediate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.11 (d, <i>J</i> = 4.7 Hz, 2H), 8.84 (s, 1H), 8.58 (ddd, <i>J</i> = 5.0, 1.8, 1.0 Hz, 1H), 7.78–7.61 (m, 2H), 7.31 (s, 1H), 7.14 (ddd, <i>J</i> = 7.2, 5.0, 1.4 Hz, 1H), 5.81 (s, 2H), 5.30 (s, 1H), 4.10 (s, 3H), 4.07 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 349.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-(6,7-Dimethoxyquinazolin-4-yl)-1<i>H</i>-1,2,4-triazole-3,5-diamine (<b>23k</b>)</h4><div class="NLM_p last">Procedure followed as described above using <sup>1</sup>H-1,2,4-triazole-3,5-diamine as the key intermediate. After the reaction, the crude material was purified on NH<sub>2</sub> silica using a 25–100% EtOAc/Hex gradient to give the desired product in 75% overall yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.21 (s, 1H), 8.73 (s, 1H), 9.27–9.17 (m, 1H), 7.81 (s, 1H), 7.26 (s, 1H), 4.05 (s, 3H), 4.03 (s, 3H). LC-MS (ESI): <i>m</i>/<i>z</i> 288.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-(6-(Benzyloxy)-7-methoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>24a</b>)</h4><div class="NLM_p last">Compound was synthesized from 6-(benzyloxy)-4-chloro-7-methoxyquinazoline, which was synthesized from literature procedures,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and coupled with 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine as described in general procedure II. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.21 (s, 1H), 8.84 (s, 1H), 8.72 (d, <i>J</i> = 4.7 Hz, 1H), 8.06–7.95 (m, 1H), 7.74 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.49 (dd, <i>J</i> = 6.6, 2.8 Hz, 2H), 7.35–7.15 (m, 2H), 7.26–7.22 (m, 3H) 6.90 (s, 2H), 5.38 (s, 2H), 4.03 (s, 3H). LC-MS: 426.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-ol (<b>24b</b>)</h4><div class="NLM_p last">Prepared from <b>24a</b> upon debenzylation using 10% Pd–C in MeOH. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.28 (s, 1H), 8.87 (s, 1H), 8.70 (d, <i>J</i> = 4.8 Hz, 1H), 8.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.97 (t, <i>J</i> = 7.7 Hz, 1H), 7.50 (t, <i>J</i> = 6.3 Hz, 1H), 7.37 (s, 1H), 4.12 (s, 3H). LC-MS: 336.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-(7-(Benzyloxy)-6-methoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>24c</b>)</h4><div class="NLM_p last">Synthesized from commercially available 7-(benzyloxy)-4-chloro-6-methoxyquinazoline and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine as described in general procedure II. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.22 (s, 1H), 8.90 (s, 1H), 8.78 (ddd, <i>J</i> = 4.8, 1.9, 0.9 Hz, 1H), 8.15 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.82 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.52 (dd, <i>J</i> = 8.2, 1.4 Hz, 2H), 7.45–7.34 (m, 5H), 7.00 (s, 2H), 5.37 (s, 2H), 4.15 (s, 3H). LC-MS: 426.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-6-methoxyquinazolin-7-ol (<b>24d</b>)</h4><div class="NLM_p last">Prepared from <b>24c</b> upon debenzylation using 10% Pd–C in MeOH. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + 1 drop of CD<sub>3</sub>OD) δ 9.13 (s, 1H), 8.84 (s, 1H),8.72 (s, 1H), 8.16 (d, <i>J</i> = 7.9 Hz, 1H), 7.90 (ddd, <i>J</i> = 7.2, 5.0, 1.4 Hz, 1H), 7.45–7.41 (m, 1H), 7.38 (s, 1H), 7.30 (s, 1H), 4.14 (s, 3H). LC-MS: 336.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 1-(7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>24e</b>)</h4><div class="NLM_p last">Prepared from commercially available 4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine as described in general procedure II. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.07 (s, 1H), 8.83 (s, 1H), 8.65 (d, <i>J</i> = 4.7 Hz, 1H), 8.07 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (t, <i>J</i> = 7.7 Hz, 1H), 7.41–7.25 (m, 3H), 3.36–3.20 (m, 2H), 4.29 (t, <i>J</i> = 6.2 Hz, 2H), 4.01 (s, 3H), 3.69 (t, <i>J</i> = 4.7 Hz, 4H), 2.76–2.46 (m, 6H), 2.15 (p, <i>J</i> = 6.6 Hz, 2H). LC-MS: 463.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-(6-Methoxy-7-(3-morpholinopropoxy)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>24f</b>)</h4><div class="NLM_p last">Prepared from commercially available 6-methoxy-7-(3-morpholinopropoxy)quinazolin-4(3<i>H</i>)-one and 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine as described in general procedure II. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.11 (s, 1H), 8.85 (s, 1H), 8.71 (d, <i>J</i> = 4.6, 1H), 8.07 (d, <i>J</i> = 7.9, 1H), 7.75 (t, <i>J</i> = 7.7, 1H), 7.39–7.26 (m, 2H), 4.25 (t, <i>J</i> = 6.5, 2H), 4.05 (s, 3H), 3.75–3.63 (m, 4H), 2.67–2.54 (m, 2H), 2.51 (s, 4H), 2.20–2.00 (m, 2H). LC-MS: 463.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-(6-(3-(Dimethylamino)propoxy)-7-methoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>27a</b>)</h4><div class="NLM_p last">The reactive key intermediate 3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)-<i>N</i>,<i>N</i>-dimethylpropan-1-amine was prepared from a mixture of 4-chloro-7-methoxyquinazolin-6-ol and 3-chloro-<i>N</i>,<i>N</i>-dimethylpropan-1-amine in DMF using potassium carbonate as discussed in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.97 (s, 1H), 8.80 (s, 1H), 8.74–8.62 (m, 1H), 8.50 (s, 1H), 8.06 (d, <i>J</i> = 7.9 Hz, 1H), 7.93 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.52–7.47 (m, 1H), 4.35 (t, <i>J</i> = 5.6 Hz, 2H), 4.08 (s, 3H), 3.44 (t, <i>J</i> = 7.2 Hz, 2H), 3.01 (s, 6H), 2.39 (p, <i>J</i> = 6.6 Hz, 2H). LC-MS: 421.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-(6-(2-(Diisopropylamino)ethoxy)-7-methoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>27b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.20 (s, 1H), 8.92 (s, 1H), 8.82–8.67 (m, 1H), 8.20 (d, <i>J</i> = 7.9 Hz, 1H), 7.86 (td, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.39 (d, <i>J</i> = 5.1 Hz, 2H), 7.29 (d, <i>J</i> = 16.8 Hz, 2H), 4.47 (t, <i>J</i> = 6.6 Hz, 2H), 4.07 (s, 3H), 3.49–3.45 (m, 2H), 3.31 (t, <i>J</i> = 6.6 Hz, 2H), 2.63 (d, <i>J</i> = 1.0 Hz, 1H), 1.25 (d, <i>J</i> = 6.6 Hz, 12H). LC-MS: 463.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 1-(7-Methoxy-6-(2-(pyrrolidin-1-yl)ethoxy)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>27c</b>)</h4><div class="NLM_p last">Procedure followed as described for <b>27a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.10 (s, 2H), 8.85 (s, 1H), 8.76–8.64 (m, 1H), 8.38 (s, 2H), 8.11 (d, <i>J</i> = 7.9 Hz, 1H), 7.94 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.52–7.50 (m, 1H), 4.65–4.52 (m, 2H), 4.10 (s, 3H), 3.87–3.75 (m, 2H), 3.70–3.52 (m, 4H), 2.68 (s, 1H), 2.17–2.14 (m, 4H). LC-MS: 433.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-(7-Methoxy-6-(2-(piperidin-1-yl)ethoxy)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>27d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.20 (s, 1H), 8.91 (s, 1H), 8.74 (d, <i>J</i> = 4.4 Hz, 1H), 8.11 (t, <i>J</i> = 14.0 Hz, 1H), 7.97–7.79 (m, 1H), 7.47–7.30 (m, 4H), 4.63 (t, <i>J</i> = 5.1 Hz, 2H), 4.03 (d, <i>J</i> = 18.5 Hz, 3H), 3.38 (dt, <i>J</i> = 22.6, 5.2 Hz, 2H), 3.02 (d, <i>J</i> = 37.3 Hz, 5H), 1.83 (dd, <i>J</i> = 11.3, 5.6 Hz, 5H), 1.63 (dd, <i>J</i> = 18.0, 12.2 Hz, 3H). LC-MS: 447.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-(7-Methoxy-6-(2-(4-methylpiperidin-1-yl)ethoxy)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>27e</b>)</h4><div class="NLM_p last">Procedure followed as described for <b>27a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.22 (s, 1H), 8.92 (s, 1H), 8.77–8.76 (m, 1H), 8.17 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.80 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.43–7.32 (m, 2H), 7.01 (s, 2H), 4.46 (t, <i>J</i> = 6.6 Hz, 2H), 4.07 (s, 3H), 3.08–2.87 (m, 3H), 2.21–2.06 (m, 2H), 1.77–1.54 (m, 4H), 1.45–1.16 (m, 3H), 0.93 (d, <i>J</i> = 6.3 Hz, 3H). LC-MS: 461.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 1-(6-(3-(2,6-Dimethylmorpholino)propoxy)-7-methoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>27f</b>)</h4><div class="NLM_p last">Key intermediate 4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)-2,6-dimethylmorpholine was prepared from 4-chloro-7-methoxyquinazolin-6-ol and 4-(3-chloropropyl)-2,6-dimethylmorpholinein in DMF using potassium carbonate as described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The reactive linker was coupled to 4-chloro-7-methoxyquinazolin-6-ol to obtain the key intermediate as described above and further coupled with triazole amine from the general procedure described above to obtain the target compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 3H), 8.93 (s, 3H), 8.79 (d, <i>J</i> = 4.7 Hz, 3H), 8.13 (d, <i>J</i> = 7.9 Hz, 3H), 7.85 (td, <i>J</i> = 7.7, 1.8 Hz, 3H), 7.39 (d, <i>J</i> = 6.5 Hz, 6H), 7.23 (s, 1H), 4.38 (t, <i>J</i> = 6.2 Hz, 6H), 1.14–1.12 (m, 0H), 4.07 (s, 3H), 3.87 (d, <i>J</i> = 9.0 Hz, 2H), 3.05 (d, <i>J</i> = 11.3 Hz, 2H), 2.84 (q, <i>J</i> = 10.9, 9.3 Hz, 2H), 2.63 (s, 2H), 1.99 (t, <i>J</i> = 10.9 Hz, 3H), 1.17 (d, <i>J</i> = 6.3 Hz, 6H). LC-MS: 491.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 1-(7-Methoxy-6-(2-methoxyethoxy)quinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (<b>27g</b>)</h4><div class="NLM_p last">A key intermediate 4-chloro-7-methoxy-6-(2-methoxyethoxy) quinazoline <b>26g</b> was prepared from commercially available 4-chloro-7-methoxyquinazolin-6-ol <b>25</b> as described below. Di-<i>tert</i>-butylazodicarboxylate (0.262 g, 1.13 mmol) was added portionwise at 0 °C to a stirred suspension of 4-chloro-7-methoxyquinazolin-6-ol (<b>25</b>, 0.22 g, 1.045 mmol), 2-methoxy ethanol (0.91 g, 6.27 mmol), and triphenylphosphine (0.329 g, 1.25 mmol) in dichloromethane (15 mL). The reaction mixture was stirred for 5 h, and then the resulting orange solution was purified directly by silica gel chromatography, eluting with a mixture of 10% ethyl acetate in DCM to afford the reactive key intermediate, which was directly coupled with triazole amine using the general procedure described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.24 (s, 1H), 8.92 (s, 1H), 8.83–8.72 (m, 1H), 8.17 (d, <i>J</i> = 7.9 Hz, 1H), 7.82 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.41–7.30 (m, 2H), 7.05 (s, 2H), 4.52–4.41 (m, 2H), 4.07 (s, 3H), 3.98–3.83 (m, 2H), 3.49 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO) δ 159.71, 158.87, 156.26, 153.46, 151.57, 151.02, 150.37, 149.68, 149.31, 137.50, 124.94, 122.32, 111.24, 107.59, 107.08, 70.36, 68.25, 58.70, 56.66. HRMS (ESI): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>7</sub>O<sub>3</sub><sup>+</sup>, 394.1627; found, 394.1620.</div></div><div id="sec4_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)-<i>N</i>,<i>N</i>-diethylacetamide (<b>27h</b>)</h4><div class="NLM_p last">The reactive key intermediate 2-(4-chloro-7-methoxyquinazolin-6-yloxy)-<i>N</i>,<i>N</i>-diethylacetamide was prepared from a mixture of 4-chloro-7-methoxyquinazolin-6-ol and 2-chloro-<i>N</i>,<i>N</i>-diethylacetamide in DMF using potassium carbonate. It was further diluted with water, extracted in DCM, and filtered to purify it. The obtained intermediate was coupled with triazole amine using the general procedures described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (s, 1H), 8.91 (s, 1H), 8.81–8.67 (m, 1H), 8.20 (t, <i>J</i> = 14.1 Hz, 1H), 7.89–7.76 (m, 1H), 7.48–7.32 (m, 4H), 5.09–4.94 (m, 2H), 4.12–4.01 (m, 4H), 3.49–3.25 (m, 5H), 1.20–1.07 (m, 3H), 1.04 (t, <i>J</i> = 7.1 Hz, 3H). LC-MS: 449.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-(3-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)-2-(2,6-dimethylmorpholino)acetamide (<b>27i</b>)</h4><div class="NLM_p last">The key synthetic intermediate <i>N</i>-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)-2-(2,6-dimethylmorpholino)acetamide was synthesized as described below. A solution of morpholine (10.91 mmol) in DCM (40 mL) was treated with 0.692 mL of benzyl 2-bromo acetate at 0 °C. The resulting solutions was stirred at ambient temperature for 16 h, filtered, and concentrated. The residue was purified by silica gel chromatography using DCM/ethyl acetate to obtain benzyl 2-(2,6-dimethylmorpholino)acetate. Debenzylation in MeOH/Pd–C followed by treatment with 3-chloropropan-1-amine hydrochloride in the presence of DIEA in DCM resulted in <i>N</i>-(3-chloropropyl)-2-(2,6-dimethylmorpholino)acetamide. The resulting linker was treated with <b>25</b> in the presence of K<sub>2</sub>CO<sub>3</sub> in DMF, forming the target intermediate <i>N</i>-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)-2-(2,6 dimethylmorpholino)acetamide in 62.3% overall yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.88 (s, 1H), 7.40 (s, 1H), 7.35 (s, 1H), 4.25 (t, <i>J</i> = 6.1 Hz, 2H), 4.06 (s, 3H), 3.61–3.59 (m, 4H), 2.99 (d, <i>J</i> = 7.0 Hz, 2H), 2.66 (d, <i>J</i> = 10.4 Hz, 2H), 2.29–2.13 (m, 2H), 1.96–1.91 (t, <i>J</i> = 8.0 Hz, 2H), 1.52 (d, 8.0 Hz, 6H). LC-MS: 423.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>tert</i>-Butyl (3-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate (<b>27j</b>)</h4><div class="NLM_p last">The reactive key intermediate <i>tert</i>-butyl (3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate was prepared from a mixture of 4-chloro-7-methoxyquinazolin-6-ol (0.95 mmol) and commercially available <i>tert</i>-butyl (3-bromopropyl)carbamate (1.14 mmol) in DMF (5 mL) using potassium carbonate (1.42 mmol) as discussed above. The mixture was stirred at 65 °C for 4 h, after which the reaction mixture was cooled, diluted with water, and extracted in chloroform. The organic layer was dried and evaporated. The crude extract was purified by flash chromatography on silica (20:1 DCM/MeOH) to give 0.2 g of (60.2%). The obtained fragment was coupled with 3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine as discussed above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.19 (s, 1H), 8.93 (s, 1H), 8.77 (d, <i>J</i> = 4.8 Hz, 1H), 8.14 (d, <i>J</i> = 7.9 Hz, 1H), 7.84 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.42–7.28 (m, 2H), 6.99 (s, 2H), 5.52 (s, 1H), 4.39 (t, <i>J</i> = 5.9 Hz, 2H), 4.06 (d, <i>J</i> = s, 3H), 3.45 (d, <i>J</i> = 5.9 Hz, 2H), 2.25–2.06 (m, 2H), 1.46 (d, <i>J</i> = 6.4 Hz, 8H). LC-MS: 493.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>tert</i>-Butyl (4-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)butyl)carbamate (<b>27k</b>)</h4><div class="NLM_p last">The reactive key intermediate <i>tert</i>-butyl (4-((4-chloro-7-methoxyquinazolin-6-yl)oxy)butyl)carbamate was prepared from 4-chloro-7-methoxyquinazolin-6-ol and <i>tert</i>-butyl (4-bromobutyl)carbamate as discussed above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.20 (s, 1H), 8.92 (s, 1H), 8.77 (m, 1H), 8.14 (dt, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.83 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.42–7.30 (m, 2H), 6.99 (s, 2H), 1.66–1.52 (m, 4H), 4.33 (t, <i>J</i> = 6.4 Hz, 2H), 4.08 (s, 3H), 3.25 (d, <i>J</i> = 6.5 Hz, 2H), 2.08–1.96 (m, 2H), 1.82–1.70 (m, 2H), 1.43 (s, 9H). LC-MS: 507.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>tert</i>-Butyl (2-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)ethyl)carbamate (<b>27l</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.13 (s, 1H), 8.90 (s, 1H), 8.73 (d, <i>J</i> = 4.8 Hz, 1H), 8.08 (d, <i>J</i> = 7.9 Hz, 1H), 7.88 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.35–7.26 (m, 2H), 6.99 (s, 2H), 5.54 (s, 1H), 4.28 (t, <i>J</i> = 5.9 Hz, 2H), 4.04 (s, 3H), 3.35 (t, <i>J</i> = 5.9 Hz, 2H), 1.46 (s, 9H). LC-MS: 479.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Ethyl (3-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate (<b>27m</b>)</h4><div class="NLM_p last">Reactive key intermediate ethyl (3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate was prepared from commercially available 4-chloro-7-methoxyquinazolin-6-ol and ethyl (3-chloropropyl)carbamate as described for <b>27a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1H), 8.93 (s, 1H), 8.78–8.76 (m, 1H), 8.15–8.13 (m, 1H), 7.84 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.43–7.30 (m, 2H), 7.02 (d, <i>J</i> = 13.4 Hz, 2H), 5.76 (s, 1H), 4.41 (t, <i>J</i> = 5.8 Hz, 2H), 4.17–4.03 (m, 4H), 3.50 (d, <i>J</i> = 5.7 Hz, 2H), 2.26–2.08 (m, 2H), 1.58 (s, 4H), 1.26 (q, <i>J</i> = 7.5 Hz, 3H). LC-MS: 465.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Isopropyl (3-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate (<b>27n</b>)</h4><div class="NLM_p last">Reactive key intermediate ethyl (3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate was prepared from commercially available 4-chloro-7-methoxyquinazolin-6-ol and isopropyl (3-chloropropyl)carbamate as described for <b>27a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.17 (s, 1H), 8.91 (s, 1H), 8.78–8.76 m, 1H), 8.13 (d, <i>J</i> = 7.9 Hz, 1H), 7.84 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.42–7.31 (m, 2H), 7.12 (d, <i>J</i> = 25.1 Hz, 2H), 5.73 (s, 1H), 4.92 (dt, <i>J</i> = 12.4, 6.2 Hz, 1H), 4.40 (t, <i>J</i> = 5.8 Hz, 2H), 4.10 (s, 3H), 3.50 (dd, <i>J</i> = 11.2, 5.9 Hz, 2H), 2.26–2.09 (m, 2H), 1.68 (s, 2H), 1.31–1.14 (m, 7H). <sup>13</sup>C NMR (125 MHz, DMSO) δ 159.68, 158.92, 156.42, 156.24, 153.38, 151.44, 150.94, 150.31, 149.64, 149.40, 137.44, 124.88, 122.31, 111.22, 107.51, 106.98, 66.99, 66.74, 56.66, 37.78, 29.21, 22.52. HRMS (ESI): [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>27</sub>N<sub>8</sub>O<sub>4</sub><sup>+</sup>, 479.2155; found, 479.2158.</div></div><div id="sec4_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 2,2,2-Trifluoroethyl (3-((4-(5-amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate (<b>27o</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 9.13 (s, 1H), 8.95 (s, 1H), 8.74–8.72 (m, 1H), 8.16–8.13 (m,1H), 7.82 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.43–7.30 (m, 2H), 7.05 (d, <i>J</i> = 13.4 Hz, 2H), 5.76 (s, 1H),4.41 (t, <i>J</i> = 5.8 Hz, 2H), 4.19–4.05 (m, 4H), 3.50 (t, <i>J</i> = 5.7 Hz, 2H), 2.26–2.08 (m, 2H). LC-MS: 519.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Hexyl (3-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate (<b>27p</b>)</h4><div class="NLM_p last">General procedure for the synthesis of carbamates: 1-(6-(3-aminopropoxy)-7-methoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-amine (1.0 mmol) was dissolved in DCM (3 mL), which was prepared from <b>27j</b> by deprotection of the <i>tert</i>-butoxycarbonyl (Boc) group using HCl/THF. The mixture was cooled to 0 °C and treated with triethylamine (3.0 mmol) under a nitrogen atmosphere. The resulting mixture was stirred for 15 min, then treated with the corresponding hexyl chloroformate (1.5), and dissolved in DCM, added dropwise. The mixture was stirred at 0 °C for 1 h and then stirred overnight at room temperature. The contents were evaporated to dryness, redissolved in CHCl<sub>3</sub>, and washed with bicarbonate solution. The organic layer was evaporated to dryness and purified by flash chromatography on silica gel, eluting with 20:1 DCM/MeOH. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.19 (s, 1H), 8.93 (s, 1H), 8.74 (t, <i>J</i> = 19.2 Hz, 1H), 8.14 (d, <i>J</i> = 7.9 Hz, 1H), 7.84 (td, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.44–7.30 (m, 2H), 6.99 (d, <i>J</i> = 7.2 Hz, 2H), 5.71 (s, 1H), 4.41 (t, <i>J</i> = 5.8 Hz, 2H), 4.15–3.96 (m, 4H), 3.50 (d, <i>J</i> = 6.3 Hz, 2H), 2.30–2.04 (m, 3H), 1.67–1.41 (m, 4H), 1.32 (dd, <i>J</i> = 17.8, 9.8 Hz, 6H), 0.88 (t, <i>J</i> = 6.8 Hz, 3H). LC-MS: 479.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Phenyl (3-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate (<b>27q</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.22 (s, 1H), 8.94 (s, 1H), 8.75 (t, <i>J</i> = 18.4 Hz, 1H), 8.14 (d, <i>J</i> = 7.9 Hz, 1H), 7.83 (t, <i>J</i> = 6.9 Hz, 1H), 7.36 (dd, <i>J</i> = 15.7, 7.8 Hz, 3H), 7.15 (dd, <i>J</i> = 24.0, 7.7 Hz, 2H), 6.98 (s, 2H), 6.38 (s, 1H), 4.48 (t, <i>J</i> = 5.7 Hz, 2H), 4.12–4.02 (m, 3H), 3.65–3.49 (m, 2H), 2.35–2.17 (m, 2H). LC-MS: 513.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> neopentyl (3-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)carbamate (<b>27r</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.09 (s, 1H), 8.88 (s, 2H), 8.66–8.51 (m, 1H), 8.53 (d, <i>J</i> = 14.7 Hz, 1H), 8.17 (d, <i>J</i> = 8.0 Hz, 1H), 7.95 (t, <i>J</i> = 7.1 Hz, 1H), 7.48–7.41 (m, 1H), 4.32 (t, <i>J</i> = 6.0 Hz, 2H), 4.04 (s, 3H), 3.68 (d, <i>J</i> = 13.9 Hz, 3H), 2.08 (t, <i>J</i> = 6.4 Hz, 2H), 0.85 (s, 9H). LC-MS: 507.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> N-(3-((4-(5-Amino-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)-7-methoxyquinazolin-6-yl)oxy)propyl)-2,2,2-trifluoroacetamide (<b>27s</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 9.03 (s, 1H), 8.96 (s, 1H), 8.72–8.68 (m, 1H), 8.20–8.15 (m,1H), 7.84 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.44–7.35 (m, 2H), 7.06 (d, <i>J</i> = 13.4 Hz, 2H), 5.76 (s, 1H), 4.41 (t, <i>J</i> = 5.8 Hz, 2H), 4.19–4.05 (m, 2H), 4.03 (s, 3H), 2.26–2.08 (m, 2H). LC-MS: 489.0 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Biology</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Cell Culture and Irradiation</h4><div class="NLM_p last">MCF7 cells were obtained from ATCC (American Type Culture Collection, Manassas, VA) and cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum at 37 °C in a humidified atmosphere (5% CO<sub>2</sub>). Cells were irradiated using a <sup>137</sup>Cs source (Gamma cell 40-exactor, MDS Nordion, Ottawa, Ontario, Canada) at a dose of 2–10 Gy.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> In-Cell Western Assay</h4><div class="NLM_p last">Quantitative immunofluorescence assay (in-cell western assay) was used for testing ATM kinase inhibitors. MCF7 cells (10<sup>5</sup>) were plated in 384-well plates and incubated overnight in an incubator under a 5% CO<sub>2</sub> atmosphere at 37 °C. After incubation, using a Biomek FX (Beckman Coulter) liquid handling automation workstation, compounds were transferred into the wells of plates, with DMSO included as a negative control and compound <b>4</b> as a positive control. Etoposide, a DNA damaging agent, was transferred to each well to a final concentration of 25 μM to activate ATM kinase. Next, cells were incubated at 37 °C for 1 h, immediately fixed by adding formaldehyde to a final concentration of 4% (v/v), and further incubated for 20 min at room temperature. After being washed three times with 1× PBS, cells were permeabilized by incubating with 1× PBS containing 0.1% Triton X-100 for 20 min. After permeabilization, cells were then incubated overnight at 4 °C with 20 μL of p-KAP1 antibody (1:1000, Bethyl Laboratories). The next day, plates were washed three times with 1× PBS containing 0.1% Tween-20. Subsequently, 20 μL of IRDye 800CW goat anti-rabbit secondary antibody solution (1:5000, LI-COR life science) containing DNA stain DRAQ5 (1:5000) was added into each well. After a 1 h incubation at room temperature, the plates were washed three times with 1× PBS containing 0.1% Tween-20, and the plate was turned upside down to remove washing buffer and scanned on an Aerius automated infrared imaging system (LI-COR Biosciences) for quantitative analysis. Images for nuclear and p-KAP1 staining were obtained by using the 700 and 800 nm channels of the Aerius infrared imaging system, respectively. Fluorescence intensities were measured using the software provided with the imaging system.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Western Blotting</h4><div class="NLM_p last">MCF7 cells were pretreated with ATM inhibitors or DMSO for 30 min and then irradiated at 10 Gy. One hour after IR, cells were harvested and lysed in RIPA buffer (10 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 0.1% SDS, 1% NP-40) supplemented with protease and phosphatase inhibitor cocktails from Roche diagnostics. Lysates were centrifuged at 13 000<i>g</i> for 20 min at 4 °C. After centrifugation, supernatants were transferred into new 1.5 mL tubes, and protein concentrations were quantitated using DCTM protein assay from Bio-Rad laboratories (Hercules, CA). Equal amounts of total protein (100 μg) for each lysate were loaded on a 4–12% NuPAGE Bis-Tris precast gel (Life Technologies, Grand Island, NY). After running for 1.5 h under a constant 120 V, resolved proteins were electronically transferred onto 0.45 μM PVDF transfer membrane overnight at 800 mA in a TE 62 transfer unit (GE Healthcare Life Sciences, Pittsburgh, PA). After transfer, the membrane was cut into four strips for blotting with anti-phospho-ATM(S1981), anti-phospho-KAP1(S824), anti-phospho-p53(S15), and anti-β-actin. Membranes were then blocked with 1× Tris-buffered saline with 0.1% Tween (TBST) buffer containing 5% nonfat milk for 1 h at room tempterature. After blocking, membranes were rinsed with TBST buffer and incubated with different primary antibodies overnight at 4 °C with gentle agitation. Primary antibodies were prepared in 1:1000 dilutions in 1× Tris-buffered saline with Tween (TBST) buffer containing 5% bovine serum albumin (BSA). Antibodies used in this experiment include anti-phospho-ATM(S1981) (cat. 2152-1; Epitomics, Burlingame, CA), anti-phospho-p53(S15) (cat. 9284L; Cell Signaling, Danvers, MA), anti-phospho-KAP1(S824) (cat. A300-767A; Bethyl Laboratories, Montgomery, TX), anti-total-ATM (cat. ab59541; Abcam, Cambridge, MA), and anti-β-actin (cat. A5316; Sigma, St. Louis, MO). The next day, after removing primary antibodies, membranes were washed four times for 5 min/wash with TBST. Next, membranes were incubated in the dark for 1 h at room temperature with gentle agitation with IRDye 800CW goat anti-rabbit or anti-mouse secondary antibodies (LI-COR Biosciences, Lincoln, NE) at a 1:5000 dilution in TBST containing 5% nonfat milk. After incubation, membranes were washed four times for 5 min/wash with TBST and then visualized using an Odyssey CLx infrared imaging system (LI-COR Biosciences, Lincoln, NE).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Clonogenic Assay</h4><div class="NLM_p last">MCF7 cells (0.5 × 10<sup>6</sup>) were plated in each well of a 6-well plate and incubated overnight at 37 °C. The next day, cells were pretreated with DMSO or various ATM kinase inhibitors at a final concentration of 10 μM. After 1 h of pretreatment with inhibitors, cells were irradiated at 2 or 4 Gy and incubated for another 4 h with DMSO or ATM inhibitors. Cells were then harvested, resuspended in media, and counted using a cell counter. A total of 2000 cells for each treatment were placed in a 10 cm plate in the absence of inhibitors and cultured for 10 days. After a 10 day incubation, the culture media was removed. Cells were washed with PBS once. Then, 5 mL of a mixture of 6.0% glutaraldehyde and 0.5% crystal violet was added into each plate and incubated for 30 min. Next, the glutaraldehyde–crystal violet mixture was decanted. The plates were rinsed with tap water and air-dried at room temperature. Colonies containing over 50 cells were counted for each plate. This experiment was run in triplicate. The average number of colonies was calculated and normalized to that of the DMSO-treated plates. Surviving fractions for each treatment were plotted using GraphPad Prism software.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> In Vivo Pharmacokinetic Study</h4><div class="NLM_p last">Female C57BL/6 mice (22–27 g) were purchased from Charles River Laboratories (Wilmington, MA). Food and water were provided ad libitum. For each compound, 18 mice were divided into 3 dosage groups of 0, 10, and 20 mg/kg. Solubilized compound in formulation (5:45:50, EtOH/PPG/PBS (pH 7.4), HβCD 10 mM, with 5% DMSO) was given to each animal by tail vein injection at a volume of 4 mL/kg. Blood (0.1 mL) was collected retro-orbitally from a different mouse within each dosage group at 5, 15, and 30 min and 1, 4, and 24 h postadministration (<i>n</i> = 6 for 6 time points). Terminal blood collection via cardiac puncture was conducted on each animal to obtain 0.5–0.7 mL blood at the 48 h time point. Blood samples were treated with 10% EDTA disodium at collection. Each blood sample was centrifuged for 3 min at 13 200 rpm in a desktop centrifuge to obtain plasma samples. Each sample was combined with three volumes of internal standard (2 μM warfarin in acetonitrile) and centrifuged at 3 min at 13 200 rpm twice. The supernatant was transferred to a 96-well assay plate, and concentration was determined with UPLC-MS (Waters Corp., Milford, MA). Quantification was based on the peak area ratio (compound of interest/internal standard).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01092">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01092" class="ext-link">10.1021/acs.jmedchem.5b01092</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures for early ADMET and MTD study; permeability data for all compounds; in vivo PK and metabolic identification data for compound <b>4</b>; synthetic scheme for <b>19</b>, <b>20</b>, and linker intermediates for <b>27m</b>–<b>o</b> and <b>27i</b>; cytotoxicity data against HepG2, HEK293, and Raji cell lines for all compounds; kinome scan analysis for compounds <b>4</b> and <b>27g</b>; <i>K</i><sub>d</sub>’s of compound <b>27g</b> for selected kinases; western blot analysis for the effect of compounds <b>1</b>, <b>4</b>, and <b>20</b>; liver microsome stability data for compounds <b>4</b>, <b>20</b>, and <b>27g</b>; complete blood count data, blood chemistry panel, and pathological review of tissues for compounds <b>20</b> and <b>27g</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES strings and ATM inhibition IC<sub>50</sub>, solubility, and BJ EC<sub>50</sub> data (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf">jm5b01092_si_001.pdf (1.12 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_002.csv">jm5b01092_si_002.csv (5.88 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01092" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Kiplin Guy</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a0cbc9d08ec7d5d9e0d3d4cad5c4c58ecfd2c7"><span class="__cf_email__" data-cfemail="fc97958cd29b8985bc8f8896899899d2938e9b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaeki Min</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kexiao Guo</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Praveen K. Suryadevara</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fangyi Zhu</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gloria Holbrook</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yizhe Chen</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clementine Feau</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brandon M. Young</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Lemoff</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele C. Connelly</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemical Biology and Therapeutics, ‡Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael B. Kastan</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke University School of Medicine, 422 Seeley Mudd Building, Durham, North Carolina 27710, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.M. and K.G. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i103" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i103"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i104" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i104"> Abbreviations Used</h2><tr><td class="NLM_term">ATM</td><td class="NLM_def"><p class="first last">ataxia-telangiectasia mutated</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">PIKK</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase-related kinase</p></td></tr><tr><td class="NLM_term">DSB</td><td class="NLM_def"><p class="first last">DNA double-strand break</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">ionizing radiation</p></td></tr><tr><td class="NLM_term">NBS1</td><td class="NLM_def"><p class="first last">Nijmegen breakage syndrome gene</p></td></tr><tr><td class="NLM_term">Smc</td><td class="NLM_def"><p class="first last">structural maintenance of chromosome</p></td></tr><tr><td class="NLM_term">FancD2</td><td class="NLM_def"><p class="first last">Fanconi anemia group D2</p></td></tr><tr><td class="NLM_term">Rad17</td><td class="NLM_def"><p class="first last">cell cycle checkpoint protein RAD17</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">DNA-PKcs</td><td class="NLM_def"><p class="first last">DNA-dependent protein kinase catalytic subunit</p></td></tr><tr><td class="NLM_term">HNO<sub>3</sub></td><td class="NLM_def"><p class="first last">nitric acid</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">FeCl<sub>3</sub></td><td class="NLM_def"><p class="first last">iron(III) chloride</p></td></tr><tr><td class="NLM_term">Cs<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">cesium carbonate</p></td></tr><tr><td class="NLM_term">ELSD</td><td class="NLM_def"><p class="first last">evaporative light scattering detector</p></td></tr><tr><td class="NLM_term">CLND</td><td class="NLM_def"><p class="first last">chemiluminescent nitrogen detection</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration observed</p></td></tr><tr><td class="NLM_term">KAP1</td><td class="NLM_def"><p class="first last">KRAB domain-associated protein 1</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lovejoy, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortez, D.</span><span> </span><span class="NLM_article-title">Common mechanisms of PIKK regulation</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/j.dnarep.2009.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1016%2Fj.dnarep.2009.04.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1004-8&author=C.+A.+Lovejoyauthor=D.+Cortez&title=Common+mechanisms+of+PIKK+regulation&doi=10.1016%2Fj.dnarep.2009.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2009.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2009.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DLovejoy%26aufirst%3DC.%2BA.%26aulast%3DCortez%26aufirst%3DD.%26atitle%3DCommon%2520mechanisms%2520of%2520PIKK%2520regulation%26jtitle%3DDNA%2520Repair%26date%3D2009%26volume%3D8%26spage%3D1004%26epage%3D8%26doi%3D10.1016%2Fj.dnarep.2009.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">Cell cycle checkpoint signaling through the ATM and ATR kinases</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2196</span><span class="refDoi"> DOI: 10.1101/gad.914401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1101%2Fgad.914401" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=2177-2196&author=R.+T.+Abraham&title=Cell+cycle+checkpoint+signaling+through+the+ATM+and+ATR+kinases&doi=10.1101%2Fgad.914401"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fgad.914401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.914401%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DCell%2520cycle%2520checkpoint%2520signaling%2520through%2520the%2520ATM%2520and%2520ATR%2520kinases%26jtitle%3DGenes%2520Dev.%26date%3D2001%26volume%3D15%26spage%3D2177%26epage%3D2196%26doi%3D10.1101%2Fgad.914401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Shiloh, Y.</span><span> </span><span class="NLM_article-title">ATM and related protein kinases: safeguarding genome integrity</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1038/nrc1011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2Fnrc1011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=12612651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=155-168&author=Y.+Shiloh&title=ATM+and+related+protein+kinases%3A+safeguarding+genome+integrity&doi=10.1038%2Fnrc1011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">ATM and related protein kinases: safeguarding genome integrity</span></div><div class="casAuthors">Shiloh, Yosef</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-168</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Maintenance of genome stability is essential for avoiding the passage to neoplasia.  The DNA-damage response - a cornerstone of genome stability - occurs by a swift transduction of the DNA-damage signal to many cellular pathways.  A prime example is the cellular response to DNA double-strand breaks, which activate the ATM protein kinase that, in turn, modulates numerous signaling pathways.  ATM mutations lead to the cancer-predisposing genetic disorder ataxia-telangiectasia (A-T).  Understanding ATM's mode of action provides new insights into the assocn. between defective responses to DNA damage and cancer, and brings us closer to resolving the issue of cancer predisposition in some A-T carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6rldvrvSuQLVg90H21EOLACvtfcHk0lgzY50tvUkGjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGhtr4%253D&md5=2d84325b04979dad3e33155fefa421e6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc1011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1011%26sid%3Dliteratum%253Aachs%26aulast%3DShiloh%26aufirst%3DY.%26atitle%3DATM%2520and%2520related%2520protein%2520kinases%253A%2520safeguarding%2520genome%2520integrity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D155%26epage%3D168%26doi%3D10.1038%2Fnrc1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zakian, V. A.</span><span> </span><span class="NLM_article-title">ATM-related genes: what do they tell us about functions of the human gene?</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1016/0092-8674(95)90463-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1016%2F0092-8674%2895%2990463-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1995&pages=685-7&author=V.+A.+Zakian&title=ATM-related+genes%3A+what+do+they+tell+us+about+functions+of+the+human+gene%3F&doi=10.1016%2F0092-8674%2895%2990463-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990463-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990463-8%26sid%3Dliteratum%253Aachs%26aulast%3DZakian%26aufirst%3DV.%2BA.%26atitle%3DATM-related%2520genes%253A%2520what%2520do%2520they%2520tell%2520us%2520about%2520functions%2520of%2520the%2520human%2520gene%253F%26jtitle%3DCell%26date%3D1995%26volume%3D82%26spage%3D685%26epage%3D7%26doi%3D10.1016%2F0092-8674%2895%2990463-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bassing, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, F. W.</span><span> </span><span class="NLM_article-title">The cellular response to general and programmed DNA double strand breaks</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1016/j.dnarep.2004.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1016%2Fj.dnarep.2004.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=781-96&author=C.+H.+Bassingauthor=F.+W.+Alt&title=The+cellular+response+to+general+and+programmed+DNA+double+strand+breaks&doi=10.1016%2Fj.dnarep.2004.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2004.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2004.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBassing%26aufirst%3DC.%2BH.%26aulast%3DAlt%26aufirst%3DF.%2BW.%26atitle%3DThe%2520cellular%2520response%2520to%2520general%2520and%2520programmed%2520DNA%2520double%2520strand%2520breaks%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D781%26epage%3D96%26doi%3D10.1016%2Fj.dnarep.2004.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Khanna, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span> </span><span class="NLM_article-title">DNA double-strand breaks: signaling, repair and the cancer connection</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1038/85798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2F85798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=11242102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslKqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2001&pages=247-254&author=K.+K.+Khannaauthor=S.+P.+Jackson&title=DNA+double-strand+breaks%3A+signaling%2C+repair+and+the+cancer+connection&doi=10.1038%2F85798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">DNA double-strand breaks: signaling, repair and the cancer connection</span></div><div class="casAuthors">Khanna, Kum Kum; Jackson, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review, with 76 refs.,.  To ensure the high-fidelity transmission of genetic information, cells have evolved mechanisms to monitor genome integrity.  Cells respond to DNA damage by activating a complex DNA-damage-response pathway that includes cell-cycle arrest, the transcriptional and post-transcriptional activation of a subset of genes including those assocd. with DNA repair, and under some circumstances, the triggering of programmed cell death.  An inability to respond properly to, or to repair, DNA damage leads to genetic instability, which in turn may enhance the rate of cancer development.  Indeed, it is becoming increasingly clear that deficiencies in DNA-damage signaling and repair pathways are fundamental to the etiol. of most, if not all, human cancers.  Here, recent progress in the understanding of how cells detect and signal the presence and repair of one particularly important form of DNA damage induced by ionizing radiation, the DNA double-strand break (DSB), is described.  Moreover, how tumor suppressor proteins such as p53, ATM, Brca1 and Brca2 have been linked to such pathways and how accumulating evidence is connecting deficiencies in cellular responses to DNA DSBs with tumorigenesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2_Aw1LLx3LVg90H21EOLACvtfcHk0lgzY50tvUkGjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslKqtLg%253D&md5=e5ccb5ac64c8dbf39375d33a056f34ad</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F85798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85798%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26atitle%3DDNA%2520double-strand%2520breaks%253A%2520signaling%252C%2520repair%2520and%2520the%2520cancer%2520connection%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D27%26spage%3D247%26epage%3D254%26doi%3D10.1038%2F85798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">van Gent, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeijmakers, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaar, R.</span><span> </span><span class="NLM_article-title">Chromosomal stability and the DNA double-stranded break connection</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1038/35056049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2F35056049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=11256071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A280%3ADC%252BD3M7pvVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=196-206&author=D.+C.+van+Gentauthor=J.+H.+Hoeijmakersauthor=R.+Kanaar&title=Chromosomal+stability+and+the+DNA+double-stranded+break+connection&doi=10.1038%2F35056049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Chromosomal stability and the DNA double-stranded break connection</span></div><div class="casAuthors">van Gent D C; Hoeijmakers J H; Kanaar R</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">196-206</span>
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    </div><div class="casAbstract">Genome stability is of primary importance for the survival and proper functioning of all organisms.  Double-stranded breaks in DNA are important threats to genome integrity because they can result in chromosomal aberrations that can affect, simultaneously, many genes, and lead to cell malfunctioning and cell death.  These detrimental consequences are counteracted by two mechanistically distinct pathways of double-stranded break repair: homologous recombination and non-homologous end-joining.  Recently, unexpected links between these double-stranded break-repair systems, and several human genome instability and cancer predisposition syndromes, have emerged.  Now, interactions between both double-stranded break-repair pathways and other cellular processes, such as cell-cycle regulation and replication, are being unveiled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnFunGJMZss2K_SFaaT9INfW6udTcc2eYdT6V36D31E7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7pvVCqtw%253D%253D&md5=1fb0f52a76360bb82709925dbd253946</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F35056049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35056049%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BGent%26aufirst%3DD.%2BC.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BH.%26aulast%3DKanaar%26aufirst%3DR.%26atitle%3DChromosomal%2520stability%2520and%2520the%2520DNA%2520double-stranded%2520break%2520connection%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2001%26volume%3D2%26spage%3D196%26epage%3D206%26doi%3D10.1038%2F35056049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Shiloh, Y.</span><span> </span><span class="NLM_article-title">Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart</span> <span class="citation_source-journal">Annu. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1146/annurev.genet.31.1.635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1146%2Fannurev.genet.31.1.635" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1997&pages=635-662&author=Y.+Shiloh&title=Ataxia-telangiectasia+and+the+Nijmegen+breakage+syndrome%3A+related+disorders+but+genes+apart&doi=10.1146%2Fannurev.genet.31.1.635"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev.genet.31.1.635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.genet.31.1.635%26sid%3Dliteratum%253Aachs%26aulast%3DShiloh%26aufirst%3DY.%26atitle%3DAtaxia-telangiectasia%2520and%2520the%2520Nijmegen%2520breakage%2520syndrome%253A%2520related%2520disorders%2520but%2520genes%2520apart%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D1997%26volume%3D31%26spage%3D635%26epage%3D662%26doi%3D10.1146%2Fannurev.genet.31.1.635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kastan, M.</span><span> </span><span class="NLM_article-title">Ataxia-telangiectasia--broad implications for a rare disorder</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span><span class="refDoi"> DOI: 10.1056/NEJM199509073331014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1056%2FNEJM199509073331014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=7637733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A280%3ADyaK2MzmsVyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1995&pages=662-3&author=M.+Kastan&title=Ataxia-telangiectasia%2D%2Dbroad+implications+for+a+rare+disorder&doi=10.1056%2FNEJM199509073331014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Ataxia-telangiectasia--broad implications for a rare disorder</span></div><div class="casAuthors">Kastan M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">662-3</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnJQbHO1aQjpWtyewyzkyLfW6udTcc2eZHmT_BzcE9lLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MzmsVyksg%253D%253D&md5=bccf23b85b095f0ba5601bf7b2875774</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJM199509073331014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199509073331014%26sid%3Dliteratum%253Aachs%26aulast%3DKastan%26aufirst%3DM.%26atitle%3DAtaxia-telangiectasia--broad%2520implications%2520for%2520a%2520rare%2520disorder%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1995%26volume%3D333%26spage%3D662%26epage%3D3%26doi%3D10.1056%2FNEJM199509073331014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Moding, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch, D. G.</span><span> </span><span class="NLM_article-title">Strategies for optimizing the response of cancer and normal tissues to radiation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1038/nrd4003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2Fnrd4003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=23812271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVaiu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=526-42&author=E.+J.+Modingauthor=M.+B.+Kastanauthor=D.+G.+Kirsch&title=Strategies+for+optimizing+the+response+of+cancer+and+normal+tissues+to+radiation&doi=10.1038%2Fnrd4003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for optimizing the response of cancer and normal tissues to radiation</span></div><div class="casAuthors">Moding, Everett J.; Kastan, Michael B.; Kirsch, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">526-542</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Approx. 50% of all patients with cancer receive radiation therapy at some point during the course of their treatment, and the majority of these patients are treated with curative intent.  Despite recent advances in the planning of radiation treatment and the delivery of image-guided radiation therapy, acute toxicity and potential long-term side effects often limit the ability to deliver a sufficient dose of radiation to control tumors locally.  In the past two decades, a better understanding of the hallmarks of cancer and the discovery of specific signalling pathways by which cells respond to radiation have provided new opportunities to design molecularly targeted therapies to increase the therapeutic window of radiation therapy.  Here, we review efforts to develop approaches that could improve outcomes with radiation therapy by increasing the probability of tumor cure or by decreasing normal tissue toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou7EQIkMMxvrVg90H21EOLACvtfcHk0lgHvPT2R16W4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaiu7zK&md5=f7a6b5ed442870ec03086ded64a28fc5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd4003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4003%26sid%3Dliteratum%253Aachs%26aulast%3DModing%26aufirst%3DE.%2BJ.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DKirsch%26aufirst%3DD.%2BG.%26atitle%3DStrategies%2520for%2520optimizing%2520the%2520response%2520of%2520cancer%2520and%2520normal%2520tissues%2520to%2520radiation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D526%26epage%3D42%26doi%3D10.1038%2Fnrd4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bakkenist, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastan, M. B.</span><span> </span><span class="NLM_article-title">DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span><span class="refDoi"> DOI: 10.1038/nature01368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2Fnature01368" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=499-506&author=C.+J.+Bakkenistauthor=M.+B.+Kastan&title=DNA+damage+activates+ATM+through+intermolecular+autophosphorylation+and+dimer+dissociation&doi=10.1038%2Fnature01368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature01368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01368%26sid%3Dliteratum%253Aachs%26aulast%3DBakkenist%26aufirst%3DC.%2BJ.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DDNA%2520damage%2520activates%2520ATM%2520through%2520intermolecular%2520autophosphorylation%2520and%2520dimer%2520dissociation%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D499%26epage%3D506%26doi%3D10.1038%2Fnature01368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kastan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span> </span><span class="NLM_article-title">Cell-cycle checkpoints and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1038/nature03097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2Fnature03097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=15549093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=316-23&author=M.+B.+Kastanauthor=J.+Bartek&title=Cell-cycle+checkpoints+and+cancer&doi=10.1038%2Fnature03097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle checkpoints and cancer</span></div><div class="casAuthors">Kastan, Michael B.; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7015</span>),
    <span class="NLM_cas:pages">316-323</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  All life on earth must cope with const. exposure to DNA-damaging agents such as the Sun's radiation.  Highly conserved DNA-repair and cell-cycle checkpoint pathways allow cells to deal with both endogenous and exogenous sources of DNA damage.  How much an individual is exposed to these agents and how their cells respond to DNA damage are crit. determinants of whether that individual will develop cancer.  These cellular responses are also important for detg. toxicities and responses to current cancer therapies, most of which target the DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONns98smbebVg90H21EOLACvtfcHk0lj9FjogO2sG6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtLo%253D&md5=23577cd35313a3a11afee151281c3fd4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature03097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03097%26sid%3Dliteratum%253Aachs%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DCell-cycle%2520checkpoints%2520and%2520cancer%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D316%26epage%3D23%26doi%3D10.1038%2Fnature03097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Khalil, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hupp, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhelev, N.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1258/ebm.2012.011378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1258%2Febm.2012.011378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOns7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2012&pages=622-34&author=H.+S.+Khalilauthor=H.+Tummalaauthor=T.+R.+Huppauthor=N.+Zhelev&title=Pharmacological+inhibition+of+ATM+by+KU55933+stimulates+ATM+transcription&doi=10.1258%2Febm.2012.011378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription</span></div><div class="casAuthors">Khalil, Hilal S.; Tummala, Hemanth; Hupp, Tedd R.; Zhelev, Nikolai</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">622-634</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Medicine Press Ltd.</span>)
        </div><div class="casAbstract">Ataxia-telangiectasia mutated (ATM) kinase is a component of a signalling mechanism that dets. the process of decision-making in response to DNA damage and involves the participation of multiple proteins.  ATM is activated by DNA double-strand breaks (DSBs) through the Mre11-Rad50-Nbs1 (MRN) DNA repair complex, and orchestrates signalling cascades that initiate the DNA damage response.  Cells lacking ATM are hypersensitive to insults, particularly genotoxic stress, induced through radiation or radiomimetic drugs.  Here, we investigate the degree of ATM activation during time-dependent treatment with genotoxic agents and the effects of ATM on phospho-induction and localization of its downstream substrates.  Addnl., we have demonstrated a new cell-cycle-independent mechanism of ATM gene regulation following ATM kinase inhibition with KU5593.  Inhibition of ATM activity causes induction of ATM protein followed by oscillation and this mechanism is governed at the transcriptional level.  Furthermore, this autoregulatory induction of ATM is also accompanied by a transient upregulation of p53, pATR and E2F1 levels.  Since ATM inhibition is believed to sensitize cancer cells to genotoxic agents, this novel insight into the mechanism of ATM regulation might be useful for designing more precise strategies for modulation of ATM activity in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOQN3qa-VRUbVg90H21EOLACvtfcHk0lj9FjogO2sG6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOns7%252FF&md5=095b9cd39521a25357f9053485a454b0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1258%2Febm.2012.011378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2012.011378%26sid%3Dliteratum%253Aachs%26aulast%3DKhalil%26aufirst%3DH.%2BS.%26aulast%3DTummala%26aufirst%3DH.%26aulast%3DHupp%26aufirst%3DT.%2BR.%26aulast%3DZhelev%26aufirst%3DN.%26atitle%3DPharmacological%2520inhibition%2520of%2520ATM%2520by%2520KU55933%2520stimulates%2520ATM%2520transcription%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2012%26volume%3D237%26spage%3D622%26epage%3D34%26doi%3D10.1258%2Febm.2012.011378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Rainey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastan, M. B.</span><span> </span><span class="NLM_article-title">Transient Inhibition of ATM kinase Is sufficient to enhance cellular sensitivity to ionizing radiation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7466</span><span class="NLM_x">–</span> <span class="NLM_lpage">7474</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-0763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1158%2F0008-5472.CAN-08-0763" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=7466-7474&author=M.+D.+Raineyauthor=M.+E.+Charltonauthor=R.+V.+Stantonauthor=M.+B.+Kastan&title=Transient+Inhibition+of+ATM+kinase+Is+sufficient+to+enhance+cellular+sensitivity+to+ionizing+radiation&doi=10.1158%2F0008-5472.CAN-08-0763"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0763%26sid%3Dliteratum%253Aachs%26aulast%3DRainey%26aufirst%3DM.%2BD.%26aulast%3DCharlton%26aufirst%3DM.%2BE.%26aulast%3DStanton%26aufirst%3DR.%2BV.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DTransient%2520Inhibition%2520of%2520ATM%2520kinase%2520Is%2520sufficient%2520to%2520enhance%2520cellular%2520sensitivity%2520to%2520ionizing%2520radiation%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D7466%26epage%3D7474%26doi%3D10.1158%2F0008-5472.CAN-08-0763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Andrs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodny, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moravcova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzlikova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span> </span><span class="NLM_article-title">The development of ataxia telangiectasia mutated kinase inhibitors</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span><span class="refDoi"> DOI: 10.2174/1389557514666141013140217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.2174%2F1389557514666141013140217" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=805-811&author=M.+Andrsauthor=J.+Korabecnyauthor=E.+Nepovimovaauthor=D.+Junauthor=Z.+Hodnyauthor=S.+Moravcovaauthor=H.+Hanzlikovaauthor=K.+Kuca&title=The+development+of+ataxia+telangiectasia+mutated+kinase+inhibitors&doi=10.2174%2F1389557514666141013140217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1389557514666141013140217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557514666141013140217%26sid%3Dliteratum%253Aachs%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DHodny%26aufirst%3DZ.%26aulast%3DMoravcova%26aufirst%3DS.%26aulast%3DHanzlikova%26aufirst%3DH.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DThe%2520development%2520of%2520ataxia%2520telangiectasia%2520mutated%2520kinase%2520inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D805%26epage%3D811%26doi%3D10.2174%2F1389557514666141013140217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sarkaria, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbetts, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4375</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=4375-82&author=J.+N.+Sarkariaauthor=R.+S.+Tibbettsauthor=E.+C.+Busbyauthor=A.+P.+Kennedyauthor=D.+E.+Hillauthor=R.+T.+Abraham&title=Inhibition+of+phosphoinositide+3-kinase+related+kinases+by+the+radiosensitizing+agent+wortmannin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DTibbetts%26aufirst%3DR.%2BS.%26aulast%3DBusby%26aufirst%3DE.%2BC.%26aulast%3DKennedy%26aufirst%3DA.%2BP.%26aulast%3DHill%26aufirst%3DD.%2BE.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DInhibition%2520of%2520phosphoinositide%25203-kinase%2520related%2520kinases%2520by%2520the%2520radiosensitizing%2520agent%2520wortmannin%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D4375%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaper, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span> </span><span class="NLM_article-title">Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">9152</span><span class="NLM_x">–</span> <span class="NLM_lpage">9159</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-2727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1158%2F0008-5472.CAN-04-2727" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=9152-9159&author=I.+Hicksonauthor=Y.+Zhaoauthor=C.+J.+Richardsonauthor=S.+J.+Greenauthor=N.+M.+B.+Martinauthor=A.+I.+Orrauthor=P.+M.+Reaperauthor=S.+P.+Jacksonauthor=N.+J.+Curtinauthor=G.+C.+M.+Smith&title=Identification+and+characterization+of+a+novel+and+specific+inhibitor+of+the+ataxia-telangiectasia+mutated+kinase+ATM&doi=10.1158%2F0008-5472.CAN-04-2727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-2727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-2727%26sid%3Dliteratum%253Aachs%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DGreen%26aufirst%3DS.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DOrr%26aufirst%3DA.%2BI.%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520and%2520specific%2520inhibitor%2520of%2520the%2520ataxia-telangiectasia%2520mutated%2520kinase%2520ATM%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D9152%26epage%3D9159%26doi%3D10.1158%2F0008-5472.CAN-04-2727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Golding, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valerie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussaini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigoreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Povirk, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valerie, K.</span><span> </span><span class="NLM_article-title">Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2894</span><span class="NLM_x">–</span> <span class="NLM_lpage">2902</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1158%2F1535-7163.MCT-09-0519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=19808981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2894-2902&author=S.+E.+Goldingauthor=E.+Rosenbergauthor=N.+Valerieauthor=I.+Hussainiauthor=M.+Frigerioauthor=X.+F.+Cockcroftauthor=W.+Y.+Chongauthor=M.+Hummersoneauthor=L.+Rigoreauauthor=K.+A.+Menearauthor=M.+J.+O%E2%80%99Connorauthor=L.+F.+Povirkauthor=T.+van+Meterauthor=K.+Valerie&title=Improved+ATM+kinase+inhibitor+KU-60019+radiosensitizes+glioma+cells%2C+compromises+insulin%2C+AKT+and+ERK+prosurvival+signaling%2C+and+inhibits+migration+and+invasion&doi=10.1158%2F1535-7163.MCT-09-0519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion</span></div><div class="casAuthors">Golding, Sarah E.; Rosenberg, Elizabeth; Valerie, Nicholas; Hussaini, Isa; Frigerio, Mark; Cockcroft, Xiaoling F.; Chong, Wei Yee; Hummersone, Marc; Rigoreau, Laurent; Menear, Keith A.; O'Connor, Mark J.; Povirk, Lawrence F.; van Meter, Timothy; Valerie, Kristoffer</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2894-2902</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ataxia telangiectasia (A-T) mutated (ATM) is crit. for cell cycle checkpoints and DNA repair.  Thus, specific small mol. inhibitors targeting ATM could perhaps be developed into efficient radiosensitizers.  Recently, a specific inhibitor of the ATM kinase, KU-55933, was shown to radiosensitize human cancer cells.  Herein, we report on an improved analog of KU-55933 (KU-60019) with Ki and IC50 values half of those of KU-55933.  KU-60019 is 10-fold more effective than KU-55933 at blocking radiation-induced phosphorylation of key ATM targets in human glioma cells.  As expected, KU-60019 is a highly effective radiosensitizer of human glioma cells.  A-T fibroblasts were not radiosensitized by KU-60019, strongly suggesting that the ATM kinase is specifically targeted.  Furthermore, KU-60019 reduced basal S473 AKT phosphorylation, suggesting that the ATM kinase might regulate a protein phosphatase acting on AKT.  In line with this finding, the effect of KU-60019 on AKT phosphorylation was countered by low levels of okadaic acid, a phosphatase inhibitor, and A-T cells were impaired in S473 AKT phosphorylation in response to radiation and insulin and unresponsive to KU-60019.  We also show that KU-60019 inhibits glioma cell migration and invasion in vitro, suggesting that glioma growth and motility might be controlled by ATM via AKT.  Inhibitors of MEK and AKT did not further radiosensitize cells treated with KU-60019, supporting the idea that KU-60019 interferes with prosurvival signaling sep. from its radiosensitizing properties.  Altogether, KU-60019 inhibits the DNA damage response, reduces AKT phosphorylation and prosurvival signaling, inhibits migration and invasion, and effectively radiosensitizes human glioma cells. [Mol Cancer Ther 2009;8(10):2894-902].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXun9h1lvdbbVg90H21EOLACvtfcHk0lhQ4DQUqjfYzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7F&md5=32fab13cdf80a5fcb520e358252c8764</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0519%26sid%3Dliteratum%253Aachs%26aulast%3DGolding%26aufirst%3DS.%2BE.%26aulast%3DRosenberg%26aufirst%3DE.%26aulast%3DValerie%26aufirst%3DN.%26aulast%3DHussaini%26aufirst%3DI.%26aulast%3DFrigerio%26aufirst%3DM.%26aulast%3DCockcroft%26aufirst%3DX.%2BF.%26aulast%3DChong%26aufirst%3DW.%2BY.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DRigoreau%26aufirst%3DL.%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DPovirk%26aufirst%3DL.%2BF.%26aulast%3Dvan%2BMeter%26aufirst%3DT.%26aulast%3DValerie%26aufirst%3DK.%26atitle%3DImproved%2520ATM%2520kinase%2520inhibitor%2520KU-60019%2520radiosensitizes%2520glioma%2520cells%252C%2520compromises%2520insulin%252C%2520AKT%2520and%2520ERK%2520prosurvival%2520signaling%252C%2520and%2520inhibits%2520migration%2520and%2520invasion%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2894%26epage%3D2902%26doi%3D10.1158%2F1535-7163.MCT-09-0519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hollick, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigoreau, L. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano-Soumillac, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ord, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span> </span><span class="NLM_article-title">Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1958</span><span class="NLM_x">–</span> <span class="NLM_lpage">1972</span><span class="refDoi"> DOI: 10.1021/jm061121y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061121y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1958-1972&author=J.+J.+Hollickauthor=L.+J.+M.+Rigoreauauthor=C.+Cano-Soumillacauthor=X.+Cockcroftauthor=N.+J.+Curtinauthor=M.+Frigerioauthor=B.+T.+Goldingauthor=S.+Guiardauthor=I.+R.+Hardcastleauthor=I.+Hicksonauthor=M.+G.+Hummersoneauthor=K.+A.+Menearauthor=N.+M.+B.+Martinauthor=I.+Matthewsauthor=D.+R.+Newellauthor=R.+Ordauthor=C.+J.+Richardsonauthor=G.+C.+M.+Smithauthor=R.+J.+Griffin&title=Pyranone%2C+thiopyranone%2C+and+pyridone+inhibitors+of+phosphatidylinositol+3-kinase+related+kinases.+Structure-activity+relationships+for+DNA-dependent+protein+kinase+inhibition%2C+and+identification+of+the+first+potent+and+selective+inhibitor+of+the+ataxia+telangiectasia+mutated+kinase&doi=10.1021%2Fjm061121y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm061121y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061121y%26sid%3Dliteratum%253Aachs%26aulast%3DHollick%26aufirst%3DJ.%2BJ.%26aulast%3DRigoreau%26aufirst%3DL.%2BJ.%2BM.%26aulast%3DCano-Soumillac%26aufirst%3DC.%26aulast%3DCockcroft%26aufirst%3DX.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DFrigerio%26aufirst%3DM.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGuiard%26aufirst%3DS.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHummersone%26aufirst%3DM.%2BG.%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DMatthews%26aufirst%3DI.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DOrd%26aufirst%3DR.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26atitle%3DPyranone%252C%2520thiopyranone%252C%2520and%2520pyridone%2520inhibitors%2520of%2520phosphatidylinositol%25203-kinase%2520related%2520kinases.%2520Structure-activity%2520relationships%2520for%2520DNA-dependent%2520protein%2520kinase%2520inhibition%252C%2520and%2520identification%2520of%2520the%2520first%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520ataxia%2520telangiectasia%2520mutated%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1958%26epage%3D1972%26doi%3D10.1021%2Fjm061121y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.-Q.</span><span> </span><span class="NLM_article-title">The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking AKT in cancer cells with overactivated AKT</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-1189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1158%2F1535-7163.MCT-08-1189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=20053781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=113-125&author=Y.+Liauthor=D.-Q.+Yang&title=The+ATM+inhibitor+KU-55933+suppresses+cell+proliferation+and+induces+apoptosis+by+blocking+AKT+in+cancer+cells+with+overactivated+AKT&doi=10.1158%2F1535-7163.MCT-08-1189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The ATM Inhibitor KU-55933 Suppresses Cell Proliferation and Induces Apoptosis by Blocking Akt In Cancer Cells with Overactivated Akt</span></div><div class="casAuthors">Li, Yan; Yang, Da-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-125</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant activation of Akt plays a pivotal role in cancer development.  ATM, a protein deficient in patients with ataxia-telangiectasia disease, is traditionally considered as a nuclear protein kinase that functions as a signal transducer in response to DNA damage.  It has recently been shown that ATM is also a cytoplasmic protein that mediates the full activation of Akt in response to insulin.  Our study shows that a specific ATM inhibitor, KU-55933, blocks the phosphorylation of Akt induced by insulin and insulin-like growth factor I in cancer cells that exhibit abnormal Akt activity.  Moreover, KU-55933 inhibits cancer cell proliferation by inducing G1 cell cycle arrest.  It does so through the downregulation of the synthesis of cyclin D1, a protein known to be elevated in a variety of tumors.  In addn., KU-55933 treatment during serum starvation triggers apoptosis in these cancer cells.  Our results suggest that KU-55933 may be a novel chemotherapeutic agent targeting cancer resistant to traditional chemotherapy or immunotherapy due to aberrant activation of Akt.  Furthermore, KU-55933 completely abrogates rapamycin-induced feedback activation of Akt.  Combination of KU-55933 and rapamycin not only induces apoptosis, which is not seen in cancer cells treated only with rapamycin, but also shows better efficacy in inhibiting cancer cell proliferation than each drug alone.  Therefore, combining KU-55933 with rapamycin may provide a highly effective approach for improving mammalian target of rapamycin-targeted anticancer therapy that is currently hindered by rapamycin-induced feedback activation of Akt.  Mol Cancer Ther; 9(1); 113-25.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDofd5EPrPDLVg90H21EOLACvtfcHk0lgtU8V3e5-FpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVOjuw%253D%253D&md5=0fc2e60dc9332fcda9c10cdef3a75ad8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1189%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DD.-Q.%26atitle%3DThe%2520ATM%2520inhibitor%2520KU-55933%2520suppresses%2520cell%2520proliferation%2520and%2520induces%2520apoptosis%2520by%2520blocking%2520AKT%2520in%2520cancer%2520cells%2520with%2520overactivated%2520AKT%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D113%26epage%3D125%26doi%3D10.1158%2F1535-7163.MCT-08-1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mukherjee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomimatsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amancherla, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichamoorthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burma, S.</span><span> </span><span class="NLM_article-title">The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1593/neo.111512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1593%2Fneo.111512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=34-43&author=B.+Mukherjeeauthor=N.+Tomimatsuauthor=K.+Amancherlaauthor=C.+V.+Camachoauthor=N.+Pichamoorthyauthor=S.+Burma&title=The+dual+PI3K%2FmTOR+inhibitor+NVP-BEZ235+is+a+potent+inhibitor+of+ATM-+and+DNA-PKCs-mediated+DNA+damage+responses&doi=10.1593%2Fneo.111512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1593%2Fneo.111512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.111512%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DTomimatsu%26aufirst%3DN.%26aulast%3DAmancherla%26aufirst%3DK.%26aulast%3DCamacho%26aufirst%3DC.%2BV.%26aulast%3DPichamoorthy%26aufirst%3DN.%26aulast%3DBurma%26aufirst%3DS.%26atitle%3DThe%2520dual%2520PI3K%252FmTOR%2520inhibitor%2520NVP-BEZ235%2520is%2520a%2520potent%2520inhibitor%2520of%2520ATM-%2520and%2520DNA-PKCs-mediated%2520DNA%2520damage%2520responses%26jtitle%3DNeoplasia%26date%3D2012%26volume%3D14%26spage%3D34%26epage%3D43%26doi%3D10.1593%2Fneo.111512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Guo, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastan, M. B.</span><span> </span><span class="NLM_article-title">Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1177/1087057113520325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1177%2F1087057113520325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=24464432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslWgs73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=538-546&author=K.+X.+Guoauthor=A.+A.+Shelatauthor=R.+K.+Guyauthor=M.+B.+Kastan&title=Development+of+a+cell-based%2C+high-throughput+screening+assay+for+ATM+kinase+inhibitors&doi=10.1177%2F1087057113520325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors</span></div><div class="casAuthors">Guo, Kexiao; Shelat, Anang A.; Guy, R. Kiplin; Kastan, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">538-546, 9</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The ATM (ataxia-telangiectasia, mutated) protein kinase is a major regulator of cellular responses to DNA double-strand breaks (DSBs), DNA lesions that can be caused by ionizing irradn. (IR), oxidative damage, or exposure to certain chem. agents.  In response to DSBs, the ATM kinase is activated and subsequently phosphorylates numerous downstream substrates, including p53, Chk2, BRCA1, and KAP1, which affect processes such as cell cycle progression and DNA repair.  Numerous studies have demonstrated that loss of ATM function results in enhanced sensitivity to ionizing irradn. in clin. relevant dose ranges, suggesting that ATM kinase is an attractive therapeutic target for enhancing tumor cell kill with radiotherapy.  Previously identified small-mol. ATM kinase inhibitors, such as CP466722 and Ku55933, were identified using in vitro kinase assays carried out with recombinant ATM kinase isolated from mammalian cells.  Since it has not been feasible to express full-length recombinant ATM in bacterial or baculovirus systems, a robust in vitro screening tool has been lacking.  We have developed a cell-based assay that is robust, straightforward, and sensitive.  Using this highthroughput assay, we screened more than 7000 compds. and discovered addnl. small mols. that inhibit the ATM kinase and further validated these hits by secondary assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRWwxDBJCPwrVg90H21EOLACvtfcHk0ljRmNumx5_0lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslWgs73F&md5=ecb063a8f1f78c619ae6d285725245f8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1177%2F1087057113520325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057113520325%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DK.%2BX.%26aulast%3DShelat%26aufirst%3DA.%2BA.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DDevelopment%2520of%2520a%2520cell-based%252C%2520high-throughput%2520screening%2520assay%2520for%2520ATM%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2014%26volume%3D19%26spage%3D538%26epage%3D546%26doi%3D10.1177%2F1087057113520325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: unusually steep structure-activity relationship for analogs of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1021/jm9503613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9503613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=267-76&author=A.+J.+Bridgesauthor=H.+Zhouauthor=D.+R.+Codyauthor=G.+W.+Rewcastleauthor=A.+McMichaelauthor=H.+D.+H.+Showalterauthor=D.+W.+Fryauthor=A.+J.+Krakerauthor=W.+A.+Denny&title=Tyrosine+kinase+inhibitors%3A+unusually+steep+structure-activity+relationship+for+analogs+of+4-%283-bromoanilino%29-6%2C7-dimethoxyquinazoline+%28PD+153035%29%2C+a+potent+inhibitor+of+the+epidermal+growth+factor+receptor&doi=10.1021%2Fjm9503613"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9503613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9503613%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520unusually%2520steep%2520structure-activity%2520relationship%2520for%2520analogs%2520of%25204-%25283-bromoanilino%2529-6%252C7-dimethoxyquinazoline%2520%2528PD%2520153035%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D267%26epage%3D76%26doi%3D10.1021%2Fjm9503613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, E. S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J.-J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span> </span><span class="NLM_article-title">Lambert-van, d. B. C. Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5369</span><span class="NLM_x">–</span> <span class="NLM_lpage">5389</span><span class="refDoi"> DOI: 10.1021/jm990345w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990345w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5369-5389&author=L.+F.+Hennequinauthor=A.+P.+Thomasauthor=C.+Johnstoneauthor=E.+S.+E.+Stokesauthor=P.+A.+Pleauthor=J.-J.+M.+Lohmannauthor=D.+J.+Ogilvieauthor=M.+Dukesauthor=S.+R.+Wedgeauthor=J.+O.+Curwenauthor=J.+Kendrewauthor=C.+Lambert-van+der+Brempt&title=Lambert-van%2C+d.+B.+C.+Design+and+structure-activity+relationship+of+a+new+class+of+potent+VEGF+receptor+tyrosine+kinase+inhibitors&doi=10.1021%2Fjm990345w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm990345w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990345w%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DE.%2BS.%2BE.%26aulast%3DPle%26aufirst%3DP.%2BA.%26aulast%3DLohmann%26aufirst%3DJ.-J.%2BM.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26atitle%3DLambert-van%252C%2520d.%2520B.%2520C.%2520Design%2520and%2520structure-activity%2520relationship%2520of%2520a%2520new%2520class%2520of%2520potent%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5369%26epage%3D5389%26doi%3D10.1021%2Fjm990345w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Matsuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushiki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomoto, Y.</span><span> </span><span class="NLM_article-title">Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-Substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4910</span><span class="NLM_x">–</span> <span class="NLM_lpage">4925</span><span class="refDoi"> DOI: 10.1021/jm020505v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020505v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4910-4925&author=K.+Matsunoauthor=J.+Ushikiauthor=T.+Seishiauthor=M.+Ichimuraauthor=N.+A.+Gieseauthor=J.-C.+Yuauthor=S.+Takahashiauthor=S.+Odaauthor=Y.+Nomoto&title=Potent+and+selective+inhibitors+of+platelet-derived+growth+factor+receptor+phosphorylation.+3.+Replacement+of+quinazoline+moiety+and+improvement+of+metabolic+polymorphism+of+4-%5B4-%28N-Substituted+%28thio%29carbamoyl%29-1-piperazinyl%5D-6%2C7-dimethoxyquinazoline+derivatives&doi=10.1021%2Fjm020505v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm020505v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020505v%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuno%26aufirst%3DK.%26aulast%3DUshiki%26aufirst%3DJ.%26aulast%3DSeishi%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DM.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26aulast%3DYu%26aufirst%3DJ.-C.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DOda%26aufirst%3DS.%26aulast%3DNomoto%26aufirst%3DY.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520platelet-derived%2520growth%2520factor%2520receptor%2520phosphorylation.%25203.%2520Replacement%2520of%2520quinazoline%2520moiety%2520and%2520improvement%2520of%2520metabolic%2520polymorphism%2520of%25204-%255B4-%2528N-Substituted%2520%2528thio%2529carbamoyl%2529-1-piperazinyl%255D-6%252C7-dimethoxyquinazoline%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4910%26epage%3D4925%26doi%3D10.1021%2Fjm020505v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lemoff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span> </span><span class="NLM_article-title">Dual detection approach to a more accurate measure of relative purity in high-throughput characterization of compound collections</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span><span class="refDoi"> DOI: 10.1021/cc800100g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc800100g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpslent7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=746-751&author=A.+Lemoffauthor=B.+Yan&title=Dual+detection+approach+to+a+more+accurate+measure+of+relative+purity+in+high-throughput+characterization+of+compound+collections&doi=10.1021%2Fcc800100g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dual detection approach to a more accurate measure of relative purity in high-throughput characterization of compound collections</span></div><div class="casAuthors">Lemoff, Andrew; Yan, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">746-751</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The accurate detn. of compd. purity is crucial for characterizing library purity, monitoring the stability of storage compds., and obtaining meaningful high-throughput screening results.  However, current high-throughput techniques for the detn. of compd. purity are inadequate.  The authors evaluated online chromatog. detectors, including UVTWC, UV214, and ELSD detectors, in studies of 233 compd. mixts. prepd. with known compns.  Both UVTWC and UV214 overestimate the minor component in a mixt. whereas ELSD underestimates the minor component.  An av. of UVTWC and ELSD purities gives a more accurate measure of the relative purity for a wide range of compds. in various purity ranges.  This technique was applied to 959 compds. from the authors' compd. collection to more accurately det. their relative purity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl9HA2KAiorLVg90H21EOLACvtfcHk0lgoQNbVih5UmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpslent7w%253D&md5=143cb2670feafb27f0dea15e262b1006</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcc800100g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc800100g%26sid%3Dliteratum%253Aachs%26aulast%3DLemoff%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DB.%26atitle%3DDual%2520detection%2520approach%2520to%2520a%2520more%2520accurate%2520measure%2520of%2520relative%2520purity%2520in%2520high-throughput%2520characterization%2520of%2520compound%2520collections%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2008%26volume%3D10%26spage%3D746%26epage%3D751%26doi%3D10.1021%2Fcc800100g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushby, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson-Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herron, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaisland, H. C.</span><span> </span><span class="NLM_article-title">Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span><span class="refDoi"> DOI: 10.1080/00498250400009171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1080%2F00498250400009171" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=917-934&author=D.+McKillopauthor=M.+Hutchisonauthor=E.+A.+Partridgeauthor=N.+Bushbyauthor=C.+M.+F.+Cooperauthor=J.+A.+Clarkson-Jonesauthor=W.+Herronauthor=H.+C.+Swaisland&title=Metabolic+disposition+of+gefitinib%2C+an+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+in+rat%2C+dog+and+man&doi=10.1080%2F00498250400009171"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F00498250400009171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250400009171%26sid%3Dliteratum%253Aachs%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DHutchison%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DE.%2BA.%26aulast%3DBushby%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DC.%2BM.%2BF.%26aulast%3DClarkson-Jones%26aufirst%3DJ.%2BA.%26aulast%3DHerron%26aufirst%3DW.%26aulast%3DSwaisland%26aufirst%3DH.%2BC.%26atitle%3DMetabolic%2520disposition%2520of%2520gefitinib%252C%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520rat%252C%2520dog%2520and%2520man%26jtitle%3DXenobiotica%26date%3D2004%26volume%3D34%26spage%3D917%26epage%3D934%26doi%3D10.1080%2F00498250400009171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhead, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardsley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaisland, H. C.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1080/00498250400009189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1080%2F00498250400009189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=901-915&author=D.+McKillopauthor=E.+A.+Partridgeauthor=M.+Hutchisonauthor=S.+A.+Rheadauthor=A.+C.+Parryauthor=J.+Bardsleyauthor=H.+M.+Woodmanauthor=H.+C.+Swaisland&title=Pharmacokinetics+of+gefitinib%2C+an+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+in+rat+and+dog&doi=10.1080%2F00498250400009189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F00498250400009189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250400009189%26sid%3Dliteratum%253Aachs%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DPartridge%26aufirst%3DE.%2BA.%26aulast%3DHutchison%26aufirst%3DM.%26aulast%3DRhead%26aufirst%3DS.%2BA.%26aulast%3DParry%26aufirst%3DA.%2BC.%26aulast%3DBardsley%26aufirst%3DJ.%26aulast%3DWoodman%26aufirst%3DH.%2BM.%26aulast%3DSwaisland%26aufirst%3DH.%2BC.%26atitle%3DPharmacokinetics%2520of%2520gefitinib%252C%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520rat%2520and%2520dog%26jtitle%3DXenobiotica%26date%3D2004%26volume%3D34%26spage%3D901%26epage%3D915%26doi%3D10.1080%2F00498250400009189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Leonard, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">JAKS and STATS: biological implications</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1146/annurev.immunol.16.1.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1146%2Fannurev.immunol.16.1.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=9597132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADyaK1cXislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=293-322&author=W.+J.+Leonardauthor=J.+J.+O%E2%80%99Shea&title=JAKS+and+STATS%3A+biological+implications&doi=10.1146%2Fannurev.immunol.16.1.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">JAKS and STATS: Biological implications</span></div><div class="casAuthors">Leonard, Warren J.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293-322</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 185 refs.  Cytokines and interferons are mols. that play central roles in the regulation of a wide array of cellular functions in the lympho-hematopoietic system.  These factors stimulate proliferation, differentiation, and survival signals, as well as specialized functions in host resistance to pathogens.  Although cytokines are known to activate multiple signaling pathways that together mediate these important functions, one of these pathways, the Jak-STAT pathway, is the focus of this chapter.  This pathway is triggered by both cytokines and interferons, and it very rapidly allows the transduction of an extracellular signal into the nucleus.  The pathway uses a novel mechanism in which cytosolic latent transcription factors, known as signal transducers and activators of transcription (STATs), are tyrosine phosphorylated by Janus family tyrosine kinases (Jaks), allowing STAT protein dimerization and nuclear translocation.  STATs then can modulate the expression of target genes.  The basic biol. of this system, including the range of known Jaks and STATs, is discussed, as are the defects in animals and human lacking some of these signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrO-nJd5D_LVg90H21EOLACvtfcHk0lg17AmlzvL-8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislygurs%253D&md5=ac5eeeb0159c2c8769e2cb28720cdf98</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.16.1.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.16.1.293%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAKS%2520and%2520STATS%253A%2520biological%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1998%26volume%3D16%26spage%3D293%26epage%3D322%26doi%3D10.1146%2Fannurev.immunol.16.1.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling&doi=10.1111%2Fj.1600-065X.2008.00754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lgvpIv4rqVXkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D273%26epage%3D287%26doi%3D10.1111%2Fj.1600-065X.2008.00754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Li, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. Y.</span><span> </span><span class="NLM_article-title">Assignment of NEK6, a NIMA-related gene, to human chromosome 9q33.3 -> q34.11 by radiation hybrid mapping</span> <span class="citation_source-journal">Cytogenet. Genome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1159/000015445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1159%2F000015445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1999&pages=271-272&author=M.+Z.+Liauthor=L.+Yuauthor=Q.+Liuauthor=J.+Y.+Chuauthor=S.+Y.+Zhao&title=Assignment+of+NEK6%2C+a+NIMA-related+gene%2C+to+human+chromosome+9q33.3+-%3E+q34.11+by+radiation+hybrid+mapping&doi=10.1159%2F000015445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1159%2F000015445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000015445%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%2BZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DChu%26aufirst%3DJ.%2BY.%26aulast%3DZhao%26aufirst%3DS.%2BY.%26atitle%3DAssignment%2520of%2520NEK6%252C%2520a%2520NIMA-related%2520gene%252C%2520to%2520human%2520chromosome%25209q33.3%2520-%253E%2520q34.11%2520by%2520radiation%2520hybrid%2520mapping%26jtitle%3DCytogenet.%2520Genome%2520Res.%26date%3D1999%26volume%3D87%26spage%3D271%26epage%3D272%26doi%3D10.1159%2F000015445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kandli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feige, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilfin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motro, B.</span><span> </span><span class="NLM_article-title">Isolation and characterization of two evolutionarily conserved murine kinases (NEK6 and NEK7) related to the fungal mitotic regulator, NIMA</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1006/geno.2000.6293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1006%2Fgeno.2000.6293" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=187-196&author=M.+Kandliauthor=E.+Feigeauthor=A.+Chenauthor=G.+Kilfinauthor=B.+Motro&title=Isolation+and+characterization+of+two+evolutionarily+conserved+murine+kinases+%28NEK6+and+NEK7%29+related+to+the+fungal+mitotic+regulator%2C+NIMA&doi=10.1006%2Fgeno.2000.6293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fgeno.2000.6293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.2000.6293%26sid%3Dliteratum%253Aachs%26aulast%3DKandli%26aufirst%3DM.%26aulast%3DFeige%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DKilfin%26aufirst%3DG.%26aulast%3DMotro%26aufirst%3DB.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520two%2520evolutionarily%2520conserved%2520murine%2520kinases%2520%2528NEK6%2520and%2520NEK7%2529%2520related%2520to%2520the%2520fungal%2520mitotic%2520regulator%252C%2520NIMA%26jtitle%3DGenomics%26date%3D2000%26volume%3D68%26spage%3D187%26epage%3D196%26doi%3D10.1006%2Fgeno.2000.6293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Toulany, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihatsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaachouay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodemann, H. P.</span><span> </span><span class="NLM_article-title">Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition</span> <span class="citation_source-journal">Radiother. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">228</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span><span class="refDoi"> DOI: 10.1016/j.radonc.2014.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1016%2Fj.radonc.2014.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=24857596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslCmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=228-36&author=M.+Toulanyauthor=J.+Mihatschauthor=M.+Hollerauthor=H.+Chaachouayauthor=H.+P.+Rodemann&title=Cisplatin-mediated+radiosensitization+of+non-small+cell+lung+cancer+cells+is+stimulated+by+ATM+inhibition&doi=10.1016%2Fj.radonc.2014.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition</span></div><div class="casAuthors">Toulany, Mahmoud; Mihatsch, Julia; Holler, Marina; Chaachouay, Hassan; Rodemann, H. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">228-236</span>CODEN:
                <span class="NLM_cas:coden">RAONDT</span>;
        ISSN:<span class="NLM_cas:issn">0167-8140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Cisplatin activates ataxia-telangiectasia-mutated (ATM), a protein with roles in DNA repair, cell cycle progression and autophagy.  We investigated the radiosensitizing effect of cisplatin with respect to its effect on ATM pathway activation.  Non-small cell lung cancer cells (NSCLC) cell lines (A549, H460) and human fibroblast (ATM-deficient AT5, ATM-proficient 1BR3) cells were used.  The effects of cisplatin combined with irradn. on ATM pathway activity, clonogenicity, DNA double-strand break (DNA-DSB) repair and cell cycle progression were analyzed with Western blotting, colony formation and γ-H2AX foci assays as well as FACS anal., resp.  Cisplatin radiosensitized H460 cells, but not A549 cells.  Radiosensitization of H460 cells was not due to impaired DNA-DSB repair, increased apoptosis or cell cycle dysregulation.  The lack of radiosensitization demonstrated for A549 cells was assocd. with cisplatin-mediated stimulation of ATM (S1981) and AMPKα (T172) phosphorylation and autophagy.  However, in both cell lines inhibition of ATM and autophagy by KU-55933 and chloroquine diphosphate (CQ) resp. resulted in a significant radiosensitization.  Combined treatment with the AMPK inhibitor compd.-C led to radiosensitization of A549 but not of H460 cells.  As compared to the treatment with KU-55933 alone, radiosensitivity of A549 cells was markedly stimulated by the combination of KU-55933 and cisplatin.  However, the combination of CQ and cisplatin did not modulate the pattern of radiation sensitivity of A549 or H460 cells.  In accordance with the results that cisplatin via stimulation of ATM activity can abrogate its radiosensitizing effect, ATM deficient cells were significantly sensitized to ionizing radiation by cisplatin.  The results obtained indicate that ATM targeting can potentiate cisplatin-induced radiosensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUEfpCM_nObVg90H21EOLACvtfcHk0lgvpIv4rqVXkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslCmtro%253D&md5=1e3cb17ab9441176ecc5bd70f58200f3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.radonc.2014.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radonc.2014.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DToulany%26aufirst%3DM.%26aulast%3DMihatsch%26aufirst%3DJ.%26aulast%3DHoller%26aufirst%3DM.%26aulast%3DChaachouay%26aufirst%3DH.%26aulast%3DRodemann%26aufirst%3DH.%2BP.%26atitle%3DCisplatin-mediated%2520radiosensitization%2520of%2520non-small%2520cell%2520lung%2520cancer%2520cells%2520is%2520stimulated%2520by%2520ATM%2520inhibition%26jtitle%3DRadiother.%2520Oncol.%26date%3D2014%26volume%3D111%26spage%3D228%26epage%3D36%26doi%3D10.1016%2Fj.radonc.2014.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhijiang Fan, Jun Shi, Na Luo, Muhan Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoping Bao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Crystal Structure, and Agricultural Antimicrobial Evaluation of Novel Quinazoline Thioether Derivatives Incorporating the 1,2,4-Triazolo[4,3-a]pyridine Moiety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2019,</strong> <em>67 </em>
                                    (42)
                                     , 11598-11606. <a href="https://doi.org/10.1021/acs.jafc.9b04733" title="DOI URL">https://doi.org/10.1021/acs.jafc.9b04733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.9b04733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.9b04733%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DSynthesis%25252C%252BCrystal%252BStructure%25252C%252Band%252BAgricultural%252BAntimicrobial%252BEvaluation%252Bof%252BNovel%252BQuinazoline%252BThioether%252BDerivatives%252BIncorporating%252Bthe%252B1%25252C2%25252C4-Triazolo%25255B4%25252C3-a%25255Dpyridine%252BMoiety%26aulast%3DFan%26aufirst%3DZhijiang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06082019%26date%3D27092019%26date%3D23092019%26date%3D10102019%26date%3D27092019%26volume%3D67%26issue%3D42%26spage%3D11598%26epage%3D11606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kurt G. Pike, Bernard Barlaam, Elaine Cadogan, Andrew Campbell, Yingxue Chen, Nicola Colclough, Nichola L. Davies, Camila de-Almeida, Sebastien L. Degorce, Myriam Didelot, Allan Dishington, Richard Ducray, Stephen T. Durant, Lorraine A. Hassall, Jane Holmes, Gareth D. Hughes, Philip A. MacFaul, Keith R. Mulholland, Thomas M. McGuire, Gilles Ouvry, Martin Pass, Graeme Robb, Natalie Stratton, Zhenhua Wang, Joanne Wilson, Baochang Zhai, Kang Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Nidal Al-Huniti</span>. </span><span class="cited-content_cbyCitation_article-title">The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 3823-3841. <a href="https://doi.org/10.1021/acs.jmedchem.7b01896" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01896%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BIdentification%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BAvailable%252BInhibitors%252Bof%252BAtaxia%252BTelangiectasia%252BMutated%252B%252528ATM%252529%252BKinase%25253A%252BThe%252BDiscovery%252Bof%252BAZD0156%252B%2525288-%25257B6-%25255B3-%252528Dimethylamino%252529propoxy%25255Dpyridin-3-yl%25257D-3-methyl-1-%252528tetrahydro-2H-pyran-4-yl%252529-1%25252C3-dihydro-2H-imidazo%25255B4%25252C5-c%25255Dquinolin-2-one%252529%26aulast%3DPike%26aufirst%3DKurt%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08012018%26date%3D02052018%26date%3D23042018%26volume%3D61%26issue%3D9%26spage%3D3823%26epage%3D3841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Dadong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaodi  Qin</span>, <span class="hlFld-ContribAuthor ">Kouros  Owzar</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  McCann</span>, <span class="hlFld-ContribAuthor ">Michael B.  Kastan</span>. </span><span class="cited-content_cbyCitation_article-title">DNA-Damage-Induced Alternative Splicing of p53. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 251. <a href="https://doi.org/10.3390/cancers13020251" title="DOI URL">https://doi.org/10.3390/cancers13020251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13020251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13020251%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DDNA-Damage-Induced%252BAlternative%252BSplicing%252Bof%252Bp53%26aulast%3DChen%26aufirst%3DJing%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. K.  Abdulwahab</span>, <span class="hlFld-ContribAuthor ">R.  Dzulkeflee</span>, <span class="hlFld-ContribAuthor ">T. K.  Han</span>, <span class="hlFld-ContribAuthor ">R. A.  Ruslan</span>, <span class="hlFld-ContribAuthor ">K. H.  Leong</span>, <span class="hlFld-ContribAuthor ">C. H.  Heh</span>, <span class="hlFld-ContribAuthor ">A.  Ariffin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, In Vitro Antiproliferative Activity, and In Silico Studies of New Anilinoquinazoline Derivatives as Potential AntitumorAgents. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2020,</strong> <em>90 </em>
                                    (12)
                                     , 2410-2418. <a href="https://doi.org/10.1134/S1070363220120294" title="DOI URL">https://doi.org/10.1134/S1070363220120294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363220120294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363220120294%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DSynthesis%25252C%252BIn%252BVitro%252BAntiproliferative%252BActivity%25252C%252Band%252BIn%252BSilico%252BStudies%252Bof%252BNew%252BAnilinoquinazoline%252BDerivatives%252Bas%252BPotential%252BAntitumorAgents%26aulast%3DAbdulwahab%26aufirst%3DM.%2BK.%26date%3D2020%26date%3D2021%26volume%3D90%26issue%3D12%26spage%3D2410%26epage%3D2418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleksandr  Grytsai</span>, <span class="hlFld-ContribAuthor ">Oksana  Valiashko</span>, <span class="hlFld-ContribAuthor ">Manon  Penco-Campillo</span>, <span class="hlFld-ContribAuthor ">Maeva  Dufies</span>, <span class="hlFld-ContribAuthor ">Anais  Hagege</span>, <span class="hlFld-ContribAuthor ">Luc  Demange</span>, <span class="hlFld-ContribAuthor ">Sonia  Martial</span>, <span class="hlFld-ContribAuthor ">Gilles  Pagès</span>, <span class="hlFld-ContribAuthor ">Cyril  Ronco</span>, <span class="hlFld-ContribAuthor ">Rachid  Benhida</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>104 </em>, 104271. <a href="https://doi.org/10.1016/j.bioorg.2020.104271" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104271%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3-amino-1%25252C2%25252C4-triazole%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bcompounds%26aulast%3DGrytsai%26aufirst%3DOleksandr%26date%3D2020%26volume%3D104%26spage%3D104271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srimadhavi  Ravi</span>, <span class="hlFld-ContribAuthor ">Sugata  Barui</span>, <span class="hlFld-ContribAuthor ">Sivapriya  Kirubakaran</span>, <span class="hlFld-ContribAuthor ">Parul  Duhan</span>, <span class="hlFld-ContribAuthor ">Kaushik  Bhowmik</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of Quinoline-3-Carboxamide Derivatives as Inhibitors of the ATM Kinase. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (23)
                                     , 2070-2079. <a href="https://doi.org/10.2174/1568026620666200731174216" title="DOI URL">https://doi.org/10.2174/1568026620666200731174216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200731174216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200731174216%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BQuinoline-3-Carboxamide%252BDerivatives%252Bas%252BInhibitors%252Bof%252Bthe%252BATM%252BKinase%26aulast%3DRavi%26aufirst%3DSrimadhavi%26date%3D2020%26volume%3D20%26issue%3D23%26spage%3D2070%26epage%3D2079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thi Ngoc  Nguyen</span>, <span class="hlFld-ContribAuthor ">Thi Huong  Tran</span>, <span class="hlFld-ContribAuthor ">Nguyet Suong Huyen  Dao</span>, <span class="hlFld-ContribAuthor ">Van Giang  Nguyen</span>, <span class="hlFld-ContribAuthor ">Dinh Luyen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Nguyen Trieu  Trinh</span>, <span class="hlFld-ContribAuthor ">Van Hai  Nguyen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Spectral Characterization of 4,7-Dichloro-6-nitroquinazoline. </span><span class="cited-content_cbyCitation_journal-name">Molbank</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (2)
                                     , M1134. <a href="https://doi.org/10.3390/M1134" title="DOI URL">https://doi.org/10.3390/M1134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/M1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2FM1134%26sid%3Dliteratum%253Aachs%26jtitle%3DMolbank%26atitle%3DSynthesis%252Band%252BSpectral%252BCharacterization%252Bof%252B4%25252C7-Dichloro-6-nitroquinazoline%26aulast%3DNguyen%26aufirst%3DThi%2BNgoc%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D2%26spage%3DM1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claude  Grison</span>, <span class="hlFld-ContribAuthor ">David  Carrasco</span>, <span class="hlFld-ContribAuthor ">Franck  Pelissier</span>, <span class="hlFld-ContribAuthor ">Alexandra  Moderc</span>. </span><span class="cited-content_cbyCitation_article-title">Reflexion on Bio-Sourced Mosquito Repellents: Nature, Activity, and Preparation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Ecology and Evolution</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fevo.2020.00008" title="DOI URL">https://doi.org/10.3389/fevo.2020.00008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fevo.2020.00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffevo.2020.00008%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Ecology%2520and%2520Evolution%26atitle%3DReflexion%252Bon%252BBio-Sourced%252BMosquito%252BRepellents%25253A%252BNature%25252C%252BActivity%25252C%252Band%252BPreparation%26aulast%3DGrison%26aufirst%3DClaude%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaling  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiaoli  Hou</span>, <span class="hlFld-ContribAuthor ">Xiabing  Li</span>, <span class="hlFld-ContribAuthor ">Jiuling  Zhu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Baolin  Li</span>, <span class="hlFld-ContribAuthor ">Lijun  Zhao</span>, <span class="hlFld-ContribAuthor ">Haibin  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Enrichment of novel quinazoline derivatives with high antitumor activity in mitochondria tracked by its self-fluorescence. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 417-432. <a href="https://doi.org/10.1016/j.ejmech.2019.06.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnrichment%252Bof%252Bnovel%252Bquinazoline%252Bderivatives%252Bwith%252Bhigh%252Bantitumor%252Bactivity%252Bin%252Bmitochondria%252Btracked%252Bby%252Bits%252Bself-fluorescence%26aulast%3DZhang%26aufirst%3DYaling%26date%3D2019%26volume%3D178%26spage%3D417%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi-Dai  Long</span>, <span class="hlFld-ContribAuthor ">Zhou-Ximao  Long</span>, <span class="hlFld-ContribAuthor ">Xiao-Ying  Huang</span>, <span class="hlFld-ContribAuthor ">Jin-Guang  Yao</span>, <span class="hlFld-ContribAuthor ">Qiang  Xia</span>, <span class="hlFld-ContribAuthor ">Yan  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatocarcinoma Angiogenesis and DNA Damage Repair Response: An Update. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.82034" title="DOI URL">https://doi.org/10.5772/intechopen.82034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.82034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.82034%26sid%3Dliteratum%253Aachs%26atitle%3DHepatocarcinoma%252BAngiogenesis%252Band%252BDNA%252BDamage%252BRepair%252BResponse%25253A%252BAn%252BUpdate%26aulast%3DLong%26aufirst%3DXi-Dai%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DDNA%252BRepair-%252BAn%252BUpdate%26aulast%3DMognato%26aufirst%3DMaddalena%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinxuan  Li</span>, <span class="hlFld-ContribAuthor ">Jing-Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Ya-Lin  Deng</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Deyan  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel PDE10 Inhibitors With Antioxidant Activities. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00167" title="DOI URL">https://doi.org/10.3389/fchem.2018.00167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00167%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DStructure-Based%252BDesign%25252C%252BSynthesis%25252C%252BBiological%252BEvaluation%25252C%252Band%252BMolecular%252BDocking%252Bof%252BNovel%252BPDE10%252BInhibitors%252BWith%252BAntioxidant%252BActivities%26aulast%3DLi%26aufirst%3DJinxuan%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. I.  Wells</span>, <span class="hlFld-ContribAuthor ">N. R.  Kapadia</span>, <span class="hlFld-ContribAuthor ">R. M.  Couñago</span>, <span class="hlFld-ContribAuthor ">D. H.  Drewry</span>. </span><span class="cited-content_cbyCitation_article-title">In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     , 44-66. <a href="https://doi.org/10.1039/C7MD00510E" title="DOI URL">https://doi.org/10.1039/C7MD00510E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00510E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00510E%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIn%252Bdepth%252Banalysis%252Bof%252Bkinase%252Bcross%252Bscreening%252Bdata%252Bto%252Bidentify%252Bchemical%252Bstarting%252Bpoints%252Bfor%252Binhibition%252Bof%252Bthe%252BNek%252Bfamily%252Bof%252Bkinases%26aulast%3DWells%26aufirst%3DC.%2BI.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D44%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felicia Phei Lin  Lim</span>, <span class="hlFld-ContribAuthor ">Lin Yuing  Tan</span>, <span class="hlFld-ContribAuthor ">Edward R. T.  Tiekink</span>, <span class="hlFld-ContribAuthor ">Anton V.  Dolzhenko</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-(5-amino-1
              H
              -1,2,4-triazol-3-yl)propanamides and their tautomerism. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (40)
                                     , 22351-22360. <a href="https://doi.org/10.1039/C8RA04576C" title="DOI URL">https://doi.org/10.1039/C8RA04576C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA04576C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA04576C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Bof%252B3-%2525285-amino-1%252BH%252B-1%25252C2%25252C4-triazol-3-yl%252529propanamides%252Band%252Btheir%252Btautomerism%26aulast%3DLim%26aufirst%3DFelicia%2BPhei%2BLin%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D40%26spage%3D22351%26epage%3D22360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy J.C.  Dohmen</span>, <span class="hlFld-ContribAuthor ">Xiaohang  Qiao</span>, <span class="hlFld-ContribAuthor ">Anja  Duursma</span>, <span class="hlFld-ContribAuthor ">Ruud H.  Wijdeven</span>, <span class="hlFld-ContribAuthor ">Cor  Lieftink</span>, <span class="hlFld-ContribAuthor ">Floor  Hageman</span>, <span class="hlFld-ContribAuthor ">Ben  Morris</span>, <span class="hlFld-ContribAuthor ">Pasi  Halonen</span>, <span class="hlFld-ContribAuthor ">Conchita  Vens</span>, <span class="hlFld-ContribAuthor ">Michiel W.M.  van den Brekel</span>, <span class="hlFld-ContribAuthor ">Huib  Ovaa</span>, <span class="hlFld-ContribAuthor ">Jacques  Neefjes</span>, <span class="hlFld-ContribAuthor ">Charlotte L.  Zuur</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (43)
                                     , 73925-73937. <a href="https://doi.org/10.18632/oncotarget.18034" title="DOI URL">https://doi.org/10.18632/oncotarget.18034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.18034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.18034%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DIdentification%252Bof%252Ba%252Bnovel%252BATM%252Binhibitor%252Bwith%252Bcancer%252Bcell%252Bspecific%252Bradiosensitization%252Bactivity%26aulast%3DDohmen%26aufirst%3DAmy%2BJ.C.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D43%26spage%3D73925%26epage%3D73937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel C  Scott</span>, <span class="hlFld-ContribAuthor ">Jared T  Hammill</span>, <span class="hlFld-ContribAuthor ">Jaeki  Min</span>, <span class="hlFld-ContribAuthor ">David Y  Rhee</span>, <span class="hlFld-ContribAuthor ">Michele  Connelly</span>, <span class="hlFld-ContribAuthor ">Vladislav O  Sviderskiy</span>, <span class="hlFld-ContribAuthor ">Deepak  Bhasin</span>, <span class="hlFld-ContribAuthor ">Yizhe  Chen</span>, <span class="hlFld-ContribAuthor ">Su-Sien  Ong</span>, <span class="hlFld-ContribAuthor ">Sergio C  Chai</span>, <span class="hlFld-ContribAuthor ">Asli N  Goktug</span>, <span class="hlFld-ContribAuthor ">Guochang  Huang</span>, <span class="hlFld-ContribAuthor ">Julie K  Monda</span>, <span class="hlFld-ContribAuthor ">Jonathan  Low</span>, <span class="hlFld-ContribAuthor ">Ho Shin  Kim</span>, <span class="hlFld-ContribAuthor ">Joao A  Paulo</span>, <span class="hlFld-ContribAuthor ">Joe R  Cannon</span>, <span class="hlFld-ContribAuthor ">Anang A  Shelat</span>, <span class="hlFld-ContribAuthor ">Taosheng  Chen</span>, <span class="hlFld-ContribAuthor ">Ian R  Kelsall</span>, <span class="hlFld-ContribAuthor ">Arno F  Alpi</span>, <span class="hlFld-ContribAuthor ">Vishwajeeth  Pagala</span>, <span class="hlFld-ContribAuthor ">Xusheng  Wang</span>, <span class="hlFld-ContribAuthor ">Junmin  Peng</span>, <span class="hlFld-ContribAuthor ">Bhuvanesh  Singh</span>, <span class="hlFld-ContribAuthor ">J Wade  Harper</span>, <span class="hlFld-ContribAuthor ">Brenda A  Schulman</span>, <span class="hlFld-ContribAuthor ">R Kip  Guy</span>. </span><span class="cited-content_cbyCitation_article-title">Blocking an N-terminal acetylation–dependent protein interaction inhibits an E3 ligase. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2017,</strong> <em>13 </em>
                                    (8)
                                     , 850-857. <a href="https://doi.org/10.1038/nchembio.2386" title="DOI URL">https://doi.org/10.1038/nchembio.2386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.2386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.2386%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DBlocking%252Ban%252BN-terminal%252Bacetylation%2525E2%252580%252593dependent%252Bprotein%252Binteraction%252Binhibits%252Ban%252BE3%252Bligase%26aulast%3DScott%26aufirst%3DDaniel%2BC%26date%3D2017%26date%3D2017%26volume%3D13%26issue%3D8%26spage%3D850%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Da-hong  Li</span>, <span class="hlFld-ContribAuthor ">Ping  Hu</span>, <span class="hlFld-ContribAuthor ">Sheng-tao  Xu</span>, <span class="hlFld-ContribAuthor ">Chun-yan  Fang</span>, <span class="hlFld-ContribAuthor ">Shuang  Tang</span>, <span class="hlFld-ContribAuthor ">Xin-yu  Wang</span>, <span class="hlFld-ContribAuthor ">Xing-yan  Sun</span>, <span class="hlFld-ContribAuthor ">He  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao-ke  Gu</span>, <span class="hlFld-ContribAuthor ">Jin-yi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Lasiokaurin derivatives: synthesis, antimicrobial and antitumor biological evaluation, and apoptosis-inducing effects. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2017,</strong> <em>40 </em>
                                    (7)
                                     , 796-806. <a href="https://doi.org/10.1007/s12272-016-0867-9" title="DOI URL">https://doi.org/10.1007/s12272-016-0867-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-016-0867-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-016-0867-9%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DLasiokaurin%252Bderivatives%25253A%252Bsynthesis%25252C%252Bantimicrobial%252Band%252Bantitumor%252Bbiological%252Bevaluation%25252C%252Band%252Bapoptosis-inducing%252Beffects%26aulast%3DLi%26aufirst%3DDa-hong%26date%3D2017%26date%3D2017%26volume%3D40%26issue%3D7%26spage%3D796%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Wang</span>, <span class="hlFld-ContribAuthor ">Nicholas  Jette</span>, <span class="hlFld-ContribAuthor ">Daniel  Moussienko</span>, <span class="hlFld-ContribAuthor ">D. Gwyn  Bebb</span>, <span class="hlFld-ContribAuthor ">Susan P.  Lees-Miller</span>. </span><span class="cited-content_cbyCitation_article-title">ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib. </span><span class="cited-content_cbyCitation_journal-name">Translational Oncology</span><span> <strong>2017,</strong> <em>10 </em>
                                    (2)
                                     , 190-196. <a href="https://doi.org/10.1016/j.tranon.2017.01.007" title="DOI URL">https://doi.org/10.1016/j.tranon.2017.01.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tranon.2017.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tranon.2017.01.007%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Oncology%26atitle%3DATM-Deficient%252BColorectal%252BCancer%252BCells%252BAre%252BSensitive%252Bto%252Bthe%252BPARP%252BInhibitor%252BOlaparib%26aulast%3DWang%26aufirst%3DChen%26date%3D2017%26volume%3D10%26issue%3D2%26spage%3D190%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Alexander</span>, <span class="hlFld-ContribAuthor ">Cansu  Karakas</span>, <span class="hlFld-ContribAuthor ">Xian  Chen</span>, <span class="hlFld-ContribAuthor ">Jason P.W.  Carey</span>, <span class="hlFld-ContribAuthor ">Min  Yi</span>, <span class="hlFld-ContribAuthor ">Melissa  Bondy</span>, <span class="hlFld-ContribAuthor ">Patricia  Thompson</span>, <span class="hlFld-ContribAuthor ">Kwok Leung  Cheung</span>, <span class="hlFld-ContribAuthor ">Ian O.  Ellis</span>, <span class="hlFld-ContribAuthor ">Yun  Gong</span>, <span class="hlFld-ContribAuthor ">Savitri  Krishnamurthy</span>, <span class="hlFld-ContribAuthor ">Ricardo H.  Alvarez</span>, <span class="hlFld-ContribAuthor ">Naoto T.  Ueno</span>, <span class="hlFld-ContribAuthor ">Kelly K.  Hunt</span>, <span class="hlFld-ContribAuthor ">Khandan  Keyomarsi</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 14897-14911. <a href="https://doi.org/10.18632/oncotarget.14689" title="DOI URL">https://doi.org/10.18632/oncotarget.14689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.14689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.14689%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCyclin%252BE%252Boverexpression%252Bas%252Ba%252Bbiomarker%252Bfor%252Bcombination%252Btreatment%252Bstrategies%252Bin%252Binflammatory%252Bbreast%252Bcancer%26aulast%3DAlexander%26aufirst%3DAngela%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D9%26spage%3D14897%26epage%3D14911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyril  Ronco</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Martin</span>, <span class="hlFld-ContribAuthor ">Luc  Demange</span>, <span class="hlFld-ContribAuthor ">Rachid  Benhida</span>. </span><span class="cited-content_cbyCitation_article-title">ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 295-319. <a href="https://doi.org/10.1039/C6MD00439C" title="DOI URL">https://doi.org/10.1039/C6MD00439C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00439C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00439C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DATM%25252C%252BATR%25252C%252BCHK1%25252C%252BCHK2%252Band%252BWEE1%252Binhibitors%252Bin%252Bcancer%252Band%252Bcancer%252Bstem%252Bcells%26aulast%3DRonco%26aufirst%3DCyril%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D295%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.G.  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of AZD0156: The First Potent and Selective Inhibitor of ATM Kinase for Clinical Evaluation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-177. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13801-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13801-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13801-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13801-6%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BAZD0156%25253A%252BThe%252BFirst%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BATM%252BKinase%252Bfor%252BClinical%252BEvaluation%26aulast%3DPike%26aufirst%3DK.G.%26date%3D2017%26spage%3D161%26epage%3D177%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jana  Kralovicova</span>, <span class="hlFld-ContribAuthor ">Pedro M.D.  Moreno</span>, <span class="hlFld-ContribAuthor ">Nicholas C.P.  Cross</span>, <span class="hlFld-ContribAuthor ">Ana Paula  Pêgo</span>, <span class="hlFld-ContribAuthor ">Igor  Vorechovsky</span>. </span><span class="cited-content_cbyCitation_article-title">Antisense Oligonucleotides Modulating Activation of a Nonsense-Mediated RNA Decay Switch Exon in the
              ATM
              Gene. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acid Therapeutics</span><span> <strong>2016,</strong> <em>26 </em>
                                    (6)
                                     , 392-400. <a href="https://doi.org/10.1089/nat.2016.0635" title="DOI URL">https://doi.org/10.1089/nat.2016.0635</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/nat.2016.0635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fnat.2016.0635%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acid%2520Therapeutics%26atitle%3DAntisense%252BOligonucleotides%252BModulating%252BActivation%252Bof%252Ba%252BNonsense-Mediated%252BRNA%252BDecay%252BSwitch%252BExon%252Bin%252Bthe%252BATM%252BGene%26aulast%3DKralovicova%26aufirst%3DJana%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D392%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative ATM inhibitors. The median potency (IC<sub>50</sub>) of the inhibitors is shown, measured using either the in vitro kinase assay (biochemical) or the in-cell western assay (cellular).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Outline of lead optimization studies of compound <b>4</b> presented herein, indicating positions varied in the studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0015.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Route for the Synthesis of Substituted Triazol <b>14</b> and Quinazoline Derivatives <b>15</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 70% HNO<sub>3</sub>, AcOH, 50 °C, 3 h, 91–94%; (b) Fe/FeCl<sub>3</sub>, AcOH, EtOH, H<sub>2</sub>O, or H<sub>2</sub>Pd–C, MeOH, 80 °C, 90%; (c) NH<sub>2</sub>CHO, 190 °C, 75–86%; (d) SOCl<sub>2</sub>, catalytic DMF, 85 °C, 95%; (e) substituted 1,2,4-triazol-5-amines, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 50–85%; (f) reflux/Wood’s metal bath, 210 °C, 2 h, quant.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0016.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of C-2-Substituted Quinazolines <b>22a</b>–<b>j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 6 h, 61%; (b) morpholine (for <b>22b</b>), <i>N</i>-methyl piperizine (for <b>22c</b>), 2-(piperazine-1-yl) ethanol (for <b>22d</b>), or ethyl-2-amino acetate·HCl (for <b>22e</b>), NMP, 140 °C, 4 h, 52–70%, diethylamine, <i>i</i>-PrOH, 4 M HCl/dioxane, microwave, 160 °C, 10 min, 55% (for <b>22i</b>); (c) Li<sub>2</sub>O<sub>2</sub>, MeOH/H<sub>2</sub>O (3:1), 40 min, rt, 45% (for <b>22f</b>).</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0017.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>23a</b>–<b>k</b> and <b>24a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amines, anilines, or substituted triazoles, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90–130 °C, 6–16 h, 46–75%; (b) <b>14</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 6 h, 65–75%; (c) 10% Pd–C/MeOH, 80–85%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0018.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthesis of Compounds <b>27a</b>–<b>s</b> Containing Linkers at the C-6 Position<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) substituted alcohols (correspond to <b>27d</b>, <b>27e</b>, and <b>27g</b>), DTAD, TPP, DCM, 0 °C to rt, 55–70%; (b) substituted alkyl halides (correspond to <b>27a–c</b>,<b> 27f</b>, and <b>27h</b>–<b>o</b>), K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 70–75%; (c) <b>14</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 6–8 h, 50–65%; (d) HCl/THF, rt, 1 h, 95%; (e) substituted chloroformates (for <b>27p</b>–<b>r</b>) or CF<sub>3</sub>C(O)Cl (for <b>27s</b>), TEA/DCM, 0 °C to rt, overnight, 70–85%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0019.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route for the Preparation of Compound <b>27i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>34</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 4 h, 62%; (b) <b>14</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 4 h, 54%.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacokinetics of compounds <b>4</b>, <b>20</b>, and <b>27g</b> observed during in vivo murine dose ranging studies by the intravenous route. Graph shows plasma concentrations of parent molecule versus time after dosing. Each compound (20 mg/kg) was dissolved in 5% DMSO with a final formulation of 5:45:50 (v/v/v) EtOH/PPG/PBS (pH 7.4) and HβCD (10 mM) and was dosed via tail vein injection. At 5, 15, and 30 min and 1, 4, 24, and 48 h, blood was taken and plasma was analyzed by LC-MS. Concentrations of all three compounds vs time were plotted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Observed in vivo metabolism of compound <b>4</b>. Three metabolites were identified: phase I metabolites <b>5</b> and <b>6</b> and phase II metabolite <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of ATM-driven phosphorylation events by selected analogues after IR-induced DNA damage. MCF7 cells were treated with DMSO or compounds <b>1</b>, <b>4</b>, <b>27g</b>, or <b>27n</b> at concentrations of 1, 5, or 10 μM for 30 min before mock-IR (control) or IR (10 Gy). Cells were lysed 1 h after IR and probed by western blot analysis using anti-phospho-ATM, anti-phospho-KAP1, or anti-phospho-p53 antibodies. Total ATM and β-actin protein levels were used as loading controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/medium/jm-2015-010927_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0014.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Sensitization of MCF7 cells to IR-induced DNA damage by compounds <b>1</b>, <b>4</b>, <b>20</b>, <b>27g</b>, or <b>27n</b>. MCF7 cells were plated in triplicate and incubated for 16 h. Cells were preincubated with DMSO or 10 μM of compound <b>4</b>, <b>1</b>, <b>27g</b>, <b>27n</b>, or <b>20</b> for 10 min before being exposed to escalating doses of IR (0–4 Gy). Media was removed 4 h after IR and replaced with fresh media without drugs. After 10 days of incubation, the cells were fixed and stained with crystal violet (0.5%). Surviving colonies on each plate were counted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01092/20160122/images/large/jm-2015-010927_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01092&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i105">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63443" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63443" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lovejoy, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortez, D.</span><span> </span><span class="NLM_article-title">Common mechanisms of PIKK regulation</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/j.dnarep.2009.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1016%2Fj.dnarep.2009.04.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1004-8&author=C.+A.+Lovejoyauthor=D.+Cortez&title=Common+mechanisms+of+PIKK+regulation&doi=10.1016%2Fj.dnarep.2009.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2009.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2009.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DLovejoy%26aufirst%3DC.%2BA.%26aulast%3DCortez%26aufirst%3DD.%26atitle%3DCommon%2520mechanisms%2520of%2520PIKK%2520regulation%26jtitle%3DDNA%2520Repair%26date%3D2009%26volume%3D8%26spage%3D1004%26epage%3D8%26doi%3D10.1016%2Fj.dnarep.2009.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">Cell cycle checkpoint signaling through the ATM and ATR kinases</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2196</span><span class="refDoi"> DOI: 10.1101/gad.914401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1101%2Fgad.914401" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=2177-2196&author=R.+T.+Abraham&title=Cell+cycle+checkpoint+signaling+through+the+ATM+and+ATR+kinases&doi=10.1101%2Fgad.914401"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fgad.914401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.914401%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DCell%2520cycle%2520checkpoint%2520signaling%2520through%2520the%2520ATM%2520and%2520ATR%2520kinases%26jtitle%3DGenes%2520Dev.%26date%3D2001%26volume%3D15%26spage%3D2177%26epage%3D2196%26doi%3D10.1101%2Fgad.914401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Shiloh, Y.</span><span> </span><span class="NLM_article-title">ATM and related protein kinases: safeguarding genome integrity</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1038/nrc1011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2Fnrc1011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=12612651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=155-168&author=Y.+Shiloh&title=ATM+and+related+protein+kinases%3A+safeguarding+genome+integrity&doi=10.1038%2Fnrc1011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">ATM and related protein kinases: safeguarding genome integrity</span></div><div class="casAuthors">Shiloh, Yosef</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-168</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Maintenance of genome stability is essential for avoiding the passage to neoplasia.  The DNA-damage response - a cornerstone of genome stability - occurs by a swift transduction of the DNA-damage signal to many cellular pathways.  A prime example is the cellular response to DNA double-strand breaks, which activate the ATM protein kinase that, in turn, modulates numerous signaling pathways.  ATM mutations lead to the cancer-predisposing genetic disorder ataxia-telangiectasia (A-T).  Understanding ATM's mode of action provides new insights into the assocn. between defective responses to DNA damage and cancer, and brings us closer to resolving the issue of cancer predisposition in some A-T carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6rldvrvSuQLVg90H21EOLACvtfcHk0lgun5EYksI8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFGhtr4%253D&md5=2d84325b04979dad3e33155fefa421e6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc1011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1011%26sid%3Dliteratum%253Aachs%26aulast%3DShiloh%26aufirst%3DY.%26atitle%3DATM%2520and%2520related%2520protein%2520kinases%253A%2520safeguarding%2520genome%2520integrity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D155%26epage%3D168%26doi%3D10.1038%2Fnrc1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zakian, V. A.</span><span> </span><span class="NLM_article-title">ATM-related genes: what do they tell us about functions of the human gene?</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1016/0092-8674(95)90463-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1016%2F0092-8674%2895%2990463-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1995&pages=685-7&author=V.+A.+Zakian&title=ATM-related+genes%3A+what+do+they+tell+us+about+functions+of+the+human+gene%3F&doi=10.1016%2F0092-8674%2895%2990463-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990463-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990463-8%26sid%3Dliteratum%253Aachs%26aulast%3DZakian%26aufirst%3DV.%2BA.%26atitle%3DATM-related%2520genes%253A%2520what%2520do%2520they%2520tell%2520us%2520about%2520functions%2520of%2520the%2520human%2520gene%253F%26jtitle%3DCell%26date%3D1995%26volume%3D82%26spage%3D685%26epage%3D7%26doi%3D10.1016%2F0092-8674%2895%2990463-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bassing, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, F. W.</span><span> </span><span class="NLM_article-title">The cellular response to general and programmed DNA double strand breaks</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1016/j.dnarep.2004.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1016%2Fj.dnarep.2004.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=781-96&author=C.+H.+Bassingauthor=F.+W.+Alt&title=The+cellular+response+to+general+and+programmed+DNA+double+strand+breaks&doi=10.1016%2Fj.dnarep.2004.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.dnarep.2004.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dnarep.2004.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBassing%26aufirst%3DC.%2BH.%26aulast%3DAlt%26aufirst%3DF.%2BW.%26atitle%3DThe%2520cellular%2520response%2520to%2520general%2520and%2520programmed%2520DNA%2520double%2520strand%2520breaks%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D781%26epage%3D96%26doi%3D10.1016%2Fj.dnarep.2004.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Khanna, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span> </span><span class="NLM_article-title">DNA double-strand breaks: signaling, repair and the cancer connection</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1038/85798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2F85798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=11242102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslKqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2001&pages=247-254&author=K.+K.+Khannaauthor=S.+P.+Jackson&title=DNA+double-strand+breaks%3A+signaling%2C+repair+and+the+cancer+connection&doi=10.1038%2F85798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">DNA double-strand breaks: signaling, repair and the cancer connection</span></div><div class="casAuthors">Khanna, Kum Kum; Jackson, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-254</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review, with 76 refs.,.  To ensure the high-fidelity transmission of genetic information, cells have evolved mechanisms to monitor genome integrity.  Cells respond to DNA damage by activating a complex DNA-damage-response pathway that includes cell-cycle arrest, the transcriptional and post-transcriptional activation of a subset of genes including those assocd. with DNA repair, and under some circumstances, the triggering of programmed cell death.  An inability to respond properly to, or to repair, DNA damage leads to genetic instability, which in turn may enhance the rate of cancer development.  Indeed, it is becoming increasingly clear that deficiencies in DNA-damage signaling and repair pathways are fundamental to the etiol. of most, if not all, human cancers.  Here, recent progress in the understanding of how cells detect and signal the presence and repair of one particularly important form of DNA damage induced by ionizing radiation, the DNA double-strand break (DSB), is described.  Moreover, how tumor suppressor proteins such as p53, ATM, Brca1 and Brca2 have been linked to such pathways and how accumulating evidence is connecting deficiencies in cellular responses to DNA DSBs with tumorigenesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs2_Aw1LLx3LVg90H21EOLACvtfcHk0ljquYOa-m56vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslKqtLg%253D&md5=e5ccb5ac64c8dbf39375d33a056f34ad</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F85798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85798%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26atitle%3DDNA%2520double-strand%2520breaks%253A%2520signaling%252C%2520repair%2520and%2520the%2520cancer%2520connection%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D27%26spage%3D247%26epage%3D254%26doi%3D10.1038%2F85798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">van Gent, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeijmakers, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaar, R.</span><span> </span><span class="NLM_article-title">Chromosomal stability and the DNA double-stranded break connection</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1038/35056049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2F35056049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=11256071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A280%3ADC%252BD3M7pvVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=196-206&author=D.+C.+van+Gentauthor=J.+H.+Hoeijmakersauthor=R.+Kanaar&title=Chromosomal+stability+and+the+DNA+double-stranded+break+connection&doi=10.1038%2F35056049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Chromosomal stability and the DNA double-stranded break connection</span></div><div class="casAuthors">van Gent D C; Hoeijmakers J H; Kanaar R</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">196-206</span>
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    </div><div class="casAbstract">Genome stability is of primary importance for the survival and proper functioning of all organisms.  Double-stranded breaks in DNA are important threats to genome integrity because they can result in chromosomal aberrations that can affect, simultaneously, many genes, and lead to cell malfunctioning and cell death.  These detrimental consequences are counteracted by two mechanistically distinct pathways of double-stranded break repair: homologous recombination and non-homologous end-joining.  Recently, unexpected links between these double-stranded break-repair systems, and several human genome instability and cancer predisposition syndromes, have emerged.  Now, interactions between both double-stranded break-repair pathways and other cellular processes, such as cell-cycle regulation and replication, are being unveiled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnFunGJMZss2K_SFaaT9INfW6udTcc2ebhHWP0uAx8XLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7pvVCqtw%253D%253D&md5=1fb0f52a76360bb82709925dbd253946</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F35056049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35056049%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BGent%26aufirst%3DD.%2BC.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BH.%26aulast%3DKanaar%26aufirst%3DR.%26atitle%3DChromosomal%2520stability%2520and%2520the%2520DNA%2520double-stranded%2520break%2520connection%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2001%26volume%3D2%26spage%3D196%26epage%3D206%26doi%3D10.1038%2F35056049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Shiloh, Y.</span><span> </span><span class="NLM_article-title">Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart</span> <span class="citation_source-journal">Annu. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1146/annurev.genet.31.1.635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1146%2Fannurev.genet.31.1.635" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1997&pages=635-662&author=Y.+Shiloh&title=Ataxia-telangiectasia+and+the+Nijmegen+breakage+syndrome%3A+related+disorders+but+genes+apart&doi=10.1146%2Fannurev.genet.31.1.635"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev.genet.31.1.635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.genet.31.1.635%26sid%3Dliteratum%253Aachs%26aulast%3DShiloh%26aufirst%3DY.%26atitle%3DAtaxia-telangiectasia%2520and%2520the%2520Nijmegen%2520breakage%2520syndrome%253A%2520related%2520disorders%2520but%2520genes%2520apart%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D1997%26volume%3D31%26spage%3D635%26epage%3D662%26doi%3D10.1146%2Fannurev.genet.31.1.635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kastan, M.</span><span> </span><span class="NLM_article-title">Ataxia-telangiectasia--broad implications for a rare disorder</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span><span class="refDoi"> DOI: 10.1056/NEJM199509073331014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1056%2FNEJM199509073331014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=7637733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A280%3ADyaK2MzmsVyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1995&pages=662-3&author=M.+Kastan&title=Ataxia-telangiectasia%2D%2Dbroad+implications+for+a+rare+disorder&doi=10.1056%2FNEJM199509073331014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Ataxia-telangiectasia--broad implications for a rare disorder</span></div><div class="casAuthors">Kastan M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">662-3</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnJQbHO1aQjpWtyewyzkyLfW6udTcc2ebhHWP0uAx8XLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MzmsVyksg%253D%253D&md5=bccf23b85b095f0ba5601bf7b2875774</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJM199509073331014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199509073331014%26sid%3Dliteratum%253Aachs%26aulast%3DKastan%26aufirst%3DM.%26atitle%3DAtaxia-telangiectasia--broad%2520implications%2520for%2520a%2520rare%2520disorder%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1995%26volume%3D333%26spage%3D662%26epage%3D3%26doi%3D10.1056%2FNEJM199509073331014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Moding, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch, D. G.</span><span> </span><span class="NLM_article-title">Strategies for optimizing the response of cancer and normal tissues to radiation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1038/nrd4003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2Fnrd4003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=23812271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVaiu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=526-42&author=E.+J.+Modingauthor=M.+B.+Kastanauthor=D.+G.+Kirsch&title=Strategies+for+optimizing+the+response+of+cancer+and+normal+tissues+to+radiation&doi=10.1038%2Fnrd4003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for optimizing the response of cancer and normal tissues to radiation</span></div><div class="casAuthors">Moding, Everett J.; Kastan, Michael B.; Kirsch, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">526-542</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Approx. 50% of all patients with cancer receive radiation therapy at some point during the course of their treatment, and the majority of these patients are treated with curative intent.  Despite recent advances in the planning of radiation treatment and the delivery of image-guided radiation therapy, acute toxicity and potential long-term side effects often limit the ability to deliver a sufficient dose of radiation to control tumors locally.  In the past two decades, a better understanding of the hallmarks of cancer and the discovery of specific signalling pathways by which cells respond to radiation have provided new opportunities to design molecularly targeted therapies to increase the therapeutic window of radiation therapy.  Here, we review efforts to develop approaches that could improve outcomes with radiation therapy by increasing the probability of tumor cure or by decreasing normal tissue toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou7EQIkMMxvrVg90H21EOLACvtfcHk0lhKEd4qa3NH5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVaiu7zK&md5=f7a6b5ed442870ec03086ded64a28fc5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd4003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4003%26sid%3Dliteratum%253Aachs%26aulast%3DModing%26aufirst%3DE.%2BJ.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DKirsch%26aufirst%3DD.%2BG.%26atitle%3DStrategies%2520for%2520optimizing%2520the%2520response%2520of%2520cancer%2520and%2520normal%2520tissues%2520to%2520radiation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D526%26epage%3D42%26doi%3D10.1038%2Fnrd4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bakkenist, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastan, M. B.</span><span> </span><span class="NLM_article-title">DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span><span class="refDoi"> DOI: 10.1038/nature01368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2Fnature01368" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=499-506&author=C.+J.+Bakkenistauthor=M.+B.+Kastan&title=DNA+damage+activates+ATM+through+intermolecular+autophosphorylation+and+dimer+dissociation&doi=10.1038%2Fnature01368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature01368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01368%26sid%3Dliteratum%253Aachs%26aulast%3DBakkenist%26aufirst%3DC.%2BJ.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DDNA%2520damage%2520activates%2520ATM%2520through%2520intermolecular%2520autophosphorylation%2520and%2520dimer%2520dissociation%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D499%26epage%3D506%26doi%3D10.1038%2Fnature01368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kastan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span> </span><span class="NLM_article-title">Cell-cycle checkpoints and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1038/nature03097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1038%2Fnature03097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=15549093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=316-23&author=M.+B.+Kastanauthor=J.+Bartek&title=Cell-cycle+checkpoints+and+cancer&doi=10.1038%2Fnature03097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle checkpoints and cancer</span></div><div class="casAuthors">Kastan, Michael B.; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7015</span>),
    <span class="NLM_cas:pages">316-323</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  All life on earth must cope with const. exposure to DNA-damaging agents such as the Sun's radiation.  Highly conserved DNA-repair and cell-cycle checkpoint pathways allow cells to deal with both endogenous and exogenous sources of DNA damage.  How much an individual is exposed to these agents and how their cells respond to DNA damage are crit. determinants of whether that individual will develop cancer.  These cellular responses are also important for detg. toxicities and responses to current cancer therapies, most of which target the DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONns98smbebVg90H21EOLACvtfcHk0lhKEd4qa3NH5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtLo%253D&md5=23577cd35313a3a11afee151281c3fd4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature03097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03097%26sid%3Dliteratum%253Aachs%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DCell-cycle%2520checkpoints%2520and%2520cancer%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D316%26epage%3D23%26doi%3D10.1038%2Fnature03097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Khalil, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hupp, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhelev, N.</span><span> </span><span class="NLM_article-title">Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">237</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1258/ebm.2012.011378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1258%2Febm.2012.011378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOns7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2012&pages=622-34&author=H.+S.+Khalilauthor=H.+Tummalaauthor=T.+R.+Huppauthor=N.+Zhelev&title=Pharmacological+inhibition+of+ATM+by+KU55933+stimulates+ATM+transcription&doi=10.1258%2Febm.2012.011378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription</span></div><div class="casAuthors">Khalil, Hilal S.; Tummala, Hemanth; Hupp, Tedd R.; Zhelev, Nikolai</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">622-634</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Medicine Press Ltd.</span>)
        </div><div class="casAbstract">Ataxia-telangiectasia mutated (ATM) kinase is a component of a signalling mechanism that dets. the process of decision-making in response to DNA damage and involves the participation of multiple proteins.  ATM is activated by DNA double-strand breaks (DSBs) through the Mre11-Rad50-Nbs1 (MRN) DNA repair complex, and orchestrates signalling cascades that initiate the DNA damage response.  Cells lacking ATM are hypersensitive to insults, particularly genotoxic stress, induced through radiation or radiomimetic drugs.  Here, we investigate the degree of ATM activation during time-dependent treatment with genotoxic agents and the effects of ATM on phospho-induction and localization of its downstream substrates.  Addnl., we have demonstrated a new cell-cycle-independent mechanism of ATM gene regulation following ATM kinase inhibition with KU5593.  Inhibition of ATM activity causes induction of ATM protein followed by oscillation and this mechanism is governed at the transcriptional level.  Furthermore, this autoregulatory induction of ATM is also accompanied by a transient upregulation of p53, pATR and E2F1 levels.  Since ATM inhibition is believed to sensitize cancer cells to genotoxic agents, this novel insight into the mechanism of ATM regulation might be useful for designing more precise strategies for modulation of ATM activity in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOQN3qa-VRUbVg90H21EOLACvtfcHk0lhKEd4qa3NH5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOns7%252FF&md5=095b9cd39521a25357f9053485a454b0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1258%2Febm.2012.011378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2012.011378%26sid%3Dliteratum%253Aachs%26aulast%3DKhalil%26aufirst%3DH.%2BS.%26aulast%3DTummala%26aufirst%3DH.%26aulast%3DHupp%26aufirst%3DT.%2BR.%26aulast%3DZhelev%26aufirst%3DN.%26atitle%3DPharmacological%2520inhibition%2520of%2520ATM%2520by%2520KU55933%2520stimulates%2520ATM%2520transcription%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2012%26volume%3D237%26spage%3D622%26epage%3D34%26doi%3D10.1258%2Febm.2012.011378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Rainey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastan, M. B.</span><span> </span><span class="NLM_article-title">Transient Inhibition of ATM kinase Is sufficient to enhance cellular sensitivity to ionizing radiation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">7466</span><span class="NLM_x">–</span> <span class="NLM_lpage">7474</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-0763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1158%2F0008-5472.CAN-08-0763" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=7466-7474&author=M.+D.+Raineyauthor=M.+E.+Charltonauthor=R.+V.+Stantonauthor=M.+B.+Kastan&title=Transient+Inhibition+of+ATM+kinase+Is+sufficient+to+enhance+cellular+sensitivity+to+ionizing+radiation&doi=10.1158%2F0008-5472.CAN-08-0763"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0763%26sid%3Dliteratum%253Aachs%26aulast%3DRainey%26aufirst%3DM.%2BD.%26aulast%3DCharlton%26aufirst%3DM.%2BE.%26aulast%3DStanton%26aufirst%3DR.%2BV.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DTransient%2520Inhibition%2520of%2520ATM%2520kinase%2520Is%2520sufficient%2520to%2520enhance%2520cellular%2520sensitivity%2520to%2520ionizing%2520radiation%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D7466%26epage%3D7474%26doi%3D10.1158%2F0008-5472.CAN-08-0763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Andrs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korabecny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepovimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodny, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moravcova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzlikova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuca, K.</span><span> </span><span class="NLM_article-title">The development of ataxia telangiectasia mutated kinase inhibitors</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span><span class="refDoi"> DOI: 10.2174/1389557514666141013140217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.2174%2F1389557514666141013140217" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=805-811&author=M.+Andrsauthor=J.+Korabecnyauthor=E.+Nepovimovaauthor=D.+Junauthor=Z.+Hodnyauthor=S.+Moravcovaauthor=H.+Hanzlikovaauthor=K.+Kuca&title=The+development+of+ataxia+telangiectasia+mutated+kinase+inhibitors&doi=10.2174%2F1389557514666141013140217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1389557514666141013140217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557514666141013140217%26sid%3Dliteratum%253Aachs%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DHodny%26aufirst%3DZ.%26aulast%3DMoravcova%26aufirst%3DS.%26aulast%3DHanzlikova%26aufirst%3DH.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DThe%2520development%2520of%2520ataxia%2520telangiectasia%2520mutated%2520kinase%2520inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D805%26epage%3D811%26doi%3D10.2174%2F1389557514666141013140217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sarkaria, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibbetts, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4375</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=4375-82&author=J.+N.+Sarkariaauthor=R.+S.+Tibbettsauthor=E.+C.+Busbyauthor=A.+P.+Kennedyauthor=D.+E.+Hillauthor=R.+T.+Abraham&title=Inhibition+of+phosphoinositide+3-kinase+related+kinases+by+the+radiosensitizing+agent+wortmannin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DTibbetts%26aufirst%3DR.%2BS.%26aulast%3DBusby%26aufirst%3DE.%2BC.%26aulast%3DKennedy%26aufirst%3DA.%2BP.%26aulast%3DHill%26aufirst%3DD.%2BE.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DInhibition%2520of%2520phosphoinositide%25203-kinase%2520related%2520kinases%2520by%2520the%2520radiosensitizing%2520agent%2520wortmannin%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D4375%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaper, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span> </span><span class="NLM_article-title">Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">9152</span><span class="NLM_x">–</span> <span class="NLM_lpage">9159</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-2727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1158%2F0008-5472.CAN-04-2727" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=9152-9159&author=I.+Hicksonauthor=Y.+Zhaoauthor=C.+J.+Richardsonauthor=S.+J.+Greenauthor=N.+M.+B.+Martinauthor=A.+I.+Orrauthor=P.+M.+Reaperauthor=S.+P.+Jacksonauthor=N.+J.+Curtinauthor=G.+C.+M.+Smith&title=Identification+and+characterization+of+a+novel+and+specific+inhibitor+of+the+ataxia-telangiectasia+mutated+kinase+ATM&doi=10.1158%2F0008-5472.CAN-04-2727"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-2727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-2727%26sid%3Dliteratum%253Aachs%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DGreen%26aufirst%3DS.%2BJ.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DOrr%26aufirst%3DA.%2BI.%26aulast%3DReaper%26aufirst%3DP.%2BM.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520novel%2520and%2520specific%2520inhibitor%2520of%2520the%2520ataxia-telangiectasia%2520mutated%2520kinase%2520ATM%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D9152%26epage%3D9159%26doi%3D10.1158%2F0008-5472.CAN-04-2727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Golding, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valerie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussaini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigoreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Povirk, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valerie, K.</span><span> </span><span class="NLM_article-title">Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2894</span><span class="NLM_x">–</span> <span class="NLM_lpage">2902</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1158%2F1535-7163.MCT-09-0519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=19808981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2894-2902&author=S.+E.+Goldingauthor=E.+Rosenbergauthor=N.+Valerieauthor=I.+Hussainiauthor=M.+Frigerioauthor=X.+F.+Cockcroftauthor=W.+Y.+Chongauthor=M.+Hummersoneauthor=L.+Rigoreauauthor=K.+A.+Menearauthor=M.+J.+O%E2%80%99Connorauthor=L.+F.+Povirkauthor=T.+van+Meterauthor=K.+Valerie&title=Improved+ATM+kinase+inhibitor+KU-60019+radiosensitizes+glioma+cells%2C+compromises+insulin%2C+AKT+and+ERK+prosurvival+signaling%2C+and+inhibits+migration+and+invasion&doi=10.1158%2F1535-7163.MCT-09-0519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion</span></div><div class="casAuthors">Golding, Sarah E.; Rosenberg, Elizabeth; Valerie, Nicholas; Hussaini, Isa; Frigerio, Mark; Cockcroft, Xiaoling F.; Chong, Wei Yee; Hummersone, Marc; Rigoreau, Laurent; Menear, Keith A.; O'Connor, Mark J.; Povirk, Lawrence F.; van Meter, Timothy; Valerie, Kristoffer</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2894-2902</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ataxia telangiectasia (A-T) mutated (ATM) is crit. for cell cycle checkpoints and DNA repair.  Thus, specific small mol. inhibitors targeting ATM could perhaps be developed into efficient radiosensitizers.  Recently, a specific inhibitor of the ATM kinase, KU-55933, was shown to radiosensitize human cancer cells.  Herein, we report on an improved analog of KU-55933 (KU-60019) with Ki and IC50 values half of those of KU-55933.  KU-60019 is 10-fold more effective than KU-55933 at blocking radiation-induced phosphorylation of key ATM targets in human glioma cells.  As expected, KU-60019 is a highly effective radiosensitizer of human glioma cells.  A-T fibroblasts were not radiosensitized by KU-60019, strongly suggesting that the ATM kinase is specifically targeted.  Furthermore, KU-60019 reduced basal S473 AKT phosphorylation, suggesting that the ATM kinase might regulate a protein phosphatase acting on AKT.  In line with this finding, the effect of KU-60019 on AKT phosphorylation was countered by low levels of okadaic acid, a phosphatase inhibitor, and A-T cells were impaired in S473 AKT phosphorylation in response to radiation and insulin and unresponsive to KU-60019.  We also show that KU-60019 inhibits glioma cell migration and invasion in vitro, suggesting that glioma growth and motility might be controlled by ATM via AKT.  Inhibitors of MEK and AKT did not further radiosensitize cells treated with KU-60019, supporting the idea that KU-60019 interferes with prosurvival signaling sep. from its radiosensitizing properties.  Altogether, KU-60019 inhibits the DNA damage response, reduces AKT phosphorylation and prosurvival signaling, inhibits migration and invasion, and effectively radiosensitizes human glioma cells. [Mol Cancer Ther 2009;8(10):2894-902].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXun9h1lvdbbVg90H21EOLACvtfcHk0ljTWo6oC6t1iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7F&md5=32fab13cdf80a5fcb520e358252c8764</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0519%26sid%3Dliteratum%253Aachs%26aulast%3DGolding%26aufirst%3DS.%2BE.%26aulast%3DRosenberg%26aufirst%3DE.%26aulast%3DValerie%26aufirst%3DN.%26aulast%3DHussaini%26aufirst%3DI.%26aulast%3DFrigerio%26aufirst%3DM.%26aulast%3DCockcroft%26aufirst%3DX.%2BF.%26aulast%3DChong%26aufirst%3DW.%2BY.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DRigoreau%26aufirst%3DL.%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BJ.%26aulast%3DPovirk%26aufirst%3DL.%2BF.%26aulast%3Dvan%2BMeter%26aufirst%3DT.%26aulast%3DValerie%26aufirst%3DK.%26atitle%3DImproved%2520ATM%2520kinase%2520inhibitor%2520KU-60019%2520radiosensitizes%2520glioma%2520cells%252C%2520compromises%2520insulin%252C%2520AKT%2520and%2520ERK%2520prosurvival%2520signaling%252C%2520and%2520inhibits%2520migration%2520and%2520invasion%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2894%26epage%3D2902%26doi%3D10.1158%2F1535-7163.MCT-09-0519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hollick, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigoreau, L. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano-Soumillac, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ord, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span> </span><span class="NLM_article-title">Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1958</span><span class="NLM_x">–</span> <span class="NLM_lpage">1972</span><span class="refDoi"> DOI: 10.1021/jm061121y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061121y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1958-1972&author=J.+J.+Hollickauthor=L.+J.+M.+Rigoreauauthor=C.+Cano-Soumillacauthor=X.+Cockcroftauthor=N.+J.+Curtinauthor=M.+Frigerioauthor=B.+T.+Goldingauthor=S.+Guiardauthor=I.+R.+Hardcastleauthor=I.+Hicksonauthor=M.+G.+Hummersoneauthor=K.+A.+Menearauthor=N.+M.+B.+Martinauthor=I.+Matthewsauthor=D.+R.+Newellauthor=R.+Ordauthor=C.+J.+Richardsonauthor=G.+C.+M.+Smithauthor=R.+J.+Griffin&title=Pyranone%2C+thiopyranone%2C+and+pyridone+inhibitors+of+phosphatidylinositol+3-kinase+related+kinases.+Structure-activity+relationships+for+DNA-dependent+protein+kinase+inhibition%2C+and+identification+of+the+first+potent+and+selective+inhibitor+of+the+ataxia+telangiectasia+mutated+kinase&doi=10.1021%2Fjm061121y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm061121y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061121y%26sid%3Dliteratum%253Aachs%26aulast%3DHollick%26aufirst%3DJ.%2BJ.%26aulast%3DRigoreau%26aufirst%3DL.%2BJ.%2BM.%26aulast%3DCano-Soumillac%26aufirst%3DC.%26aulast%3DCockcroft%26aufirst%3DX.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DFrigerio%26aufirst%3DM.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGuiard%26aufirst%3DS.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHummersone%26aufirst%3DM.%2BG.%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DMartin%26aufirst%3DN.%2BM.%2BB.%26aulast%3DMatthews%26aufirst%3DI.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DOrd%26aufirst%3DR.%26aulast%3DRichardson%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26atitle%3DPyranone%252C%2520thiopyranone%252C%2520and%2520pyridone%2520inhibitors%2520of%2520phosphatidylinositol%25203-kinase%2520related%2520kinases.%2520Structure-activity%2520relationships%2520for%2520DNA-dependent%2520protein%2520kinase%2520inhibition%252C%2520and%2520identification%2520of%2520the%2520first%2520potent%2520and%2520selective%2520inhibitor%2520of%2520the%2520ataxia%2520telangiectasia%2520mutated%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1958%26epage%3D1972%26doi%3D10.1021%2Fjm061121y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.-Q.</span><span> </span><span class="NLM_article-title">The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking AKT in cancer cells with overactivated AKT</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-1189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1158%2F1535-7163.MCT-08-1189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=20053781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=113-125&author=Y.+Liauthor=D.-Q.+Yang&title=The+ATM+inhibitor+KU-55933+suppresses+cell+proliferation+and+induces+apoptosis+by+blocking+AKT+in+cancer+cells+with+overactivated+AKT&doi=10.1158%2F1535-7163.MCT-08-1189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The ATM Inhibitor KU-55933 Suppresses Cell Proliferation and Induces Apoptosis by Blocking Akt In Cancer Cells with Overactivated Akt</span></div><div class="casAuthors">Li, Yan; Yang, Da-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-125</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant activation of Akt plays a pivotal role in cancer development.  ATM, a protein deficient in patients with ataxia-telangiectasia disease, is traditionally considered as a nuclear protein kinase that functions as a signal transducer in response to DNA damage.  It has recently been shown that ATM is also a cytoplasmic protein that mediates the full activation of Akt in response to insulin.  Our study shows that a specific ATM inhibitor, KU-55933, blocks the phosphorylation of Akt induced by insulin and insulin-like growth factor I in cancer cells that exhibit abnormal Akt activity.  Moreover, KU-55933 inhibits cancer cell proliferation by inducing G1 cell cycle arrest.  It does so through the downregulation of the synthesis of cyclin D1, a protein known to be elevated in a variety of tumors.  In addn., KU-55933 treatment during serum starvation triggers apoptosis in these cancer cells.  Our results suggest that KU-55933 may be a novel chemotherapeutic agent targeting cancer resistant to traditional chemotherapy or immunotherapy due to aberrant activation of Akt.  Furthermore, KU-55933 completely abrogates rapamycin-induced feedback activation of Akt.  Combination of KU-55933 and rapamycin not only induces apoptosis, which is not seen in cancer cells treated only with rapamycin, but also shows better efficacy in inhibiting cancer cell proliferation than each drug alone.  Therefore, combining KU-55933 with rapamycin may provide a highly effective approach for improving mammalian target of rapamycin-targeted anticancer therapy that is currently hindered by rapamycin-induced feedback activation of Akt.  Mol Cancer Ther; 9(1); 113-25.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDofd5EPrPDLVg90H21EOLACvtfcHk0ljTWo6oC6t1iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVOjuw%253D%253D&md5=0fc2e60dc9332fcda9c10cdef3a75ad8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1189%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DD.-Q.%26atitle%3DThe%2520ATM%2520inhibitor%2520KU-55933%2520suppresses%2520cell%2520proliferation%2520and%2520induces%2520apoptosis%2520by%2520blocking%2520AKT%2520in%2520cancer%2520cells%2520with%2520overactivated%2520AKT%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D113%26epage%3D125%26doi%3D10.1158%2F1535-7163.MCT-08-1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mukherjee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomimatsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amancherla, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camacho, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichamoorthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burma, S.</span><span> </span><span class="NLM_article-title">The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1593/neo.111512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1593%2Fneo.111512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=34-43&author=B.+Mukherjeeauthor=N.+Tomimatsuauthor=K.+Amancherlaauthor=C.+V.+Camachoauthor=N.+Pichamoorthyauthor=S.+Burma&title=The+dual+PI3K%2FmTOR+inhibitor+NVP-BEZ235+is+a+potent+inhibitor+of+ATM-+and+DNA-PKCs-mediated+DNA+damage+responses&doi=10.1593%2Fneo.111512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1593%2Fneo.111512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.111512%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DTomimatsu%26aufirst%3DN.%26aulast%3DAmancherla%26aufirst%3DK.%26aulast%3DCamacho%26aufirst%3DC.%2BV.%26aulast%3DPichamoorthy%26aufirst%3DN.%26aulast%3DBurma%26aufirst%3DS.%26atitle%3DThe%2520dual%2520PI3K%252FmTOR%2520inhibitor%2520NVP-BEZ235%2520is%2520a%2520potent%2520inhibitor%2520of%2520ATM-%2520and%2520DNA-PKCs-mediated%2520DNA%2520damage%2520responses%26jtitle%3DNeoplasia%26date%3D2012%26volume%3D14%26spage%3D34%26epage%3D43%26doi%3D10.1593%2Fneo.111512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Guo, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastan, M. B.</span><span> </span><span class="NLM_article-title">Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1177/1087057113520325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1177%2F1087057113520325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=24464432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslWgs73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=538-546&author=K.+X.+Guoauthor=A.+A.+Shelatauthor=R.+K.+Guyauthor=M.+B.+Kastan&title=Development+of+a+cell-based%2C+high-throughput+screening+assay+for+ATM+kinase+inhibitors&doi=10.1177%2F1087057113520325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors</span></div><div class="casAuthors">Guo, Kexiao; Shelat, Anang A.; Guy, R. Kiplin; Kastan, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">538-546, 9</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The ATM (ataxia-telangiectasia, mutated) protein kinase is a major regulator of cellular responses to DNA double-strand breaks (DSBs), DNA lesions that can be caused by ionizing irradn. (IR), oxidative damage, or exposure to certain chem. agents.  In response to DSBs, the ATM kinase is activated and subsequently phosphorylates numerous downstream substrates, including p53, Chk2, BRCA1, and KAP1, which affect processes such as cell cycle progression and DNA repair.  Numerous studies have demonstrated that loss of ATM function results in enhanced sensitivity to ionizing irradn. in clin. relevant dose ranges, suggesting that ATM kinase is an attractive therapeutic target for enhancing tumor cell kill with radiotherapy.  Previously identified small-mol. ATM kinase inhibitors, such as CP466722 and Ku55933, were identified using in vitro kinase assays carried out with recombinant ATM kinase isolated from mammalian cells.  Since it has not been feasible to express full-length recombinant ATM in bacterial or baculovirus systems, a robust in vitro screening tool has been lacking.  We have developed a cell-based assay that is robust, straightforward, and sensitive.  Using this highthroughput assay, we screened more than 7000 compds. and discovered addnl. small mols. that inhibit the ATM kinase and further validated these hits by secondary assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRWwxDBJCPwrVg90H21EOLACvtfcHk0lhVUlgq4CkCgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslWgs73F&md5=ecb063a8f1f78c619ae6d285725245f8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1177%2F1087057113520325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057113520325%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DK.%2BX.%26aulast%3DShelat%26aufirst%3DA.%2BA.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26aulast%3DKastan%26aufirst%3DM.%2BB.%26atitle%3DDevelopment%2520of%2520a%2520cell-based%252C%2520high-throughput%2520screening%2520assay%2520for%2520ATM%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2014%26volume%3D19%26spage%3D538%26epage%3D546%26doi%3D10.1177%2F1087057113520325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: unusually steep structure-activity relationship for analogs of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1021/jm9503613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9503613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=267-76&author=A.+J.+Bridgesauthor=H.+Zhouauthor=D.+R.+Codyauthor=G.+W.+Rewcastleauthor=A.+McMichaelauthor=H.+D.+H.+Showalterauthor=D.+W.+Fryauthor=A.+J.+Krakerauthor=W.+A.+Denny&title=Tyrosine+kinase+inhibitors%3A+unusually+steep+structure-activity+relationship+for+analogs+of+4-%283-bromoanilino%29-6%2C7-dimethoxyquinazoline+%28PD+153035%29%2C+a+potent+inhibitor+of+the+epidermal+growth+factor+receptor&doi=10.1021%2Fjm9503613"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9503613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9503613%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520unusually%2520steep%2520structure-activity%2520relationship%2520for%2520analogs%2520of%25204-%25283-bromoanilino%2529-6%252C7-dimethoxyquinazoline%2520%2528PD%2520153035%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D267%26epage%3D76%26doi%3D10.1021%2Fjm9503613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, E. S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J.-J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span> </span><span class="NLM_article-title">Lambert-van, d. B. C. Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5369</span><span class="NLM_x">–</span> <span class="NLM_lpage">5389</span><span class="refDoi"> DOI: 10.1021/jm990345w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990345w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5369-5389&author=L.+F.+Hennequinauthor=A.+P.+Thomasauthor=C.+Johnstoneauthor=E.+S.+E.+Stokesauthor=P.+A.+Pleauthor=J.-J.+M.+Lohmannauthor=D.+J.+Ogilvieauthor=M.+Dukesauthor=S.+R.+Wedgeauthor=J.+O.+Curwenauthor=J.+Kendrewauthor=C.+Lambert-van+der+Brempt&title=Lambert-van%2C+d.+B.+C.+Design+and+structure-activity+relationship+of+a+new+class+of+potent+VEGF+receptor+tyrosine+kinase+inhibitors&doi=10.1021%2Fjm990345w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm990345w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990345w%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DThomas%26aufirst%3DA.%2BP.%26aulast%3DJohnstone%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DE.%2BS.%2BE.%26aulast%3DPle%26aufirst%3DP.%2BA.%26aulast%3DLohmann%26aufirst%3DJ.-J.%2BM.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26atitle%3DLambert-van%252C%2520d.%2520B.%2520C.%2520Design%2520and%2520structure-activity%2520relationship%2520of%2520a%2520new%2520class%2520of%2520potent%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5369%26epage%3D5389%26doi%3D10.1021%2Fjm990345w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Matsuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushiki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomoto, Y.</span><span> </span><span class="NLM_article-title">Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-Substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4910</span><span class="NLM_x">–</span> <span class="NLM_lpage">4925</span><span class="refDoi"> DOI: 10.1021/jm020505v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020505v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4910-4925&author=K.+Matsunoauthor=J.+Ushikiauthor=T.+Seishiauthor=M.+Ichimuraauthor=N.+A.+Gieseauthor=J.-C.+Yuauthor=S.+Takahashiauthor=S.+Odaauthor=Y.+Nomoto&title=Potent+and+selective+inhibitors+of+platelet-derived+growth+factor+receptor+phosphorylation.+3.+Replacement+of+quinazoline+moiety+and+improvement+of+metabolic+polymorphism+of+4-%5B4-%28N-Substituted+%28thio%29carbamoyl%29-1-piperazinyl%5D-6%2C7-dimethoxyquinazoline+derivatives&doi=10.1021%2Fjm020505v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm020505v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020505v%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuno%26aufirst%3DK.%26aulast%3DUshiki%26aufirst%3DJ.%26aulast%3DSeishi%26aufirst%3DT.%26aulast%3DIchimura%26aufirst%3DM.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26aulast%3DYu%26aufirst%3DJ.-C.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DOda%26aufirst%3DS.%26aulast%3DNomoto%26aufirst%3DY.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520platelet-derived%2520growth%2520factor%2520receptor%2520phosphorylation.%25203.%2520Replacement%2520of%2520quinazoline%2520moiety%2520and%2520improvement%2520of%2520metabolic%2520polymorphism%2520of%25204-%255B4-%2528N-Substituted%2520%2528thio%2529carbamoyl%2529-1-piperazinyl%255D-6%252C7-dimethoxyquinazoline%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4910%26epage%3D4925%26doi%3D10.1021%2Fjm020505v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lemoff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span> </span><span class="NLM_article-title">Dual detection approach to a more accurate measure of relative purity in high-throughput characterization of compound collections</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span><span class="refDoi"> DOI: 10.1021/cc800100g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc800100g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpslent7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=746-751&author=A.+Lemoffauthor=B.+Yan&title=Dual+detection+approach+to+a+more+accurate+measure+of+relative+purity+in+high-throughput+characterization+of+compound+collections&doi=10.1021%2Fcc800100g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dual detection approach to a more accurate measure of relative purity in high-throughput characterization of compound collections</span></div><div class="casAuthors">Lemoff, Andrew; Yan, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">746-751</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The accurate detn. of compd. purity is crucial for characterizing library purity, monitoring the stability of storage compds., and obtaining meaningful high-throughput screening results.  However, current high-throughput techniques for the detn. of compd. purity are inadequate.  The authors evaluated online chromatog. detectors, including UVTWC, UV214, and ELSD detectors, in studies of 233 compd. mixts. prepd. with known compns.  Both UVTWC and UV214 overestimate the minor component in a mixt. whereas ELSD underestimates the minor component.  An av. of UVTWC and ELSD purities gives a more accurate measure of the relative purity for a wide range of compds. in various purity ranges.  This technique was applied to 959 compds. from the authors' compd. collection to more accurately det. their relative purity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl9HA2KAiorLVg90H21EOLACvtfcHk0lhj4Mv-wpVJbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpslent7w%253D&md5=143cb2670feafb27f0dea15e262b1006</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcc800100g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc800100g%26sid%3Dliteratum%253Aachs%26aulast%3DLemoff%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DB.%26atitle%3DDual%2520detection%2520approach%2520to%2520a%2520more%2520accurate%2520measure%2520of%2520relative%2520purity%2520in%2520high-throughput%2520characterization%2520of%2520compound%2520collections%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2008%26volume%3D10%26spage%3D746%26epage%3D751%26doi%3D10.1021%2Fcc800100g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushby, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson-Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herron, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaisland, H. C.</span><span> </span><span class="NLM_article-title">Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span><span class="refDoi"> DOI: 10.1080/00498250400009171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1080%2F00498250400009171" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=917-934&author=D.+McKillopauthor=M.+Hutchisonauthor=E.+A.+Partridgeauthor=N.+Bushbyauthor=C.+M.+F.+Cooperauthor=J.+A.+Clarkson-Jonesauthor=W.+Herronauthor=H.+C.+Swaisland&title=Metabolic+disposition+of+gefitinib%2C+an+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+in+rat%2C+dog+and+man&doi=10.1080%2F00498250400009171"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F00498250400009171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250400009171%26sid%3Dliteratum%253Aachs%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DHutchison%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DE.%2BA.%26aulast%3DBushby%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DC.%2BM.%2BF.%26aulast%3DClarkson-Jones%26aufirst%3DJ.%2BA.%26aulast%3DHerron%26aufirst%3DW.%26aulast%3DSwaisland%26aufirst%3DH.%2BC.%26atitle%3DMetabolic%2520disposition%2520of%2520gefitinib%252C%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520rat%252C%2520dog%2520and%2520man%26jtitle%3DXenobiotica%26date%3D2004%26volume%3D34%26spage%3D917%26epage%3D934%26doi%3D10.1080%2F00498250400009171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhead, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardsley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaisland, H. C.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1080/00498250400009189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1080%2F00498250400009189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=901-915&author=D.+McKillopauthor=E.+A.+Partridgeauthor=M.+Hutchisonauthor=S.+A.+Rheadauthor=A.+C.+Parryauthor=J.+Bardsleyauthor=H.+M.+Woodmanauthor=H.+C.+Swaisland&title=Pharmacokinetics+of+gefitinib%2C+an+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+in+rat+and+dog&doi=10.1080%2F00498250400009189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F00498250400009189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250400009189%26sid%3Dliteratum%253Aachs%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DPartridge%26aufirst%3DE.%2BA.%26aulast%3DHutchison%26aufirst%3DM.%26aulast%3DRhead%26aufirst%3DS.%2BA.%26aulast%3DParry%26aufirst%3DA.%2BC.%26aulast%3DBardsley%26aufirst%3DJ.%26aulast%3DWoodman%26aufirst%3DH.%2BM.%26aulast%3DSwaisland%26aufirst%3DH.%2BC.%26atitle%3DPharmacokinetics%2520of%2520gefitinib%252C%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520rat%2520and%2520dog%26jtitle%3DXenobiotica%26date%3D2004%26volume%3D34%26spage%3D901%26epage%3D915%26doi%3D10.1080%2F00498250400009189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Leonard, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">JAKS and STATS: biological implications</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1146/annurev.immunol.16.1.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1146%2Fannurev.immunol.16.1.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=9597132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADyaK1cXislygurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=293-322&author=W.+J.+Leonardauthor=J.+J.+O%E2%80%99Shea&title=JAKS+and+STATS%3A+biological+implications&doi=10.1146%2Fannurev.immunol.16.1.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">JAKS and STATS: Biological implications</span></div><div class="casAuthors">Leonard, Warren J.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">293-322</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 185 refs.  Cytokines and interferons are mols. that play central roles in the regulation of a wide array of cellular functions in the lympho-hematopoietic system.  These factors stimulate proliferation, differentiation, and survival signals, as well as specialized functions in host resistance to pathogens.  Although cytokines are known to activate multiple signaling pathways that together mediate these important functions, one of these pathways, the Jak-STAT pathway, is the focus of this chapter.  This pathway is triggered by both cytokines and interferons, and it very rapidly allows the transduction of an extracellular signal into the nucleus.  The pathway uses a novel mechanism in which cytosolic latent transcription factors, known as signal transducers and activators of transcription (STATs), are tyrosine phosphorylated by Janus family tyrosine kinases (Jaks), allowing STAT protein dimerization and nuclear translocation.  STATs then can modulate the expression of target genes.  The basic biol. of this system, including the range of known Jaks and STATs, is discussed, as are the defects in animals and human lacking some of these signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrO-nJd5D_LVg90H21EOLACvtfcHk0lguwK479D-4LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislygurs%253D&md5=ac5eeeb0159c2c8769e2cb28720cdf98</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.16.1.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.16.1.293%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAKS%2520and%2520STATS%253A%2520biological%2520implications%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1998%26volume%3D16%26spage%3D293%26epage%3D322%26doi%3D10.1146%2Fannurev.immunol.16.1.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00754.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling&doi=10.1111%2Fj.1600-065X.2008.00754.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lguwK479D-4LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D273%26epage%3D287%26doi%3D10.1111%2Fj.1600-065X.2008.00754.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Li, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. Y.</span><span> </span><span class="NLM_article-title">Assignment of NEK6, a NIMA-related gene, to human chromosome 9q33.3 -> q34.11 by radiation hybrid mapping</span> <span class="citation_source-journal">Cytogenet. Genome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1159/000015445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1159%2F000015445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1999&pages=271-272&author=M.+Z.+Liauthor=L.+Yuauthor=Q.+Liuauthor=J.+Y.+Chuauthor=S.+Y.+Zhao&title=Assignment+of+NEK6%2C+a+NIMA-related+gene%2C+to+human+chromosome+9q33.3+-%3E+q34.11+by+radiation+hybrid+mapping&doi=10.1159%2F000015445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1159%2F000015445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000015445%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%2BZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DChu%26aufirst%3DJ.%2BY.%26aulast%3DZhao%26aufirst%3DS.%2BY.%26atitle%3DAssignment%2520of%2520NEK6%252C%2520a%2520NIMA-related%2520gene%252C%2520to%2520human%2520chromosome%25209q33.3%2520-%253E%2520q34.11%2520by%2520radiation%2520hybrid%2520mapping%26jtitle%3DCytogenet.%2520Genome%2520Res.%26date%3D1999%26volume%3D87%26spage%3D271%26epage%3D272%26doi%3D10.1159%2F000015445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kandli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feige, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilfin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motro, B.</span><span> </span><span class="NLM_article-title">Isolation and characterization of two evolutionarily conserved murine kinases (NEK6 and NEK7) related to the fungal mitotic regulator, NIMA</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1006/geno.2000.6293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1006%2Fgeno.2000.6293" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=187-196&author=M.+Kandliauthor=E.+Feigeauthor=A.+Chenauthor=G.+Kilfinauthor=B.+Motro&title=Isolation+and+characterization+of+two+evolutionarily+conserved+murine+kinases+%28NEK6+and+NEK7%29+related+to+the+fungal+mitotic+regulator%2C+NIMA&doi=10.1006%2Fgeno.2000.6293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fgeno.2000.6293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.2000.6293%26sid%3Dliteratum%253Aachs%26aulast%3DKandli%26aufirst%3DM.%26aulast%3DFeige%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DKilfin%26aufirst%3DG.%26aulast%3DMotro%26aufirst%3DB.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520two%2520evolutionarily%2520conserved%2520murine%2520kinases%2520%2528NEK6%2520and%2520NEK7%2529%2520related%2520to%2520the%2520fungal%2520mitotic%2520regulator%252C%2520NIMA%26jtitle%3DGenomics%26date%3D2000%26volume%3D68%26spage%3D187%26epage%3D196%26doi%3D10.1006%2Fgeno.2000.6293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Toulany, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihatsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaachouay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodemann, H. P.</span><span> </span><span class="NLM_article-title">Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition</span> <span class="citation_source-journal">Radiother. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">228</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span><span class="refDoi"> DOI: 10.1016/j.radonc.2014.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=10.1016%2Fj.radonc.2014.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=24857596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslCmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=228-36&author=M.+Toulanyauthor=J.+Mihatschauthor=M.+Hollerauthor=H.+Chaachouayauthor=H.+P.+Rodemann&title=Cisplatin-mediated+radiosensitization+of+non-small+cell+lung+cancer+cells+is+stimulated+by+ATM+inhibition&doi=10.1016%2Fj.radonc.2014.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition</span></div><div class="casAuthors">Toulany, Mahmoud; Mihatsch, Julia; Holler, Marina; Chaachouay, Hassan; Rodemann, H. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Radiotherapy and Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">228-236</span>CODEN:
                <span class="NLM_cas:coden">RAONDT</span>;
        ISSN:<span class="NLM_cas:issn">0167-8140</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Cisplatin activates ataxia-telangiectasia-mutated (ATM), a protein with roles in DNA repair, cell cycle progression and autophagy.  We investigated the radiosensitizing effect of cisplatin with respect to its effect on ATM pathway activation.  Non-small cell lung cancer cells (NSCLC) cell lines (A549, H460) and human fibroblast (ATM-deficient AT5, ATM-proficient 1BR3) cells were used.  The effects of cisplatin combined with irradn. on ATM pathway activity, clonogenicity, DNA double-strand break (DNA-DSB) repair and cell cycle progression were analyzed with Western blotting, colony formation and γ-H2AX foci assays as well as FACS anal., resp.  Cisplatin radiosensitized H460 cells, but not A549 cells.  Radiosensitization of H460 cells was not due to impaired DNA-DSB repair, increased apoptosis or cell cycle dysregulation.  The lack of radiosensitization demonstrated for A549 cells was assocd. with cisplatin-mediated stimulation of ATM (S1981) and AMPKα (T172) phosphorylation and autophagy.  However, in both cell lines inhibition of ATM and autophagy by KU-55933 and chloroquine diphosphate (CQ) resp. resulted in a significant radiosensitization.  Combined treatment with the AMPK inhibitor compd.-C led to radiosensitization of A549 but not of H460 cells.  As compared to the treatment with KU-55933 alone, radiosensitivity of A549 cells was markedly stimulated by the combination of KU-55933 and cisplatin.  However, the combination of CQ and cisplatin did not modulate the pattern of radiation sensitivity of A549 or H460 cells.  In accordance with the results that cisplatin via stimulation of ATM activity can abrogate its radiosensitizing effect, ATM deficient cells were significantly sensitized to ionizing radiation by cisplatin.  The results obtained indicate that ATM targeting can potentiate cisplatin-induced radiosensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUEfpCM_nObVg90H21EOLACvtfcHk0lhbl9BX63LOKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslCmtro%253D&md5=1e3cb17ab9441176ecc5bd70f58200f3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.radonc.2014.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.radonc.2014.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DToulany%26aufirst%3DM.%26aulast%3DMihatsch%26aufirst%3DJ.%26aulast%3DHoller%26aufirst%3DM.%26aulast%3DChaachouay%26aufirst%3DH.%26aulast%3DRodemann%26aufirst%3DH.%2BP.%26atitle%3DCisplatin-mediated%2520radiosensitization%2520of%2520non-small%2520cell%2520lung%2520cancer%2520cells%2520is%2520stimulated%2520by%2520ATM%2520inhibition%26jtitle%3DRadiother.%2520Oncol.%26date%3D2014%26volume%3D111%26spage%3D228%26epage%3D36%26doi%3D10.1016%2Fj.radonc.2014.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i101"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01092">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_46337"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01092">10.1021/acs.jmedchem.5b01092</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures for early ADMET and MTD study; permeability data for all compounds; in vivo PK and metabolic identification data for compound <b>4</b>; synthetic scheme for <b>19</b>, <b>20</b>, and linker intermediates for <b>27m</b>–<b>o</b> and <b>27i</b>; cytotoxicity data against HepG2, HEK293, and Raji cell lines for all compounds; kinome scan analysis for compounds <b>4</b> and <b>27g</b>; <i>K</i><sub>d</sub>’s of compound <b>27g</b> for selected kinases; western blot analysis for the effect of compounds <b>1</b>, <b>4</b>, and <b>20</b>; liver microsome stability data for compounds <b>4</b>, <b>20</b>, and <b>27g</b>; complete blood count data, blood chemistry panel, and pathological review of tissues for compounds <b>20</b> and <b>27g</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES strings and ATM inhibition IC<sub>50</sub>, solubility, and BJ EC<sub>50</sub> data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_001.pdf">jm5b01092_si_001.pdf (1.12 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01092/suppl_file/jm5b01092_si_002.csv">jm5b01092_si_002.csv (5.88 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01092&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-2%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01092%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01092" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6679802f6efcd1df","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
